Microbiology and Molecular Biology Reviews, September 1998, p. 547-585, Vol. 62, No. 3
Lehrstuhl für Mikrobiologie,
Universität München, D-80638 Munich, Germany
1092-2172/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Molecular Regulation of
-Lactam Biosynthesis in
Filamentous Fungi
SUMMARY
INTRODUCTION
GENERAL ASPECTS OF
-LACTAM COMPOUNDS
BIOSYNTHESIS OF PENICILLINS AND CEPHALOSPORINS: AN OUTLINE
GENETIC NOMENCLATURE
CLUSTERING OF BIOSYNTHESIS GENES
STRUCTURAL GENES AND DEDUCED PROTEINS
Genes Common to Penicillin- and Cephalosporin-Producing
Fungi
acvA (pcbAB), encoding ACVS.
ipnA (pcbC), encoding IPNS.
Gene Specific for Penicillin Biosynthesis
aatA (penDE), encoding IAT.
Genes Specific for Cephalosporin Biosynthesis
cefD, encoding IPN epimerase.
cefEF, encoding DAOC synthetase (ring
expandase)/DAC hydroxylase.
Gene Specific for Cephalosporin C Biosynthesis in Fungi
cefG, encoding acetyl-CoA:DAC
acetyltransferase.
COMPARTMENTALIZATION OF GENE PRODUCTS
ORIGIN OF
-LACTAM BIOSYNTHESIS GENES IN
FUNGI
REGULATORY CIRCUITS AND REGULATORY GENES
Expression of Biosynthesis Genes under Standard
Fermentation Conditions
Promoter Structures of the A. nidulans
Genes acvA and ipnA
Carbon Source Regulation
pH Regulation Mediated by the Transcriptional Factor
PACC
Nitrogen Regulation
Amino Acids as Precursors and Mediators of Regulation
Influence of Phosphate and Oxygen
The CCAAT Box Binding Protein Complex PENR1
trans-Acting Mutations Affecting the Expression
of Penicillin Biosynthesis Genes
Posttranscriptional Regulation
REGULATION OF
-LACTAM BIOSYNTHESIS IN FUNGAL
PRODUCTION STRAINS
APPLICATIONS
Increase of Expression of
-Lactam Biosynthesis Genes
Genetic Engineering of
-Lactam Biosynthetic Pathways
Generation of Novel Compounds by Genetic Engineering
of Peptide Synthetases
CONCLUSIONS AND FUTURE DIRECTIONS
ACKNOWLEDGMENTS
REFERENCES
SUMMARY
|
|
|---|
The most commonly used
-lactam antibiotics for the therapy of infectious diseases are penicillin and cephalosporin. Penicillin is produced as an end product by some fungi, most notably by Aspergillus (Emericella) nidulans and Penicillium chrysogenum. Cephalosporins are synthesized by both bacteria and fungi, e.g., by the fungus Acremonium chrysogenum (Cephalosporium acremonium). The biosynthetic pathways leading to both secondary metabolites start from the same three amino acid precursors and have the first two enzymatic reactions in common. Penicillin biosynthesis is catalyzed by three enzymes encoded by acvA (pcbAB), ipnA (pcbC), and aatA (penDE). The genes are organized into a cluster. In A. chrysogenum, in addition to acvA and ipnA, a second cluster contains the genes encoding enzymes that catalyze the reactions of the later steps of the cephalosporin pathway (cefEF and cefG). Within the last few years, several studies have indicated that the fungal
-lactam biosynthesis genes are controlled by a complex regulatory network, e.g., by the ambient pH, carbon source, and amino acids. A comparison with the regulatory mechanisms (regulatory proteins and DNA elements) involved in the regulation of genes of primary metabolism in lower eukaryotes is thus of great interest. This has already led to the elucidation of new regulatory mechanisms. Furthermore, such investigations have contributed to the elucidation of signals leading to the production of
-lactams and their physiological meaning for the producing fungi, and they can be expected to have a major impact on rational strain improvement programs. The knowledge of biosynthesis genes has already been used to produce new compounds.
INTRODUCTION
|
|
|---|
The discovery of antibiotics
for clinical use started with the discovery of the efficacy of a
-lactam compound and is perhaps the most important discovery in the
history of therapeutic medicine. The application of antibiotics to the
therapy of infectious diseases may conceivably have saved more lives
than any other medical development (135). It began in 1929, when Alexander Fleming published his observation about the inhibition
of growth of Staphylococcus aureus on an agar plate
contaminated with Penicillium notatum (117). Three years later, it was shown that the growth inhibition was due to
penicillin (71). The first clinical trials with penicillin were undertaken in 1941 (reviewed in reference 2).
In parallel with efforts to provide penicillin in large amounts, its
structure was elucidated in 1945, when Hodgkin and Low showed by X-ray
crystallography analysis that it is composed of a
-lactam structure
(reviewed in reference 1).
During the late 1940s, the fungus Cephalosporium acremonium
(now renamed Acremonium chrysogenum) was isolated from the
sea at Cagliari, Italy, by Guiseppi Brotzu (51). This fungus
was first found to produce penicillin N; later, another antibiotic was
discovered in the culture broth, which was found to consist of
different derivatives of a
-lactam compound designated cephalosporin (reviewed in reference 2). The structure of
cephalosporin C was described in 1961 by Abraham and Newton
(3) and confirmed by X-ray crystallography analysis
(141). The discovery of cephalosporin C generated a whole
new group of clinically significant
-lactams.
The success of
-lactams in the treatment of infectious disease is
due to their high specificity and their low toxicity. Despite a growing
number of antibiotics and the incidence of penicillin-resistant isolates,
-lactams are still by far the most frequently used antibiotics (299).
However, it is only in the past 20 years that the biosynthetic pathways
leading to penicillins (penams) and cephalosporins (ceph-3-ems) have
been elucidated. This is partly because biosynthetic enzymes are often
unstable and are present in the cell in only small amounts, making
their purification difficult. In addition, industrial production of
penicillin and cephalosporin was achieved with P. chrysogenum and A. chrysogenum, respectively. These
fungi, however, belong to the deuteromycetes, which are in general
difficult to analyze genetically. Currently, the greatest progress in
elucidation of the molecular regulation of biosyntheses of
-lactams
in fungi has been made in the penicillin producer
Aspergillus (Emericella) nidulans,
since this fungus is an ascomycete with a sexual cycle. Therefore,
classical genetic techniques can be applied to A. nidulans (262) and hence a detailed genetic map is available
(70). Together with molecular techniques, this facilitated a
thorough analysis of the genetic regulation of metabolic pathways,
including that of penicillin biosynthesis (reviewed in references
20, 49, and 204).
Since the biochemistry of penicillin and cephalosporin biosynthesis is
rather well understood and recombinant techniques have been developed
for some filamentous fungi, recent research has aimed at elucidating
the molecular regulation of
-lactam biosynthesis. Within the last
few years, several studies have indicated that the
-lactam
biosynthesis genes are controlled by a complex regulatory network. A
comparison with known regulatory proteins and DNA elements of
eukaryotes involved in the regulation of genes of primary metabolism is
thus of great interest. Such investigations might also provide hints
about both the evolution of secondary metabolism and the signals
leading to the production of
-lactams. Furthermore, the overexpression of regulatory genes will lead to higher yields of
-lactams in the respective production strains and knowledge of
biosynthesis genes will allow the production of new compounds by
combinatorial biology.
The biosynthesis of
-lactam compounds and their molecular genetics
were the subject of several recent reviews (8, 45, 49, 152, 211,
299). In particular, the regulation of
-lactam biosynthesis in
fungi has seen a tremendous increase in knowledge within the last
years, and it is this aspect which is considered in most of the present
review.
GENERAL ASPECTS OF
-LACTAM COMPOUNDS
|
|
|---|
-Lactams can be classified into five groups on the basis of
their chemical structures (Fig. 1). All
of these compounds have in common the four-membered
-lactam ring.
Apart from the monolactams, which have a single ring only,
-lactams
consist of a bicyclic ring system. The ability to synthesize
-lactams is widespread in nature. It has been found in some fungi
but also in some gram-positive and gram-negative bacteria (Fig. 1).
However, although organisms belonging to all three groups can
synthesize the hydrophilic cephalosporin compounds (ceph-3-ems), the
hydrophobic penicillins are produced as end products only by
filamentous fungi (Fig. 1). For the remaining groups of
-lactams
listed in Fig. 1, only bacterial producers have been reported so far.
The number of prokaryotic and eukaryotic microorganisms recognized as
being able to synthesize
-lactam antibiotics is continuously
increasing (152).
|
BIOSYNTHESIS OF PENICILLINS AND CEPHALOSPORINS: AN OUTLINE
|
|
|---|
To give a brief overview of the complete biosynthetic pathways, references for fungal enzymes and genes have been omitted in the text and are given in the tables and the following sections.
The biosyntheses of penicillins and cephalosporins have the first two
steps in common (Fig. 2). All naturally
occurring penicillins and cephalosporins are formed from the same three
amino acids: L-
-aminoadipic acid
(L-
-AAA), L-cysteine, and
L-valine. L-
-AAA is a nonproteinogenic amino
acid and is derived from the fungus-specific aminoadipate pathway which
leads to the formation of L-lysine. It can also be
provided, at least in A. nidulans and P. chrysogenum, by catabolic degradation of L-lysine,
although the contribution of this pathway to penicillin biosynthesis in
these fungi has not been clarified yet (see "Amino acids as
precursors and mediators of regulation," below).
|
In the first reaction cycle, the amino acid precursors are condensed to
the tripeptide
-(L-
-aminoadipyl)-L-cysteinyl-D-valine (ACV). All reactions which are required for the formation of this tripeptide, e.g., specific recognition of amino acids, their activation via the formation of aminoacyl adenylates, and formation of peptide bonds, are catalyzed by a single multifunctional enzyme designated according to the product formed, ACV synthetase (ACVS) (Fig. 2). ACVS
is encoded by a single structural gene designated acvA
(pcbAB) (Fig. 2; Table 1).
|
In the second step, oxidative ring closure of the linear
tripeptide leads to the formation of a bicyclic ring structure,
i.e., the four-membered
-lactam ring fused to the five-membered
thiazolidine ring, which is characteristic of all penicillins. The
resulting compound, isopenicillin N (IPN), possesses weak antibiotic
activity and is thus the first bioactive intermediate of both the
penicillin and cephalosporin pathways. This reaction is catalyzed by
isopenicillin N synthase (IPNS), encoded by the ipnA
(pcbC) gene (Table 2). IPN is
the branch point of the penicillin and cephalosporin biosyntheses.
|
In the third and final step of penicillin biosynthesis, the hydrophilic
L-
-AAA side chain of IPN is exchanged for a hydrophobic acyl group; the exchange is catalyzed by acyl coenzyme A
(CoA):isopenicillin N acyltransferase (IAT). The corresponding gene has
been designated aatA (penDE) (Table
3). In their natural habitats,
penicillins DF, F, and K, which contain hexenoic acid,
3-hexenoic
acid, and octenoic acid as side chains, respectively, are synthesized.
By supplying the cultivation medium with phenoxyacetic or phenylacetic acid, the synthesis can be directed mainly toward penicillin V or
penicillin G, respectively (Fig. 2, shown for penicillin G). The side
chain precursors must be activated before they become substrates for
the IAT. It is generally believed that the activated forms of the side
chains consist of their CoA thioesters, but the mechanism behind this
activation has still not been fully elucidated.
|
The first step that commits the pathway to the production of
cephalosporins is the isomerization of the L-
-AAA side
chain of IPN to the D enantiomer to give penicillin N. This
reaction is catalyzed by IPN epimerase (Fig. 2). Penicillin N is the
precursor of antibiotics containing the ceph-3-em nucleus, i.e.,
cephalosporins and cephamycins (7-methoxycephalosporins), produced by
fungi and bacteria, respectively (Fig. 1 and 2). Penicillin N is
converted to deacetoxycephalosporin C (DAOC) by DAOC synthetase
(expandase) activity (Fig. 2). This ring expansion step involves the
oxidative opening of the penam thiazolidine ring to give, upon ring
closure, the six-membered dihydrothiazine ring, which is characteristic of all ceph-3-ems. In the next step, the methyl group at C-3 of DAOC is
hydroxylated and oxidized to form deacetylcephalosporin C (DAC)
(Fig. 2). In A. chrysogenum, both reactions are catalyzed by
a single enzyme, DAOC synthetase (expandase)/DAC hydroxylase, encoded
by the cefEF gene, whereas in the bacterial cephalosporin producer Streptomyces clavuligerus, one enzyme has been
found for each reaction, encoded by the two genes cefE and
cefF (Table 4).
|
In the last step of cephalosporin C biosynthesis, which is best studied in the fungus A. chrysogenum, an acetyl moiety from acetyl-CoA is transferred to the -OH group of DAC; this step is catalyzed by the product of cefG, acetyl CoA:DAC acetyltransferase (Fig. 2; Table 5). Several cephalosporins that differ from cephalosporin C in the substituent attached to the 3' C oxygen have been isolated from a variety of microorganisms (152).
|
In addition, cephalosporins carrying a methoxy group at C-7 (7-methoxycephalosporin, or cephamycin) are produced by both S. clavuligerus (compound A-16884A [138]) and S. lipmanii (239, 265) (Fig. 2). The specific reactions leading to the formation of cephamycin C, which have been studied best in S. clavuligerus, start from the intermediate DAC (Fig. 2). A carbamoyl group is attached to DAC to give O-carbamoyl-DAC (OCDAC). This reaction is catalyzed by 3-hydroxymethyl ceph-3-em O-carbamoyltransferase, which is encoded by the cmcH gene (79) (Fig. 2). Then, C-7 is hydroxylated by the action of OCDAC hydroxylase, encoded by cmcI (343) (Fig. 2). In the final step of cephamycin biosynthesis, the hydroxy group at C-7 is methylated to form cephamycin C (7-methoxycephalosporin C); the reaction is catalyzed by cephamycin C synthetase, whose corresponding gene has been designated cmcJ (79).
GENETIC NOMENCLATURE
|
|
|---|
Before their identification, the putative genes encoding ACVS were
designated pcbA (penicillin cephalosporin biosynthesis) and
pcbB, because it was believed that two enzymes were involved in the formation of an
L-(
-aminoadipyl)-L-cysteine (AC) dipeptide and the final ACV tripeptide, respectively (Fig. 1) (reviewed in
references 147 and 245). Cloning
and sequencing of the corresponding gene revealed, however, that a
single polypeptide encoded by a single gene is responsible for the
formation of the ACV tripeptide. Publications reporting the DNA
sequence of the P. chrysogenum, A. nidulans, and
A. chrysogenum genes named the gene acvA, which reflected the involvement of one genetic locus in the synthesis of ACVS
(201, 203, 305, 307), or pcbAB, derived from the
combination of pcbA and pcbB (91,
130). In the following discussion, the term acvA is
used because it indicates that a single gene encodes ACVS. The same is
relevant for the gene encoding IAT, which has been named
penDE or aat. In this review, the gene is
designated aatA, reflecting both the correct genetic
nomenclature and the fact that one genetic locus encodes the enzyme.
The IPNS gene has been named ipnA. The alternative names are
shown in parentheses at the beginning of the relevant sections.
CLUSTERING OF BIOSYNTHESIS GENES
|
|
|---|
As far as we know, in bacteria and fungi all structural genes of
-lactam biosyntheses are clustered (Fig.
3). In fungi, first the penicillin
biosynthesis genes of both A. nidulans and P. chrysogenum are tightly clustered (201, 305). In the
following, in A. chrysogenum, two clusters containing the
cephalosporin biosynthesis genes have been identified (130, 131,
219, 220), whereas in cephamycin C-producing bacteria, the genes
are organized into a single cluster (Fig. 3).
|
The linkage of antibiotic biosynthesis genes is a well-known phenomenon
in many antibiotic-producing organisms. It has been speculated that
linkage occurred during evolution owing to an ecological selective
advantage (212). Seno and Baltz (294) suggested that coordinated regulation of antibiotic biosynthesis genes could be
achieved by organizing the genes into large operons controlled by a
single promoter. For example, genes of the actinorhodin biosynthetic pathway in Streptomyces coelicolor are clustered and
expressed in several polycistronic mRNAs (207). In
eukaryotic fungi, however,
-lactam biosynthesis genes are
transcribed separately and are expressed from different promoters
(reviewed in reference 49). Hence, in fungi, there
is no obvious need for clustering, and it thus seems more likely that
linkage reflects a common ancestral origin (see "Origin of
-lactam
biosynthesis genes in fungi"). However, there is no evidence that the
IAT gene (aatA) has a close relative in modern prokaryotes,
even though it is part of the cluster. This fact supports the
hypothesis that linkage might also confer an ecological advantage to
the eukaryotic fungi in their natural habitat, although the reason for
this is not yet understood.
STRUCTURAL GENES AND DEDUCED PROTEINS
|
|
|---|
Genes Common to Penicillin- and Cephalosporin-Producing Fungi
acvA (pcbAB), encoding ACVS. The first reaction of the cephalosporin and penicillin biosynthesis is the formation of the ACV tripeptide, which was first found in 1960 as an intracellular component of P. chrysogenum (16). All the reactions required for synthesis of the tripeptide are catalyzed by a single enzyme, ACVS, which is encoded by the acvA (pcbAB) gene (reviewed in reference 169) (Fig. 2; Table 1). Thus, the ACV tripeptide is formed via a nonribosomal enzyme thiotemplate mechanism from its amino acid precursors. This is similar in many aspects to the synthesis of other microbial peptides (reviewed in reference 169).
Early studies with cell-free systems of P. chrysogenum (185) and A. chrysogenum (30) demonstrated the existence of ACVS activity. It was suggested that two separate enzymes may be involved in the formation of ACV. However, based on the observation that less ACV is formed from the dipeptide AC and L-valine than from the free amino acids, Banko et al. (31) proposed that a single multifunctional enzyme may be responsible for ACV synthesis. This proposal was supported by the first isolation of an ACVS protein by van Liempt et al. (333), who purified ACVS of A. nidulans 118-fold. Their results suggested that ACVS consists of a single polypeptide chain. Since then, ACVS enzymes have been purified from different organisms, including S. clavuligerus (25, 26, 157), A. chrysogenum (25, 26, 345), and Nocardia lactamdurans (74). Attempts to purify ACVS from P. chrysogenum have thus far been unsuccessful because the enzyme seems to be rapidly degraded during chromatographic purification (7). Although not entirely clarified, it is believed that ACVS multienzymes are monomers with molecular masses of around 420 kDa and exhibit different catalytic activities, such as the specific recognition of the three amino acid precursors and their activation, peptide bond formation, isomerization of the L-valine moiety to the D form, and release of the peptide. As in ribosomal peptide biosynthesis, the carboxyl function of the amino acid is activated by the formation of a mixed anhydride with the
-phosphate of ATP,
resulting in the release of pyrophosphate (PPi). This has been used to develop assays based on amino acid-dependent exchange of
32P between PPi and ATP (333).
After activation of an amino acid, the aminoacyl adenylate formed is
cleaved by the action of an enzyme thiol, resulting in the formation of
a thioester bond between the enzyme (at an appropriate location on the
enzyme) and the amino acid and in the release of AMP. These
thioesterified amino acids play the same role as the tRNA-bound amino
acids in the ribosomal peptide biosynthesis. They are high-energy
intermediates, which are the targets for nucleophilic attack by the
amino group of a second amino acid, resulting in the formation of a
peptide bond. As in the ribosome, the nascent peptide grows from the
amino terminus to the carboxy terminus and the intermediate peptides
remain bound (as thioesters) to the enzyme (169). The
substrate specificity is less strict than in protein synthesis, since a
variety of tripeptide analogs are known (28).
By assuming three independent activation sites, the dissociation
constants for the S. clavuligerus ACVS have been estimated to be 1.25 and 1.5 mM for cysteine and ATP, respectively, and 2.4 and
0.25 mM for valine and ATP, respectively. No
L-
-AAA-dependent ATP-PPi exchange was
detected with the enzyme preparation used, although the amino acid
binding to the enzyme was dependent on ATP (292). The reason
for the lack of detection of L-
-AAA-dependent ATP-PPi exchange remains obscure, because fungal ACVS (from
both A. nidulans and A. chrysogenum) drove
radioactivity exchange that was dependent on all three amino acids
(292, 333). Dissociation constants for aminoacyl-tRNA
synthetases are much lower than those of S. clavuligerus
ACVS, usually below 100 µM for their respective amino acids (64,
150, 161). This may be a way of guaranteeing the supply of amino
acids to the primary metabolism and avoiding the depletion of vital
cellular components by secondary metabolism (292).
L-Valine is apparently epimerized to the D form
at the tripeptide stage, since no D-valine intermediate has
been detected (292).
Each ACVS is encoded by a single structural gene (designated
acvA) of more than 11 kb (Table 1). The clustering of
penicillin biosynthesis genes (Fig. 3) was first shown for A. nidulans (201, 305) and P. chrysogenum
(305). The identification of the gene cluster was based on
the assumption that biosynthesis genes for antibiotics are clustered,
and information had accumulated about ipnA genes from
several organisms. Hence, by cross-hybridization with ipnA
genes as the probe, the acvA genes from both organisms were
detected upstream from the ipnA genes, separated by about 1 kb (Fig. 3). In A. nidulans, the presence of an open reading frame (ORF) upstream of the ipnA gene was confirmed by
disruption of the upstream region, which led to a
non-penicillin-producing phenotype of the transformants (201,
305). Furthermore, MacCabe et al. (201) had purified
A. nidulans ACVS and used it to generate partial amino acid
sequence data, from which oligonucleotides were deduced and
synthesized. They were used for Southern analysis, which showed that
the ACVS-encoding gene is in fact upstream of the ipnA gene.
In addition, the molecular mapping data obtained predicted a size of
more than 11 kb for the acvA gene (201, 305). This was supported by MacCabe et al. (201), who first showed by Northern blot analysis that the acvA transcript is indeed
larger than 9.5 kb. This finding was confirmed by the sequencing of the acvA genes of A. nidulans (203),
P. chrysogenum (91, 307) and A. chrysogenum (130) and by a Northern blot analysis of
the P. chrysogenum acvA gene (91) (Table 1).
Subsequently, the corresponding acvA genes were also cloned
and sequenced from bacterial cephamycin producers such as S. clavuligerus (Fig. 3).
Even in fungi, the acvA genes form a single ORF, which does
not seem to be interrupted by introns, although this assumption has not
been proved yet by sequencing of the respective cDNAs. The properties
of genes and their deduced enzymes are summarized in Table 1. Fungal
acvA genes are divergently oriented with respect to the
ipnA genes (Fig. 3). The sizes of the intergenic regions between the genes vary slightly among the different fungi and are about
1 kb long (Fig. 3). In both A. nidulans and P. chrysogenum, the acvA mRNA starts within the intergenic
region between acvA and ipnA (Table 1; Fig. 3).
acvA expression is driven by a rather weak promoter that is
probably located entirely in the intergenic region between
acvA and ipnA (see "Expression of biosynthesis genes under standard fermentation conditions" below).
Amino acid sequences of ACVS proteins of all fungal and bacterial
species so far identified contain three homologous regions of about 600 amino acids. These contain repeated domains that have extensive amino
acid sequence similarities to each other, to the corresponding regions
of the ACVS protein of other fungi and bacteria, and to the repeated
domains identified for Bacillus brevis gramicidin S
synthetases 1 and 2 and tyrocidine synthetase I (169, 329).
Since all of these enzymes specifically recognize amino acids and form
adenylates, it is most likely that the respective adenylate-forming
domains (for the nomenclature of ACVS domains, see reference
169) recognize and adenylate one of the constituent amino acids. The order of the biosynthesis of the
-(L-
-AAA)-L-Cys-D-Val tripeptide is believed to reflect the linear organization of the ACVS
in AAA-, Cys- and Val-activating domains (reviewed in reference 169). A surprising result, however, was the
observation of the formation of
O-methyl-seryl-D,L-valine by ACVS
upon replacement of cysteine by O-methylserine
(297). This finding suggested that the second peptide bond
is initially formed. Consequently, an order of peptide formation
starting with Cys-Val and continuing with addition of
L-
-AAA would thus be conceivable. To get more information about the order of peptide formation, Kallow et al. (162) investigated enzyme-bound intermediates by omitting
the last amino acid, L-Val, in an in vitro reaction.
Depending on the reaction mode, this would lead to the accumulation of
either L-cysteinyl- or
L-
-AAA-L-cysteinyl intermediates bound to
the A. nidulans ACVS enzyme. In fact, the formation of the
AC thioester in the absence of L-Val was observed. It was
concluded that the first peptide bond is formed between the
-carboxyl of L-
-AAA and L-Cys and that
this is followed by addition of the dipeptidyl intermediate to
L-Val. The formation of
O-methylseryl-D,L-valine by ACVS
previously observed (297) was suggested to be due either to
a side reaction initiating peptide synthesis in position 2 of ACVS or
to an N-terminal cleavage of the N-terminal aminoadipyl side chain of
the tripeptide formed (162). This conclusion is also
consistent with the result that L-Cys-D-Val is
not a substrate for ACV biosynthesis (297) while
-(L-AAA)-L-Cys is accepted as a substrate
for adenylation and biosynthesis (28, 31; reviewed in reference 7).
Using a microbiological assay for detection of pantothenic acid,
Baldwin et al. (25, 26) observed that 1 mol of pantothenic acid was liberated per mol of purified A. chrysogenum ACVS.
This implied the presence of one phosphopantetheine molecule per ACVS molecule. It was therefore thought that ACVS follows the classical thiotemplate mechanism; i.e., after activation as aminoacyl adenylates, the intermediates bound as thioesters are assembled by one central swinging arm, the cofactor 4'-phosphopantetheine. Sequencing of the
ACVS structural genes (Table 1) revealed, however, that in the three
repeated regions of each ACVS, some similarity to
4'-phosphopantetheine attachment sites described for polyketide
synthases (i.e., Asp-Ser-Leu) is evident (203). This may
reflect the attachment of multiple cofactors to ACVS. Because a single
phosphopantetheine arm is sufficient for the activity of fatty acid
synthases, the finding of several phosphopantetheine attachment sites
suggests a modified mechanism for the thiotemplate pathway to
polypeptides (multiple-cofactor model) (203, 291, 313, 314).
Although the relevance of all three pantetheine attachment sites of
ACVS enzymes has not been proved experimentally, it is believed that
peptide assembly is accomplished by the transfer of acyl intermediates
between adjacent cofactors (313, 314). In the
carboxyl-terminal region of the ACVS enzymes, sequence similarities to
the thioesterase active-site region, GXSXG, have been found which
would be required to release the generated tripeptide from the enzyme
(203).
The current view of the thiotemplate mechanism of ACVS catalysis is
summarized in detail by Zhang and Demain (347) and by Kleinkauf and von Döhren (169).
ACVS enzymes are especially interesting since they represent a route
for peptide bond formation independent of the ribosome and allow the
incorporation of many nonproteinogenic amino acids (28,
168). Furthermore, since different parts of peptide synthetases are specific for certain amino acids, this can be used to engineer genetically new peptide synthetases, and hence to produce new compounds, possibly with new pharmacological activities. This approach
has been successfully used by Stachelhaus et al. (312) and
is summarized in "Applications" below.
ipnA (pcbC), encoding IPNS. The second step of the penicillin and cephalosporin biosynthesis, i.e., cyclization of the linear ACV tripeptide to the bicyclic IPN, is catalyzed by IPNS (cyclase), a nonheme-Fe(II)-dependent oxidase (106, 107, 174, 248, 340) (Fig. 2; Table 2). The enzyme has a molecular mass of about 38 kDa and formally catalyzes the removal of four hydrogen equivalents of the ACV tripeptide in a desaturative ring closure with concomitant reduction of dioxygen to water (reviewed in reference 279).
IPNS activity was first detected in cell extracts of A. chrysogenum (107, 174, 248). The IPNS reaction requires ferrous iron, molecular oxygen as the cosubstrate, and ascorbate as the electron donor to form the
-lactam and thiazolidine ring of IPN (151, 288, 340; reviewed in reference
245). It was shown that P. chrysogenum
IPNS is strongly inhibited by glutathione and is also sensitive to
cobalt inhibition (267). IPNS was purified to homogeneity
from A. chrysogenum (27, 142, 251) and has subsequently been obtained from P. chrysogenum
(267), A. nidulans (339), several
actinomycetes such as S. clavuligerus (153), and
the gram-negative bacterium Flavobacterium sp.
(250). It was shown that two interconvertable forms of the
enzyme exist, an oxidized state with a disulfide linkage and a reduced
state (27).
Only the free thiol form of the tripeptide ACV serves as a substrate;
the bis-disulfide dimer which is spontaneously formed is inactive
(259). S. clavuligerus possesses a disulfide
reductase that recognizes bis-ACV as a substrate (6). In
P. chrysogenum, a broad-range disulfide reductase belonging
to the thioredoxin family of oxidoreductases was found which
efficiently reduced bis-ACV to the thiol monomer. When coupled to IPNS
in vitro, it converted bis-ACV to IPN and was therefore suggested to
play a role in penicillin biosynthesis (72). In enzyme
assays in vitro, the thiol groups of both the ACV tripeptide and the
IPNS enzyme are kept in a reduced state by the addition of ascorbate
and dithiothreitol (see, e.g., reference 46). In
these assays, the appearance of antibiotic activity due to the
formation of IPNS from the antibiotically inactive ACV is measured with
an indicator organism which is sufficiently sensitive (174).
Alternatively, IPN can be monitored by high-pressure liquid
chromatography (154).
Mössbauer, electron paramagnetic resonance, and optical
spectroscopy suggested that ACV binds directly to the active-site iron
of IPNS via the cysteinyl thiol of ACV (65). A
six-coordinate metal center at the active site was proposed, with two
or three endogenous histidine ligands, an aspartate, and sites for the thiolate of ACV, oxygen, and solvent (232). It was shown
that the ACV sulfur atom binds to the active-site iron of the enzyme (247, 270). The crystal structure of the A. nidulans IPNS was recently solved at a resolution of 2.5 and 1.3 Å complexed with manganese (279) and with Fe2+
and substrate (280), respectively. The secondary structure
of IPNS was found to consist of 10 helices and 16
-strands. Eight of
the
-strands fold to give a "jelly-roll" motif. The active-site structure shows the manganese ion attached to four protein ligands (His
214, Asp 216, His 270, and Gln 330) and bears two water molecules occupying coordination sites directed into a hydrophobic cavity within
the protein (279). The Fe(II)-ACV-IPNS structure has one protein molecule with ferrous ion and ACV bound at the active site. The
side chain of Gln 330, which coordinates the metal in the absence of
substrate, is replaced by the ACV thiolate (280). In the
substrate complex, three of the five coordination sites are occupied by
protein ligands: His 214, His 270, and Asp 216 (43). The
remaining two sites are occupied by a water molecule (at position 298)
and the ACV thiolate (280). Such a structural characteristic
(an iron-binding site within an unreactive hydrophobic substrate-binding cavity) is probably a requirement for this class of
enzyme, since it results in the isolation of the reactive complex and
subsequent intermediates from the external environment. Thus, the
reaction can be channelled along a single path, avoiding the many side
reactions potentially open to the highly reactive species resulting
from the reduction of dioxygen at the metal (279). The role
of enzymes in such processes has been designated negative catalysis
(275). IPNS catalyzes a unique enzyme reaction with no
precedent in chemistry (279).
All intact IPNS enzymes whose genes have been cloned to date have
proline at position 285 in a highly conserved region
(269; reviewed in reference 152).
This Pro residue seems to be essential for activity because a mutant
(N2) of A. chrysogenum (298) which did not
produce cephalosporin encodes a defective ipnA gene,
probably due to the mutation of a single base pair that results in a
change from Pro (amino acid 285) to Leu (amino acid 269).
Baldwin and Wan (29) proposed a catalytic mechanism for IPNS
which involves the formation of an intermediate carbon radical of the
LLD form of ACV, but complete details of the reaction have yet to be
determined. Additional data on the mechanism of the IPNS reaction
suggests that initial formation of the
-lactam ring is followed by
closure of the thiazolidine ring (24). A model was proposed
by Roach et al. (279, 280).
The IPNS shows a broad substrate specificity, in particular with
alterations in the L-
-AAA moiety and the valine residue of ACV. This finding has been ingeniously used to create novel penicillins from ACV analogs in vitro, although cyclization of unnatural tripeptides occurs at lower efficiency (342).
Nevertheless, many new penicillins have been produced biosynthetically
via this route (23), which is thus very promising for the
generation of new
-lactam compounds in vivo.
The genes encoding IPNS enzymes are designated ipnA
(pcbC). The ipnA gene from A. chrysogenum was the first gene encoding an enzyme of
-lactam
biosynthesis to be cloned and sequenced (283). This was
achieved by purification of the enzyme, determination of its N-terminal
amino acid sequence, and subsequent cloning of the gene by reverse
genetics. The gene was overexpressed in Escherichia coli.
ipnA genes have since been cloned and sequenced from several
different fungi and bacteria. Their features are summarized in Table 2.
The ipnA and acvA genes lie close together on the
chromosome. In contrast to bacteria, in fungi ipnA and
acvA are bidirectionally oriented (Fig. 3). For the fungal
genes, it has been demonstrated that the ipnA transcripts
start in the corresponding intergenic regions (Fig. 3). The fungal IPNS
genes identified thus far do not possess introns (reviewed in reference
49).
Gene Specific for Penicillin Biosynthesis
aatA (penDE), encoding IAT.
The third and final reaction of penicillin biosynthesis, which
does not occur in cephalosporin biosynthesis and has been found in
fungi only, is catalyzed by IAT (10, 11, 54, 98, 123, 199, 263,
265, 311). The hydrophilic L-
-AAA side chain is exchanged for a hydrophobic acyl group, e.g., phenylacetyl in penicillin G (Fig. 2). IAT shows a broad substrate specificity (reviewed in references 198 and
211). By addition of appropriate precursor
molecules, the fermentation can be directed toward a specific
penicillin; e.g., for production of penicillin G, phenylacetic acid is
added, whereas for production of penicillin V, phenoxyacetic acid is
added. Once the precursor has been taken up, it must be activated to
its CoA thioester. This reaction seems to be carried out by
phenylacetyl-CoA ligase (53, 171). It is unclear, however, whether a specific enzyme is needed for this reaction, because a
possible candidate is the acetyl-CoA synthetase (ACS), which has been
purified from P. chrysogenum and whose structural gene, acuA, has been cloned (215, 216). It was shown
that the ACS enzymes of both P. chrysogenum and A. nidulans have the capability to catalyze in vitro the activation
(to their CoA thioesters) of some of the side chain precursors required
for the production of several penicillins by these fungi
(216).
,
-heterodimer,
composed of 11-kDa (
) and 29-kDa (
) subunits, derived from a
40-kDa precursor polypeptide by posttranslational cleavage. The
processing event that generated the two subunits of recombinant IAT
from the 40-kDa precursor polypeptide occurred between Gly 102 and Cys
103 (13). Mutation of aatA in the 11-kDa (
)
subunit, resulting in replacement of Thr 105 with Asn, led to inactive
and uncleaved recombinant IAT. However, coexpression of this mutant
aatA with an aatA derivative encoding the
subunit in E. coli produced acyl-CoA:6-APA acyltransferase activity (323). These results suggest that the formation of
recombinant IAT involves cooperative folding events between the
subunits. In vitro transcription and translation were used to determine the origin of the IAT hydrolase activity that cleaved the 40-kDa precursor polypeptide. The appearance of a 29-kDa protein (and presumably the corresponding 11-kDa protein, although not observable) from the 40-kDa in vitro-translated protein provided evidence that IAT
hydrolysis is an autocatalytic event (323).
Site-directed mutagenesis of the aatA gene and expression in
E. coli revealed that Cys 103 is required for IAT proenzyme
cleavage. Whether this requirement reflects a direct participation of
Cys 103 in cleavage or as part of a cleavage recognition site has not
been clarified yet. However, it cannot be entirely excluded yet that
Cys 103 is involved in IAT enzyme activity, because all of these
experiments were based on the detection of enzyme specific activity
(324). The encoded amino acid sequence in the cleavage site
is identical in P. chrysogenum and A. nidulans
(Arg-Asp-Gly...Cys-Thr-Thr) (13, 14, 324).
IAT enzymes seem to be functionally similar to bacterial penicillin and
cephalosporin acylases that catalyze the deacylation of acyl
side chains of penicillins and cephalosporins to yield 6-APA and
7-aminocephalosporanic acid, respectively. The penicillin acylase from
E. coli ATCC 11105 is a periplasmic enzyme which consists of
two nonidentical subunits (40) that are produced by
posttranslational processing from a precursor protein (41). This functional similarity between fungal IATs and bacterial acylases is striking. However, there is only very low sequence similarity (approximately 11% identical amino acids) between fungal IATs and the
E. coli acylase.
Genes Specific for Cephalosporin Biosynthesis
cefD, encoding IPN epimerase.
The reaction
catalyzed by IPN epimerase directs the pathway (Fig. 2) to the
production of cephalosporins. IPN epimerase catalyzes the epimerization
of the L-
-AAA side chain of IPN to the D
enantiomer to give penicillin N, which is the precursor of antibiotics
containing the ceph-3-em nucleus, i.e., cephalosporins and cephamycins
(7-methoxycephalosporins) (151, 174) (Fig. 2). The
purification of A. chrysogenum IPN epimerase proved to be
difficult because the enzyme was extremely labile in cell-free
preparations (174). So far, no further data on the fungal
protein or gene are available. Therefore, it is still unknown whether
the putative cefD gene is part of one of the A. chrysogenum clusters (Fig. 3).
cefEF, encoding DAOC synthetase (ring
expandase)/DAC hydroxylase.
In cephalosporin biosynthesis,
penicillin N is converted to DAOC by expansion of the five-membered
thiazolidine ring to give the six-membered dihydrothiazine ring of DAOC
(Fig. 2). This reaction is catalyzed by DAOC synthetase, which
possesses the required expandase function (172). The enzyme
was purified from A. chrysogenum (93, 182),
S. clavuligerus (155), and S. lactamdurans (81). Fungal and bacterial expandases are
stimulated by reducing agents, like dithiothreitol or glutathione, and
show an absolute requirement for Fe2+, molecular oxygen,
-ketoglutarate, ascorbate, and possibly ATP. These unusual cofactor
requirements are characteristic of the class of intermolecular
dioxygenases which activate oxygen in the decomposition of equimolar
amounts of
-ketoglutarate to form carbon dioxide and succinate
(182; reviewed in reference 245).
-ketoglutarate-linked dioxygenases.
Ring expansion by DAOC synthetase and the hydroxylation reaction are
both carried out by the same peptide in A. chrysogenum (93, 284, 290). Purification of this enzyme, determination of its N-terminal amino acid sequence, and reverse genetics allowed the
cloning of the structural gene, designated cefEF
(284). Expression of the cloned cefEF gene in
E. coli (284) established unequivocally that in
A. chrysogenum one protein is responsible for the ring expansion of penicillin N to DAOC and the 3' hydroxylation of DAOC to
DAC (Fig. 2; Table 4). In contrast, in S. clavuligerus, the
two enzymatic activities were separated by anion-exchange chromatography (156) and were later found to be encoded by
two genes, cefE and cefF (Table 4; Fig. 2).
The cefEF gene of A. chrysogenum is located on
chromosome II (300). It is closely linked to the
cefG gene but is transcribed in the opposite direction (Fig.
3). The intergenic region of about 1 kb is believed to contain the
promoters for both genes (131). In S. clavuligerus, the cefF gene is closely linked to the
cefD and cefE genes but is transcribed in the
opposite orientation (Fig. 3) (175). In Lysobacter
lactamgenus and Nocardia lactamdurans, different orders
of genes were found (75, 77, 79, 166, 167) (Fig. 3).
The only data on regulation of the A. chrysogenum gene thus
far reported is a Northern blot analysis which showed that a 1.2-kb transcript corresponding to the cefEF gene was detectable in
cells after 48 h of growth in a defined production medium
(131).
Gene Specific for Cephalosporin C Biosynthesis in Fungi
cefG, encoding acetyl-CoA:DAC acetyltransferase. In the last step of the cephalosporin C biosynthesis, which is best studied in the fungus A. chrysogenum, an acetyl moiety from acetyl-CoA is transferred to the -OH group of DAC; this step is catalyzed by acetyl-CoA:DAC acetyltransferase (108, 122) (Fig. 2). The corresponding structural gene (cefG) of A. chrysogenum was cloned and sequenced independently by three groups (Table 5). The cefG gene was cloned based on its close linkage to cefEF. Sequencing of the region adjacent to cefEF led to the identification of an ORF, and a DNA fragment encoding this ORF allowed complementation of the A. chrysogenum mutant M40, which is deficient in acetyl-CoA:DAC acetyltransferase activity. Thus, the identified ORF most probably contained the cefG gene, which was confirmed by overexpression of the gene in A. niger, which naturally lacks such an activity (219). Gutiérrez et al. (131) screened an A. chrysogenum bacteriophage lambda library with a probe specific for the cefEF gene. Northern blotting and DNA sequence analysis revealed the existence of the cefG gene close to the cefEF gene. The authenticity of the cefG gene was proved by complementation of A. chrysogenum ATCC 20371, which lacks acetyl-CoA:DAC acetyltransferase activity. Matsuda et al. (220) cloned the gene by screening a cDNA library with oligonucleotides based on the N-terminal sequence of the enzyme. In addition, they proved the cloning of cefG by performing a gene disruption (replacement) experiment. The cefG-disrupted strains lacked the ability to produce cephalosporin C and accumulated its precursor, DAC, in the culture broth (221).
cefG contains two introns, as demonstrated by sequencing of its cDNA (219, 220). It is closely linked to cefEF but is transcribed in the opposite orientation. The size of the separating intergenic region is not clear, because Gutiérrez et al. (131) found 938 bp, Mathison et al. (219) found 1,077 bp, and Matsuda et al. (220) reported a 1,114-bp intergenic region (Fig. 3; Table 5). Northern blot analysis of A. chrysogenum RNA showed a very weak transcript of about 1.4 kb, corresponding to the cefG gene, in cells grown in a defined production medium for 48 and 96 h (131, 219). These findings seem to agree with reports on the late conversion of DAC to cephalosporin C in cephalosporin fermentations (344). cefEF appears to be expressed at an earlier stage of the fermentation, suggesting that cefEF and cefG are expressed differently from their intergenic region (131) (Fig. 3).COMPARTMENTALIZATION OF GENE PRODUCTS
|
|
|---|
The penicillin biosynthesis pathway occurs in different
compartments of the cell (Fig. 4). For
localization of the ACVS protein, subcellular fractions obtained from
protoplasts of a high-penicillin-producing P. chrysogenum
strain (BC 1505) were analyzed. Because ACVS protein was detected in
both the membrane and the soluble fraction of purified vacuoles, it was
concluded that it is located either within or bound to the vacuolar
membrane (187). In addition, a large portion of cellular
L-
-AAA, which is most probably used for
-lactam
synthesis, is also contained in the vacuoles and thus is sequestered
from the cytosol (5, 143) (Fig. 4).
|
P. chrysogenum IPNS protein was found in the cytoplasm, whereas IAT was detected in organelles with a diameter of 200 to 800 nm, which were assumed to be microbodies (238) (Fig. 4). The latter result has been supported by the finding that the P. chrysogenum IAT contains a putative targeting signal sequence, a C-terminal alanine-arginine-leucine (34, 125). The importance of this sequence was proved by deleting it in vitro. After transformation of the P. chrysogenum npe6 strain lacking IAT specific activity, the mutated enzyme was located in vacuoles and the neighboring cytoplasm. Although IAT was produced in vivo, as shown by Western blot analysis and by measurement of IAT specific activity in vitro, the mutants did not produce penicillin (237), indicating that targeting of the enzyme to microbodies is essential for penicillin biosynthesis. Furthermore, a positive correlation between the capacity for penicillin production and the number of organelles per cell was observed when different P. chrysogenum strains were compared (238). Hence, the biogenesis of organelles and the genes responsible for this process might have an impact on the penicillin production. The localization of the penicillin biosynthesis in three different cellular compartments reflects the complexity of this biosynthetic pathway. Several transport steps are thus required to bring intermediates of the penicillin biosynthesis pathway together with the enzymes.
Although the presence in P. chrysogenum Wis54-1255 of a transport system for the side chain precursor phenylacetic acid was reported (113), subsequent investigations showed that phenylacetic acid passes the plasma membrane via passive diffusion of the protonated species (140).
ORIGIN OF
-LACTAM BIOSYNTHESIS GENES IN
FUNGI
|
|
|---|
-Lactam biosynthesis genes have been found both in bacterial
species and in fungi. The availability of sequence information about
bacterial and fungal genes led to speculations about their evolutionary
relationship. Based on several observations, a horizontal transfer of
-lactam biosynthesis genes from bacteria to fungi during evolution
has been proposed by several authors (63, 184, 254, 339).
This hypothesis was recently questioned by Smith et al.
(308). The arguments in favor of a horizontal gene transfer are as follows. (i) ipnA genes of fungi and bacteria show
high sequence similarities. More than 60% of the nucleotide bases and 50% of the deduced amino acids are identical. (ii) Bacterial as well
as fungal
-lactam genes are organized in clusters. The
-lactam biosynthesis genes in bacteria are organized into a single cluster, as
are the penicillin biosynthesis genes in fungi (Fig. 3). The cephalosporin biosynthesis genes in A. chrysogenum are
organized into two clusters located on different chromosomes (Fig. 3).
This finding led to the assumption that the
-lactam biosynthesis
genes were transferred as a single cluster from an ancestral prokaryote to a common ancestor of the
-lactam-synthesizing fungi. In the eukaryotic ancestor, the biosynthesis genes were split between two
chromosomes. One part encodes the early genes of
-lactam biosynthesis, and the other encodes the late genes. Later in the lineage, an ancestor of A. nidulans and P. chrysogenum diverged from A. chrysogenum and has
presumably lost the second cluster with the genes for the late stage of
cephalosporin biosynthesis (299) (Fig. 3). (iii) The G+C
content in the third position of codons containing the ipnA
gene of A. nidulans and P. chrysogenum is
unusually high and could indicate an evolutionary origin from streptomycetes, which show G+C contents of greater than 70%
(8). (iv) Fungal acvA and ipnA genes
do not contain introns, indicating a bacterial origin of the genes.
In addition, Aharonowitz et al. (8) proposed that during the
evolution of
-lactam biosynthesis genes, Streptomyces
spp. must have evolved specific resistance mechanisms to avoid
self-toxification. If the transfer had occurred from fungi to bacteria,
it would have been lethal for bacteria. Hence, the transfer is more
likely to have occurred from bacteria to fungi, which would not have been forced to evolve resistance mechanisms because of their lack of
susceptibility. In contrast to the other penicillin biosynthesis genes,
the aatA genes contain introns. On the basis of linkage of
the aatA and ipnA genes (Fig. 3), Skatrud
(299) suggested that a sequence functionally related to
aatA was transferred together with the
-lactam genes and
was later modified to its current functional form. Since IAT possesses
amidohydrolase activity to deacylate IPN to 6-APA (11) (Fig.
2), which shows a weak antibiotic activity only, an ancestral
amidohydrolase activity in the prokaryotic ancestor might have had a
resistance function. Its corresponding gene might have been fused in
fungi with a eukaryotic gene (299). Genetic linkage of
antibiotic synthesis genes and resistance genes is common in
prokaryotes (294). Based on the DNA sequences of ipnA genes from gram-positive streptomycetes and from fungi
and a rate of nucleotide substitution of 10
9 nucleotide
change per site per year (188), Weigel et al.
(339) proposed that the transfer occurred 370 million years
ago. The cloning and sequencing of an ipnA gene from a
gram-negative bacterium, Flavobacterium sp., however, led to
an extension and modification of the hypothesis of horizontal gene
transfer. The ipnA gene of Flavobacterium sp. is
69% identical to the streptomycete gene and 64 to 65% identical to
the fungal genes (A. chrysogenum and P. chrysogenum) (73). A recent reevaluation of the
divergence times of organisms by using a protein clock suggested that
gram-positive and gram-negative bacteria split about 2 billion years
ago and that prokaryotes and a eukaryotic ancestor split about 3.2 to 3.8 billion years ago (111). If the gene transfer from
streptomycetes to fungi had occurred only 370 million years ago, as
proposed by Weigel et al. (339), it could be expected that
the fungal and streptomycete genes would show a greater similarity than
the gram-positive (streptomycete) and gram-negative
(Flavobacterium sp.) bacterial genes. As outlined above,
this is not the case (73). Hence, Aharonowitz et al.
(8) suggested that multiple gene transfer events might have
occurred from bacteria to fungi. It is difficult to imagine, however,
why these multiple gene transfers then happened at about the same time
as would be expected from the degree of similarity among the proteins
of the various organisms. In addition, Smith et al. (308)
argued against a horizontal transfer. The authors pointed out that the
hypothesis of a horizontal gene transfer, e.g., of the ipnA
gene, was made on the basis of a very limited data set and was based
solely on assumptions about rates of change. They compared the
similarity of both IPNS of A. nidulans, P. chrysogenum, A. chrysogenum, S. clavuligerus, S. anulatus, and
Flavobacterium sp. and DAOC synthetase of S. clavuligerus and A. chrysogenum. Based on these
similarities, they constructed a tree with conventional evolutionary
descent. The authors argued that the simplest interpretation is that
the genes for the two enzymes resulted from a duplication that occurred
before the prokaryote-eukaryote divergence. The topology of the tree
rooted with the duplicated enzymes, the depth of the bacterial
branches, and the different orientations of the genes in fungi and
eubacteria all appear to be consistent with an ordinary evolution for
IPNS. However, if the genes appeared very early in the evolution, why
have most of the eukaryotes and fungi lost the gene cluster? This
question cannot be satisfactorily answered at the moment. Thus, the
evolutionary origin of
-lactam biosynthesis genes remains
speculative.
REGULATORY CIRCUITS AND REGULATORY GENES
|
|
|---|
Expression of Biosynthesis Genes under Standard Fermentation Conditions
Studies of the expression of penicillin biosynthesis genes were
performed mainly with the E. coli reporter genes
lacZ and uidA, encoding
-galactosidase
(
-Gal) and
-glucuronidase (
-Glu), respectively (see, e.g.,
references 46, 124, and 194).
Most of the results based on the analysis of gene fusions were
supported by Northern or Western blot analysis or determination of
enzyme specific activities and penicillin titers.
These studies led to the finding that the promoter strengths of penicillin biosynthesis genes are rather different. It was shown that in A. nidulans, aatA had lower expression than ipnA and threefold-higher expression than acvA (46, 194). A similar observation was made for the corresponding acvA and ipnA genes of both P. chrysogenum and A. chrysogenum. On the basis of reporter gene fusions, it became evident that in both fungi the expression of acvA was much weaker than that of ipnA (109, 230). The intergenic regions between acvA and ipnA thus seem to contain the information required for the remarkable difference in expression levels between acvA and ipnA. The low expression of acvA is, at least in wild-type strains of A. nidulans, rate limiting for penicillin production, because overexpression of acvA led to drastically increased production of penicillin (165) while similar overexpression of ipnA and aatA did not (112).
It seems reasonable to assume that the expression of penicillin biosynthesis genes is coordinated to ensure the synthesis of penicillin by the concomitant appearance of all gene products. But how is coordination achieved? Biosynthesis genes could be expressed simultaneously; i.e., the genes could be activated by the same regulatory factors. Alternatively, the expression of biosynthesis genes could be sequentially induced.
Ramos et al. (268) showed that a mutant of A. chrysogenum (N-2), incapable of producing the
-lactam
cephalosporin, lacked IPNS, IPN epimerase, and DAOC synthetase
(expandase) activities (Fig. 2). Subsequent investigations revealed
that strain N-2 encodes an inactive IPNS caused by a single C-to-T
mutation within the coding region of the ipnA gene. It was
postulated that a functional IPNS or its biosynthetic product IPN might
be necessary for the regulation of the later stages of the
biosynthesis, i.e., induction of the cefD and
cefEF expression, respectively (Fig. 2 and 3) (269). Furthermore, Hoskins et al. (145)
disrupted the acvA gene of A. chrysogenum.
Although the predicted alterations of the target gene were not
detected, the authors demonstrated IPNS activity in
non-cephalosporin-producing transformants. This suggested that the
ipnA gene can be expressed without the presence of precursor tripeptide molecules. Hence, in A. chrysogenum, the
ipnA gene seems to be coordinatedly regulated whereas the
later genes of the cephalosporin pathway (cefD and
cefEF) (Fig. 3) appear to be sequentially induced.
To further study these observations, acvA was disrupted in a strain of A. nidulans (47, 305). This strain had a disrupted acvA gene on chromosome VI and, in addition, reporter gene fusions of the penicillin biosynthesis genes integrated in single copy at the chromosomal argB gene locus on chromosome III. acvA, ipnA, and aatA gene fusions were expressed at the same level in this strain as in the nondisrupted strain (47, 194). This was confirmed by determining IPNS and IAT specific activities and by Western blot analysis of IPNS, which showed the presence of both enzymes in an acvA-disrupted strain (47, 194). Hence, the genes were expressed despite the lack of precursor ACV and IPN molecules, indicating that in contrast to the cephalosporin biosynthesis genes, none of the penicillin biosynthesis genes are sequentially induced and their expression is most probably coordinated. This is also supported by the similar time course in the expression of the A. nidulans acvA and ipnA genes (46) and by the appearance of transcripts of all three penicillin biosynthesis genes in P. chrysogenum at the same time during a fermentation run (273).
However, some observations make the view of a coordinated expression of the genes more complicated. Differential regulation of acvA, ipnA, and aatA in A. nidulans has been observed in response to exogenous signals. While the expression of A. nidulans acvA and ipnA genes was significantly repressed by L-lysine, aatA expression was not (48, 191). Furthermore, in fermentation medium, only ipnA was significantly repressed by glucose (46, 194).
It is interesting that in fermentation medium, acvA and ipnA gene fusions were expressed for up to 68 and 46 h, respectively (46). In contrast, aatA expression was detected for only about 24 h. In this respect, the temporal expression pattern of aatA is more similar to that of an oliC-lacZ gene fusion; oliC encodes subunit 9 of the A. nidulans mitochondrial ATP synthase complex and is regarded as a gene of the primary metabolism (46, 194).
In contrast to the other penicillin biosynthesis genes, the aatA genes of both A. nidulans and P. chrysogenum encode three introns (Table 3; Fig. 3). In theory, introns could play a role in regulating aatA expression. This was also suggested by the observation that when the inducible alcA promoter was used for the expression of aatA, the use of aatA cDNA gave higher IAT specific activity than did the use of the genomic gene carrying all three introns (112). However, a regulatory role of the first intron in the wild-type gene is unlikely, since there was no difference in the expression pattern of an A. nidulans aatA-lacZ fusion compared with an aatA-lacZ fusion, which had the first intron included (194). It is conceivable, however, that the second and/or third intron plays a regulatory role or, alternatively, that excision of introns becomes limiting in strains in which the steady-state level of aatA mRNA is strongly increased (112).
Previous studies of the formation of secondary metabolites in batch fermentations led to the definition of two phases: the growth phase (trophophase) and the period of secondary-metabolite production (idiophase) (reviewed in reference 210). A strict separation of the two phases, with production of secondary metabolites being virtually restricted to the idiophase, has been observed in antibiotic-producing bacterial cultures. It was first reported that the expression of the ipnA gene encoding IPNS in A. nidulans is temporally delayed in a similar manner to that of expression of bacterial secondary-metabolism genes (124). However, when lactose was used as the sole carbon source, there was no sharp separation of the trophophase and idiophase with respect to penicillin production or the expression of penicillin biosynthesis genes (46, 194). The previously observed delayed expression of ipnA is due to the use of glucose as the carbon source (101), which repressed transcription and expression of the ipnA gene (46, 101) (Fig. 5). For some secondary metabolites, it seems likely that their production in a clear-cut idiophase reflects the inhibiting effects of certain compounds in the medium (46, 101) rather than an intrinsic temporal delay in the product formation pattern. This view is consistent with the results of Renno et al. (273), who showed that in wild-type P. chrysogenum (NRRL 1951) and the high-penicillin producing strain P2, the highest steady-state level of mRNAs of all penicillin biosynthesis genes was observed during maximal growth in both shake flasks and 2-liter fermentors.
|
However, some observations imply that in P. chrysogenum
there might be a temporal expression of
-lactam biosynthesis genes. ipnA steady-state mRNA levels increased with the age of the
culture, indicating preferential transcription of the gene at late
growth times (316). This is consistent with the observation
of Feng et al. (109) that expression of an
ipnA-uidA gene fusion was detectable after only 24 h in
fermentation medium with lactose as the carbon source whereas an
acvA-uidA gene fusion seemed to be expressed from the
beginning of a fermentation run. Hence, there might even be differences
in the temporal expression of genes of the same cluster as well as in
different fungi.
Promoter Structures of the A. nidulans Genes acvA and ipnA
So far, only two studies have analyzed the promoters of
-lactam
biosynthesis genes in the homologous host in detail.
Pérez-Esteban et al. (257) reported a comprehensive
deletion analysis of the A. nidulans ipnA promoter in which
the promoter region was fused in frame with the E. coli lacZ
reporter gene (encoding
-Gal). Integration of such deletion
constructs in single copy at the chromosomal argB gene locus
and determination of the
-Gal specific activity of the different
A. nidulans transformant strains revealed that several
regions of the promoter were involved in the basal expression of
ipnA and the repression by sucrose (see "Carbon source
regulation" below).
In this deletion study, the expression of the divergently transcribed
acvA gene (Fig. 3) was not determined. Divergently
transcribed genes, however, provide an interesting case of regulation,
because possible functional interactions between the promoters could
exist and single cis-acting sites might have the potential
to regulate two genes simultaneously. Hence, a moving-window analysis
was carried out; i.e., nested deletions were introduced into the
intergenic region between A. nidulans acvA and
ipnA. The ATG start codons of both genes were fused in frame
with the two E. coli reporter genes lacZ and
uidA (encoding
-Gal and
-Glu), respectively, and these
deletion constructs were integrated in single copy at the chromosomal
argB gene locus. Hence, the effects of deletions on the
expression of both genes were measured simultaneously within one
transformant strain by determining
-Gal and
-Glu specific activities (319). These deletion analyses revealed that the
intergenic region between acvA and ipnA contains
several regions with cis-acting DNA elements. Thus far, no
element was found in the intergenic region which affected the
expression of one gene only, although differential expression of genes,
e.g., as a result of the addition of amino acids to the medium, was
observed. Taken together, these findings suggest that the promoters of
both genes are, at least in part, physically overlapping and share
common cis-acting elements (319).
Carbon Source Regulation
Industrial production of penicillin by P. chrysogenum was previously carried out with lactose as the C source, since it gave the highest penicillin titer. The use of excess glucose leads to a drastic reduction of the penicillin titer (309). Fructose, galactose, and sucrose also have a negative effect on penicillin production, but lactose does not (276). Nowadays, this problem has been partially overcome by feeding subrepressing doses of glucose and by using lactose as the C source (317). Since in general the fungus grows better with glucose than with lactose (46), the production of penicillin appears to be favored by suboptimal growth conditions.
C-source regulation seems to act at several points of the penicillin
biosynthesis: (i) flux of L-
-AAA, (ii) activation of side chain precursors, (iii) transcription of penicillin biosynthesis genes (Fig. 5), and (iv) posttranscriptional regulation of penicillin biosynthesis genes.
The replacement of lactose by glucose reduced the L-
-AAA
pool in mycelia of P. chrysogenum and thus probably the flux
of L-
-AAA to ACV (144 (see "Amino
acids as precursors and mediators of regulation" below). The
formation of ACV and IPN was also repressed by glucose (277)
(Fig. 2). Indirect measurements based on the incorporation of
[14C]valine into ACV in vivo suggested that the glucose
repression of penicillin biosynthesis involves repression but not
inhibition of penicillin-synthesizing enzymes. Furthermore, the
specific activity of IPNS but not of IAT was reduced in cells of a
penicillin-producing strain (AS-P-78) grown on glucose. These results
suggested that glucose represses the formation of ACVS and IPNS in
P. chrysogenum (144, 276, 277). In agreement with
these findings was the observation that the expression of both the
acvA and ipnA genes of P. chrysogenum Q176, both measured by using the uidA reporter gene, was
repressed by glucose (109) (Fig. 5). Renno et al.
(273) claimed, however, that steady-state mRNA levels of all
three P. chrysogenum penicillin biosynthesis genes were
highest during rapid growth, when considerable levels of glucose were
present. This shows that measurement of carbon regulation depends, at
least in part, on the experimental approach used.
In A. nidulans, a similar phenomenon was observed. The use of repressing carbon sources such as glucose or sucrose in the fermentation medium reduced the amount of penicillin produced (46, 101). Results obtained with reporter gene fusions showed that the expression of the ipnA gene was repressed when glucose or sucrose was used instead of lactose as the C source during fermentation (46, 101) (Fig. 5). This was further supported by the finding that the IPNS specific activity was drastically reduced in glucose-grown mycelia (46). Repression of ipnA expression by repressing C sources occurs, at least in part, at the transcriptional level, because the steady-state level of ipnA mRNA decreased when mycelia were cultivated with repressing C sources such as sucrose (101).
Unexpectedly, the expression of both acvA and aatA reporter gene fusions was repressed only slightly, if at all, by glucose in fermentation medium (46, 194). However, the specific activity of the aatA gene product, IAT, was reduced in mycelia grown with glucose instead of lactose (46, 194). This suggests that the glucose regulation of IAT takes place, at least in part, posttranscriptionally. The effect of glucose on IAT specific activity could be reversed by washing cells and reincubating them in lactose-containing medium (194). It is unclear why glucose regulation occurs, in the case of ipnA, transcriptionally or, in the case of aatA, apparently posttranscriptionally.
The results obtained with A. chrysogenum seem to be similar
to those obtained with A. nidulans. Cephalosporin C
formation by A. chrysogenum depends on the C source used
(85). C sources which support the most rapid growth, like
glucose or glycerol, had a negative effect on
-lactam production
(87, 223). Fermentations with different C sources showed
that glucose exerted a much greater negative effect on cephalosporin C
than on penicillin N formation, suggesting that it had a more
pronounced effect on the later steps of the pathway (36).
The ACVS level was not affected by higher concentrations of glucose,
making a major repressive effect of glucose at the level of gene
expression unlikely (349). However, ACVS specific activity
measured in crude protein extracts was severely inhibited by glucose
and glycerol. The inhibition could be reversed by the addition of ATP.
Interestingly, the purified enzyme was not inhibited by glucose but was
inhibited by glyceraldehyde-3-phosphate and glyceraldehyde
(346). From these observations, the authors concluded that
inhibition of ACVS specific activity in crude extracts, by glucose and
some other sugars, is due to depletion of the cofactor ATP via sugar
metabolism.
In contrast to the penicillin production strain P. chrysogenum AS-P-78, investigated by Revilla et al. (277), the IAT specific activity of both A. nidulans and the P. chrysogenum wild-type strain NRRL 1951 was clearly reduced in glucose-grown cultures (46). Glucose was also found to cause inactivation of P. chrysogenum acetyl-CoA synthetase, which can catalyze the activation (to their CoA thioesters) of some of the side chain precursors required for the production of several penicillins in vitro (216). The contributions to the overall reduction of the penicillin titer by each of the steps affected by glucose are not yet clear.
Previously, it was reported that the uptake of side chain precursors of phenylacetic acid was regulated by glucose (see, e.g., reference 113). However, it was recently shown that phenylacetic acid passes the plasma membrane via passive diffusion of the protonated species (140), thus excluding the possibility that the uptake could be regulated by the available C source.
An involvement of cyclic AMP (cAMP) in C-source regulation is controversial. In P. chrysogenum, cAMP levels were high during growth on lactose and decreased markedly (by about 75%) when glucose was added (178). In A. nidulans, however, a correlation between intracellular cAMP levels and the C source (lactose and glucose) was not detected (44).
To study the molecular basis of C-source regulation of ipnA
expression, several mutants of A. nidulans carrying
previously characterized loci affecting the glucose repression of
several genes of the primary metabolism
(creAd-1, creB304, and
creC302) (21, 146) have been analyzed. In these
mutants, penicillin production was still reduced by glucose (46,
49). However, Espeso and Peñalva (101) observed
in mutants with extreme loss-of-function mutations in creA
slightly derepressed ipnA steady-state transcript levels.
This was consistent with a deletion analysis of the ipnA
promoter, demonstrating that a cis-acting DNA region crucial
to sucrose repression maps between
1334 and
966 relative to the
transcriptional start site of the ipnA gene
(257). A single CREA binding site was detected in this region, which was protected in DNase I footprint analysis by using a
glutathione S-transferase (GST)-CREA protein which
contained amino acids 35 to 240 of CREA (104). The
full-length CREA polypeptide deduced from the gene consists of 415 amino acids (95). To test the functionality of this putative
CREA binding site in vivo, the effect of its deletion was measured in
an ipnA-lacZ gene fusion. The expression of the gene fusion
with a deleted CREA binding site was still repressed when sucrose
instead of lactose was used as the C source (104). Hence, it
is unlikely that CREA plays a role in C-source repression of penicillin
biosynthesis. This also agrees with the finding that acetate and
glycerol, which are repressing and derepressing C sources,
respectively, of some primary-metabolism genes in the
creA-mediated circuit of carbon catabolite repression,
behaved in the opposite manner to what would be expected from
creA control. The use of acetate led to increased
steady-state levels of ipnA transcript and penicillin titers, and the use of glycerol led to the opposite effects, i.e., decreased ipnA transcript levels and penicillin titers
(104).
Previously, it was shown that in creB and creC mutants the production of penicillin was still reduced when glucose instead of lactose was used as the C source (46, 49). Additional experiments further excluded the possibility of a direct involvement of creB and creC mutations in C-source repression of ipnA transcription (100). Thus, the mechanism(s) of regulation of penicillin biosynthesis by repressing C sources remains to be elucidated.
An interesting observation was made by Kennedy and Turner (165). In A. nidulans strains such as WG355 or R21, glucose usually led to a reduction of the penicillin titer to about 30 to 50% (46, 101), whereas with strain G191, a reduction to about 10% was measured. This might represent an unexpected strain difference, with penicillin production in G191 being more sensitive to glucose repression (165). Strain G191, for example, carries a mutation in the uaY gene (uaY9), which encodes a transcriptional activator for a number of unlinked genes involved in purine utilization (315), or cryptic mutations could be present in G191 which could be responsible for this unexpected observation. It seems worth investigating the difference between strain G191 and other strains with respect to carbon regulation of penicillin biosynthesis.
pH Regulation Mediated by the Transcriptional Factor PACC
Penicillin production is subject to regulation by ambient pH (104, 295) (Fig. 5). Wild-type strains of A. nidulans can grow in media over the pH range of 2.5 to 10.5 (282). There was markedly more penicillin in the culture broth when the pH of the medium was kept constant at 8.1 than when it was kept constant at 6.5 or 5.1 (295). Control experiments excluded the possibility that the difference in penicillin yield measured was due to the higher stability of penicillin G at alkaline pH (104).
To study the molecular basis of this interesting phenomenon, mutations involved in the pH regulatory network of A. nidulans were isolated and analyzed (19, 92, 104, 295). Previously, Dorn (92) had identified mutations specifically affecting the pH regulation of the formation of alkaline and acidic phosphatases. These mutations were divided into two distinct groups (pal and pac) based on the phenotypes they encoded. Mutations in some of the pal genes (palA, palB, palC, palE, and palF), which are phenotypically indistinguishable, have been shown to mimic the effects of growth at acidic pH (57). Arst et al. (19) identified two new pal genes, palH and palI, and demonstrated that palB and palE actually represented the same gene. Thus far, there are a total of six discrete regulatory pal genes (palA, palB, palC, palF, palH, and palI) (19). The alkaline phosphatase and acidic phosphatase structural gene were designated palD and pacA, respectively (reviewed in reference 18). The regulatory pal mutations impair the pH regulation of the syntheses of extracellular enzymes, such as phosphatases and permeases. Extracellular enzymes and permeases are not protected by the intracellular pH homeostatic system; therefore, their synthesis is controlled by the external pH. This mode of regulation avoids the synthesis of, for example, secreted alkaline phosphatase in an acidic environment (57).
Mutations at the pacC locus result in the phenotypic mimicry of growth under alkaline conditions (57). It has also been noted that pacC mutations themselves can be divided into two classes defined by the phenotype when cultured at neutral pH: those that mimic growth under alkaline conditions (the type originally observed) and those (including a null allele) that mimic growth under acidic conditions (57, 322).
PacC mutants mimicking the effect of growth at alkaline pH produced about twice as much penicillin as did wild-type strains, whereas strains carrying pal mutations mimicking growth at acidic pH showed the lowest penicillin titers. These findings are consistent with the observation that penicillin titers were higher when wild-type strains were grown at alkaline pH in wild-type strains (295).
The pacC gene was cloned and sequenced by complementation of an argB2 pacCc14 (mimicking alkaline growth conditions) recipient by using a genomic A. nidulans library constructed in an argB+-containing plasmid. The DNA sequence of the pacC gene consists of 2,172 bp interrupted by two introns of 85 and 53 bp. The 678-residue-derived protein (Mr 72,939) revealed that PACC contains three putative Cys2His2 zinc fingers (322). At alkaline ambient pH, PACC activates the transcription of alkali-expressed genes (e.g., the alkaline phosphatase and protease genes palD and prtA, respectively) and also of the penicillin biosynthesis genes ipnA (322) and acvA (103, 318). The intergenic region between acvA and ipnA was found to contain four in vitro PACC binding sites designated ipnA1, ipnA2, ipnA3, and ipnA4AB, recognized by a GST-PACC (amino acids 31 to 195) fusion protein (see Fig. 10). The fusion protein was demonstrated to bind to the core consensus GCCARG (322). The mode of DNA recognition by PACC was studied in detail (105).
A mutation analysis of each of these sites by using
ipnA-lacZ gene fusions revealed that in vivo the binding
site ipnA3 was most important for PACC-dependent ipnA
expression whereas ipnA2 and ipnA4AB were less important, although
ipnA2 was bound with highest affinity by PACC in vitro. ipnA1
apparently was not required for PACC-dependent ipnA
expression (102) (see Fig. 10). As observed for expression
of an ipnA-lacZ gene fusion (104), expression of
an acvA-uidA gene fusion was increased in a PacC5 mutant
strain (318). Because pacC5 is an allele which is
active irrespective of the ambient pH (322), this suggests
that PACC also regulates the expression of acvA. This
assumption was further supported by the observation that the
steady-state levels of acvA mRNA were increased at alkaline
ambient pH (103). Furthermore, the addition of histidine and
valine to the culture medium led to its acidification and to reduced
acvA-uidA expression. This effect was not observed in a
deletion strain (
183-312) carrying a deletion spanning PACC binding
site ipnA3 (at nucleotides 265 to 270) or in the PacC5 mutant strain
with a constitutively active PACC protein. Taken together, these data
suggest that PACC also regulates the acvA expression of
A. nidulans predominantly from ipnA3 (318).
Therefore, an external alkaline pH is sufficient to give rise to
considerable transcriptional derepression of steady-state
acvA and ipnA transcript levels, expression of
both genes measured by using gene fusions, and penicillin titers.
In addition, at alkaline ambient pH, PACC prevents the transcription of acid-expressed genes (322; reviewed in reference 18). The full-length form of PACC, which predominates at acidic ambient pH or in PalB7 strains grown under acidic or neutral conditions, is not functional (90, 246). It must be specifically proteolyzed to yield the functional (for both positive and negative roles) version containing the N-terminal 40% of the protein (246) (see Fig. 10). The processed form is functional as both the activator and repressor (246; reviewed in reference 18). The pacC gene seems to be autogenously regulated, because the pacC transcript is strongest at alkaline pH, and the pacC promoter contains PACC binding sites (322).
PACC proteolysis occurs in response to a signal provided by the six regulatory pal gene products in alkaline environments (246, 322; reviewed in reference 18). Thus, the products of the palA, palB, palC, palF, palH, and palI genes constitute an alkaline ambient pH signal transduction pathway which is required for the conversion of PACC to its functional form (90).
Recently, both the palA and palB gene have been cloned and sequenced (90, 242). The amino acid sequence of the derived palA protein showed similarities to that of a hypothetical protein from the nematode Caenorhabditis elegans and also has possible yeast homologs. These data, however, did not allow speculation about the putative function of the protein (242). The predicted palB gene product has similarity to the catalytic domain of the calpain family of calcium-activated cysteine proteases. However, PALB does not catalyze the final step of proteolytic processing of PACC (90). The pal pathway is thought to introduce a modification of PACC at alkaline pH in wild-type strains, disrupting intramolecular interactions to allow activating proteolysis (246). The type of PACC modification mediated by the pal pathway in response to alkaline pH is not known, but an earlier (and more C-terminal) proteolytic cleavage of PACC resulting in susceptibility to further proteolysis might be mediated by PALB (90). Alternatively, it was suggested that PALB might proteolyze one of the other pal gene products in a signalling cascade (90).
By cross-hybridization with a nearly full-length A. nidulans pacC gene as the probe and a genomic library of P. chrysogenum NRRL 1951, the P. chrysogenum pacC gene was cloned and sequenced (316). The gene complemented an A. nidulans strain carrying a null pacC mutation, thus showing that it was functional. The gene is 1,979 bp long and is interrupted by a single intron of 56 bp. The predicted 641-residue protein (Mr 68,681) exhibits most of the features described for the A. nidulans pacC protein, including three zinc fingers of the Cys2His2 class. Steady-state levels of the pacC transcript were elevated at alkaline pH, suggesting that the P. chrysogenum pacC transcription was also pH regulated (316).
A fusion protein of GST with amino acids 46 to 154 of P. chrysogenum PACC [GST-PACC(46-154)], overexpressed in E. coli and purified, bound in vitro to the intergenic region between P. chrysogenum acvA and ipnA. By computer analysis, seven PACC binding consensus sites (5'-GCCARG-3') were found in the intergenic region. This is consistent with the finding that steady-state ipnA mRNA levels were increased at alkaline pH (316).
The upstream region of the P. chrysogenum aatA gene contains eight binding sites for PACC, whereas that of A. nidulans has just one such sequence, suggesting that these genes might be regulated by PACC as well (316).
In addition, several groups have characterized the intergenic region between the P. chrysogenum acvA and ipnA genes by band shift assays. Chu et al. (68) and Feng et al. (110) reported independently that partially purified crude extracts of P. chrysogenum bound in vitro to the sequences TGCCAAG and GCCAAGCC, respectively. Although the binding sites were located at different positions in the intergenic region, their degree of identity is striking. Furthermore, the proposed DNA binding proteins of P. chrysogenum appear to recognize the same sequence motif which is bound by the PACC proteins of both A. nidulans and P. chrysogenum (316, 322), which, for A. nidulans, has been reported to bind to GCCA(A/G)G (322). Hence, the binding sites identified almost certainly correspond to PACC binding sites (316).
In the intergenic region between acvA and ipnA of A. chrysogenum (230), there are three potential PACC binding sites, making it likely that these genes are also regulated by a PACC homolog. In addition, it will be interesting to analyze whether the genes of the second cephalosporin biosynthesis cluster are regulated by a PACC homolog in A. chrysogenum.
pacC genes are not confined to
-lactam-producing fungi,
as shown by the recent cloning of the A. niger pacC gene
(202). This gene encodes a three-zinc-finger protein of 667 amino acids (Mr 70,901; gene size of 2192 bp
interrupted by two exons of 139 and 52 bp). The gene seems to be pH
dependent and thus autogenously regulated. Hence, PACC seems to
represent a wide-domain regulator which is involved in the regulation
of expression of penicillin biosynthesis genes.
Because the use of glucose or sucrose as the C source leads to acidification of the medium (see, e.g., references 46, 101, and 104), it was conceivable that the glucose/sucrose effect was due to pH regulation (104). This was further supported by the observation that external alkaline pH could bypass the sucrose repression of steady-state ipnA transcript levels and penicillin titers. Inclusion of 100 mM Na2HPO4 in sucrose broth resulted in an initial pH of 8.0. Northern blot analysis revealed that the ipnA mRNA levels under these conditions were completely derepressed (104). Because buffering at alkaline pH with Tris-Cl increased penicillin titers in glucose media as well, this suggested that the increases were not caused by phosphate ions (104, 295). Additional experiments confirmed that alkaline pH is the factor that derepresses penicillin production in 3% sucrose broth (104). Furthermore, analysis of pacC mutants revealed that they bypassed carbon regulation of ipnA transcript levels, i.e., that pacC mutations caused derepression of steady-state levels of the ipnA mRNA in sucrose broth despite external acidic pH resulting from sucrose utilization (104). However, neither acidic external pH nor the palA1, palB7, or palF5 mutation mimicking the effects of growth at acidic pH prevented C-source derepression (104). Furthermore, the PACC binding sites determined in vitro by the use of a fusion polypeptide containing the PACC DNA binding domain are not located in the cis-acting region, which was shown to mediate C-source repression of ipnA-lacZ expression (104, 322; see "Carbon source regulation" above). Taken together, these data support the model of Espeso et al. (104) and Tilburn et al. (322) involving independent regulatory mechanisms, one mediating carbon source regulation and another mediating pH regulation through the pacC-encoded transcriptional regulator. Since alkaline pH values per se seem to derepress ipnA transcription, Espeso et al. (104) proposed that internal alkalinity represents a physiological signal which triggers penicillin biosynthesis.
However, the use of nonrepressing C sources with respect to ipnA steady-state transcript levels, such as 3% lactose, 1% L-arabinose, or 100 mM acetate, as the principal C source resulted in an increase of the external pH. Growth in repressing C sources, such as 3% sucrose, 1% D-glucose or 1% glycerol caused acidification of the media (104). The authors concluded that carbon limitation, either by using less favorable C sources or by reducing the concentration of favorable C sources, results in external alkalinization whereas the availability of sufficient amounts of a favorable C source causes external acidification. Thus, carbon and pH regulation normally act in concert although the mechanisms are different (104).
In contrast to the situation in A. nidulans, an alkaline ambient pH did not seem to override the negative effect of a repressing C source on ipnA transcription in P. chrysogenum, because full ipnA expression was dependent on carbon source derepression irrespective of the ambient pH (316).
The reason for the pH-mediated regulation of penicillin biosynthesis is
unclear. Arst (18) suggested that it might be associated with the observation that
-lactams exhibit increased toxicity on at
least some bacterial species at alkaline pH. Furthermore, bacterial
competition with fungi may be more intense at alkaline pH (reviewed in
reference 18). This agrees with the results of
Espeso et al. (104), who concluded that for A. nidulans, penicillin biosynthesis in an alkaline environment might
be advantageous even if the C source is not limiting, since alkaline pH
appears to override C repression. On the other hand, limiting C sources seem to allow derepression of ipnA expression at any
external pH; i.e., carbon derepression of ipnA transcription
bypasses the requirement for PACC (104).
Nitrogen Regulation
The effect of the availability of nitrogen source on the penicillin biosynthesis has been discussed for a long time. Sanchez et al. (286) reported the inhibition of penicillin biosynthesis in P. chrysogenum by high levels of ammonium. This effect was correlated with low levels of glutamine synthetase. Mycelia grown at low NH4+ concentrations accumulated higher concentrations of glutamine in the free pool of amino acids and lower concentrations of glutamate. In contrast, increasing the concentration of NH4+ led to a decreased pool of glutamine, an increased glutamate concentration, and poor antibiotic production. It was found that ammonium concentrations [(NH4)2SO4] higher than 100 mM also strongly interfered with cephalosporin C production in A. chrysogenum. L-Asparagine and L-arginine were better nitrogen sources than ammonium with respect to antibiotic yield (296).
Recently, it was demonstrated that in P. chrysogenum, ammonium directly influenced the expression of penicillin biosynthesis genes. By using gene fusions of both penicillin biosynthesis genes ipnA and acvA with the E. coli reporter gene uidA and integration of these gene fusions in single copy at the P. chrysogenum niaD gene locus, it was shown that the expression of both genes was repressed by the addition of 40 mM (NH4)Cl to lactose-grown mycelia (109) (Fig. 5).
Nitrogen metabolite repression is generally regarded as a wide-domain regulatory system, which operates to ensure that a constant nitrogen supply is readily available for growth in response to widely variable or rapidly changing environments. In the absence of favored nitrogen sources, such as ammonium or glutamine, many secondary nitrogen sources, e.g., nitrate, purines, proteines, and amides, were used. These require the de novo synthesis of permeases and catabolic enzymes, whose expression is highly regulated by the nitrogen regulatory circuit (reviewed in references 58 and 218). In A. nidulans and Neurospora crassa, global nitrogen repression and derepression is mediated by the major positive control genes areA and nit-2, respectively (121, 180). Recently, by using a PCR-based approach, the homologous gene of P. chrysogenum, nre, was cloned and shown to complement Nit-2 mutants of N. crassa (132). Each of these three genes encodes regulatory factors with a single Cys-X2-Cys-X17-Cys-X2-Cys-type zinc finger, which, in combination with an immediate downstream basic region, constitutes a DNA binding domain. The overall amino acid sequences of these three regulatory proteins show only 30% identity, but they have 98% identity in their DNA binding domains. A similar zinc finger motif has been found in a wide range of eukaryotic organisms including yeast, plants, chickens, mice, and humans. All of these transcription factors recognize the consensus sequence GATA and can be grouped into a GATA protein family (reviewed in reference 218). The optimal binding sites for NIT-2 were found to consist of at least two GATA elements, which can face in the same or opposite directions, with a spacing which can vary from 3 to 30 bp (66).
A protein consisting of 181 amino acid residues of the 835-residue
P. chrysogenum NRE (132), containing its zinc
finger domain, fused to the N terminus of E. coli
-Gal
was expressed in E. coli. Band shift assays with the
purified
-Gal-NRE fusion protein showed binding with high affinity
to a DNA fragment derived from the intergenic region between
acvA and ipnA of P. chrysogenum.
Although there are six GATA sequences in the intergenic region,
missing-contact experiments with the
-Gal-NRE fusion protein
revealed that NRE strongly interacts with a site that contains two of
these GATA sequences (133). The same GATA sequences were
also strongly bound by N. crassa NIT-2 (110). In
this binding site, the two GATA core sequences are arranged in a
head-to-head fashion and are separated by 27 bp. Therefore, it appears
very likely that nitrogen metabolite regulation of penicillin
biosynthesis genes is mediated through NRE and that these structural
genes for secondary metabolism are regulated as members of a nitrogen
control circuit. This suggests that the availability of favored
nitrogen sources, and thus good growth conditions, leads to reduced
penicillin synthesis by the fungus. However, in vivo studies are
clearly needed to relate NRE binding to potential regulatory functions
(133).
No evidence for nitrogen-dependent regulation of penicillin biosynthesis in A. nidulans has been reported so far. This is also consistent with the observation that the intergenic region between acvA and ipnA of A. nidulans contains only a single GATA motif whereas six GATA sequences are found in the corresponding P. chrysogenum region (133). Thus, it seems unlikely that a single GATA motif is bound by an A. nidulans GATA factor. However, it cannot be entirely ruled out, because members of the metazoan GATA transcription factor family, each containing two zinc fingers homologous to the single zinc finger motif of NRE, also bind to DNA fragments containing single GATN (where N is A, T, C, or G) motifs (170, 231). Interestingly, the P. chrysogenum promoter was shown to respond to nitrogen control when transformed in A. nidulans, indicating that the nitrogen-repressing system of A. nidulans acted on the heterologous promoter (173). Furthermore, it is worth noting that in the intergenic region of the corresponding A. chrysogenum genes (230), there are 15 GATA motifs. It is thus conceivable that these genes are also regulated by a GATA factor.
Amino Acids as Precursors and Mediators of Regulation
Radiochemical tracer studies during the 1940s and 1950s (reviewed
in reference 80) revealed that penicillins and
cephalosporins are naturally synthesized from the three amino acid
precursors L-
-AAA, L-cysteine, and
L-valine. Although only cysteine and valine are finally
incorporated in the
-lactam nucleus, the requirement for
L-
-AAA has long been established (reviewed in reference
86).
Cysteine and valine are ubiquitous, proteinogenic amino acids, whereas
L-
-AAA is an intermediate of the L-lysine
biosynthetic pathway, which occurs in this form only in higher fungi
and euglenids (Euglena gracilis) (Fig.
6). The pathway starts from
-ketoglutaric acid and is named according to its key intermediate,
-aminoadipate (336; reviewed in references
38 and 331). Hence,
L-
-AAA is a branch point between L-lysine
and penicillin and cephalosporin biosynthesis (Fig. 6). Genetic data
suggested, however, that in A. nidulans,
L-
-AAA for penicillin biosynthesis is also provided by
catabolic conversion of L-lysine by an as yet unidentified pathway. This was concluded from the observation that
lysine-auxotrophic mutants defective in the lower part of the pathway
leading to the formation of L-
-AAA produced penicillin
when L-lysine was added to the medium (330)
(Fig. 6).
|
For P. chrysogenum, a similar observation was made
(99). A lysine-auxotrophic mutant blocked in a step before
L-
-AAA was also able to synthesize penicillin when
L-lysine was added to the medium. Additional biochemical
studies with [U-14C]lysine revealed the formation of
labeled saccharopine and L-
-AAA. Hence,
L-
-AAA can also be obtained for penicillin synthesis by reversal of the last steps of the L-lysine biosynthetic
pathway (99) (Fig. 6). In addition, the authors found a high
lysine:
-ketoglutarate-
-aminotransferase activity in P. chrysogenum, which converts L-lysine into
1-piperidine-6-carboxylic acid. This finding suggests the existence of
at least two different pathways involved in the degradation of
L-lysine (99). Taken together, these data
demonstrate that L-
-AAA can be provided by both the
L-lysine biosynthetic pathway and degradation of
L-lysine. The contribution of the latter catabolic pathway
to penicillin production, however, remains to be shown.
In bacteria, the situation is different, because bacteria and green
plants synthesize L-lysine starting from aspartic acid via
a different route, designated the diaminopimelic acid pathway. Since
L-
-AAA is not an intermediate in this pathway, the
question how cephalosporin-producing bacteria obtain the required
L-
-AAA was investigated. In S. clavuligerus,
a specific enzyme activity, lysine
-aminotransferase, was
discovered; this enzyme catalyzes the removal of an amino group of
L-lysine to give cyclic 1-piperidine-6-carboxylic acid,
which is then oxidized to L-
-AAA (205). By
this means,
-lactam-producing streptomycetes can form the precursor
amino acid L-
-AAA for
-lactam biosynthesis. The gene
encoding lysine
-aminotransferase was designated lat and
cloned from both S. clavuligerus (206, 326) and
N. lactamdurans (76). In both bacteria, it is
located within the cephamycin biosynthesis gene cluster (Fig. 3). This
supports the finding that it plays a role exclusively in
-lactam
biosynthesis (76, 205, 206, 326).
A number of different by-products are commonly encountered during the
production of penicillin by P. chrysogenum, one of which is
the
-lactam of L-
-AAA, 6-oxo-piperidine-2-carboxylic
acid (OPC), formed by cyclization of L-
-AAA. This is the
reason why net synthesis of L-
-AAA is required, although
the L-
-AAA moiety of IPN can be reused (52, 120,
143, 183, 328) (Fig. 6).
The synthesis of cysteine for
-lactam biosynthesis is another
crucial factor in the economics of
-lactam formation. Sulfate assimilation in fungi has been studied primarily in S. cerevisiae and N. crassa (reviewed in reference
217). Genetic and biochemical analyses have shown
that the pathway in the
-lactam-producing A. nidulans
requires a sulfate permease (sB) to transport sulfate into
the cell, ATP sulfurylase (sC), adenosine-5-phosphosulfate (APS) kinase (sD), and 3-phosphoadenosine-5-phosphosulfate
(PAPS) reductase (17, 127) (Fig.
7A). Sulfite is reduced to sulfide by the
multienzyme complex sulfite reductase, which involves the transfer of
six electrons from NADPH to the sulfur atom. The overall consumption of
cofactors for the reduction of sulfate to sulfide is 4 mol of NADPH and
2 mol of ATP (Fig. 7A). Thus, the reduction of sulfate to sulfide
accounts for a major part of the metabolic costs in the overall
biosynthesis of L-cysteine (244). Some of the
enzymes involved in
-lactam-producing fungi have been characterized, and the first genes have been cloned (42, 55, 69, 214, 241, 274,
293). The regulation of both cysteine and methionine biosynthesis
appears to be complex and awaits further investigations. Recent work
conducted on A. nidulans and P. chrysogenum has
indicated an additional mode of regulation by allosteric inhibition,
which is absent in yeast (42, 118). This regulation is
thought to occur by the binding of PAPS to a pseudosubstrate site
located in ATP sulfurylase, thus causing feedback inhibition when
excess PAPS is present. At least four regulatory genes control sulfur metabolite repression in A. nidulans (241).
|
Starting from sulfide, three different routes leading to cysteine
biosynthesis have been described (reviewed in references 209,
327, and 331) (Fig. 7B). In the direct
sulfhydrylation pathway, reduced sulfur is incorporated by
O-acetylserine sulfhydrylase into
O-acetyl-L-serine to give cysteine. In a
different pathway, transsulfuration, sulfide incorporation is catalyzed
by O-acetylhomoserine sulfhydrylase. The third possibility
is reverse transsulfuration, in which the sulfur of methionine is
transferred to cysteine (Fig. 7B). Interestingly, different routes
leading to the formation of cysteine are used by the various
-lactam-producing fungi. This is apparently genetically determined.
Although all the pathways seem to exist in A. chrysogenum
(260, 327), the fungus prefers to generate cysteine for
optimal cephalosporin C synthesis by conversion of methionine to
cysteine via reverse transsulfuration. This finding well agrees with
the observation that methionine at certain concentrations has a
regulatory function in the cephalosporin biosynthesis of A. chrysogenum (see below). In contrast, P. chrysogenum and A. nidulans synthesize cysteine mainly from direct
sulfhydrylation starting from serine (260, 327) (Fig. 7B).
The direct sulfhydrylation pathway is energetically more favorable than
the transsulfuration pathway (244) (Fig. 7B).
The biosynthesis of valine is closely connected to the biosynthesis of
leucine. Valine biosynthesis proceeds by four enzymatic steps with two
moles of pyruvate as precursor metabolites (Fig. 8) (reviewed in reference
245). The presence of pools of the three amino acids
specific for
-lactam antibiotic biosynthesis (L-cysteine, L-valine, and
L-
-AAA), separate from the main pool of each amino acid,
has been proposed (144).
|
Because penicillin and cephalosporin are synthesized from amino acid precursors, it was conceivable that amino acids play a role in the regulation of their biosyntheses. This was supported by the observation that in both A. nidulans and P. chrysogenum the addition of L-lysine to fermentation medium led to reduced penicillin titers (48, 84). High levels of L-lysine also interfere with cephalosporin production in A. chrysogenum (227).
Since L-
-AAA is a branch point between
L-lysine and the penicillin and cephalosporin biosynthetic
pathways, L-lysine inhibition of penicillin biosynthesis
was suggested to operate at one or more steps of the
L-lysine pathway (reviewed in 209) (Fig.
6). This was based on the notion that L-lysine caused
feedback inhibition of homocitrate synthase activity in P. chrysogenum (88, 119, 200) (Fig. 6). Homocitrate
synthase catalyzes the initial reaction of L-lysine
biosynthesis. In P. chrysogenum, 75% of this activity is in
the cytoplasm and 25% is in mitochondria (148). Hence, compartmentalization might be important as well. Whether
L-lysine also represses the synthesis of the enzyme is
controversial (149, 200).
-Aminoadipate reductase is also inhibited by L-lysine,
and the inhibition occurs at physiological concentrations, i.e.,
typical cytosolic concentrations of L-lysine
(4). It was demonstrated that in A. nidulans,
another enzyme of the L-lysine biosynthetic pathway
required for the synthesis of L-
-AAA, homoaconitase
encoded by lysF, was reduced in L-lysine-grown
mycelia (338). So far, lysF is the only gene of
the L-lysine biosynthetic pathway cloned from a
-lactam-producing fungus (338). Taken together, it seems very likely that the L-
-AAA pool available for
penicillin production is reduced by L-lysine through
feedback inhibition and through repression of several
L-lysine biosynthesis genes and enzymes (4, 143, 144,
310, 338). When the
-aminoadipate reductase activities (Fig.
6) of three penicillin-producing strains of P. chrysogenum
were compared,
-aminoadipate (
-AAA) reductase from the lowest
penicillin producer was found to be least sensitive to
L-lysine inhibition. The activity in vivo of
-AAA
reductase from superior penicillin producer strains of P. chrysogenum was more strongly inhibited, suggesting that this
might explain the ability of high producers to accumulate increased
amounts of L-
-AAA and consequently produce more
penicillin (196). Furthermore, in A. nidulans,
L-lysine led to repression of the expression of both
acvA and ipnA gene fusions (48),
suggesting, in addition, a more direct effect on the expression of
penicillin biosynthesis genes (Fig. 5). Apparently, in the Panlab
strain development program, there has been selection against inhibition
and/or repression by L-lysine (186).
An important aspect with regard to L-lysine regulation is
the compartmentation of the pathway. Biochemical data obtained with Saccharomyces cerevisiae suggest that the reactions of the
first part of the pathway up to formation of L-
-AAA take
place in the mitochondria whereas those of the second part are in the
cytosol (37). Hence, L-
-AAA has to leave the
mitochondria (Fig. 4). In addition, the major part of intracellular
L-lysine is sequestered in the vacuole (38,
143).
It was reported that the addition of D,L-methionine to the A. chrysogenum medium (final concentration, 20 mM) led to a three- to fourfold increase in the production of cephalosporin C (96, 335). Early during the investigation of this methionine effect, the question arose whether the role of methionine was solely that of a sulfur donor, because the methionine analog norleucine, lacking a sulfur atom, mimicked the methionine inductive effect (289). Final and conclusive proof that the methionine effect acted at the gene expression level came from Velasco et al. (335). These authors reported that the increased production of cephalosporin C triggered by addition of methionine to the medium was paralleled by increased steady-state levels of the mRNAs of the cephalosporin biosynthesis genes acvA, ipnA, cefEF and, to a slight extent, cefG.
Lara et al. (185) reported an inductive effect of L-glutamate on penicillin biosynthesis by P. chrysogenum. However, for these experiments, ammonium chloride (8.5 mM) was used as the nitrogen source and was then replaced by L-glutamate (10 mM). With glutamate, cultures produced about five times the amount of penicillin as in the ammonium-grown controls. Recently, it was shown that the penicillin biosynthesis in P. chrysogenum was reduced when ammonium was used as the nitrogen source. This effect seems to be due, at least in part, to the repression of the penicillin biosynthesis genes acvA and ipnA by ammonium (109), which seems to be mediated by the nitrogen regulatory protein NRE (133). Therefore, it is conceivable that Lara et al. (185) measured nitrogen repression rather than an inducing effect of glutamate.
It was comprehensively tested whether the addition of different amino
acids to the medium affected penicillin biosynthesis by A. nidulans (318). Differential effects due to various
amino acids on the expression of the penicillin biosynthesis genes
acvA and ipnA and penicillin production were
measured. Interestingly, acvA expression seemed to be more
subject to regulation by external amino acids than did ipnA
expression. (i) Some amino acids (e.g., L-threonine,
L-aspartate, L-glutamate, and
L-cysteine) led to increased acvA-uidA
expression but had no major effect on ipnA-lacZ expression.
(ii) The amino acids L-methionine (at concentrations greater than 10 mM), L-leucine, L-isoleucine,
L-phenylalanine, L-valine,
L-histidine, and L-lysine led to repression of
both acvA-uidA and ipnA-lacZ expression, which
was dependent on the concentration used. (iii) The amino acids
L-tyrosine, L-tryptophan, L-proline, and L-
-AAA had no major effect on
acvA-uidA expression but led to repression of
ipnA-lacZ expression. (iv) Two amino acids,
L-serine and L-arginine, did not show any
effect on the expression of either gene fusion at any of the
concentrations tested.
L-Amino acids with a major negative effect on the
expression of acvA-uidA and ipnA-lacZ gene
fusions, i.e., histidine, valine, lysine, and methionine (only at
concentrations greater than 10 mM), led to decreased penicillin titers
and a decreased ambient pH during cultivation of the fungus. An
analysis of deletion clones lacking binding sites of the pH-dependent
transcriptional factor PACC (104, 246, 322) in the
intergenic region between the acvA-uidA and
ipnA-lacZ gene fusions and in a PacC5 mutant strain
suggested that the negative effects of L-histidine and
L-valine on acvA-uidA expression were due to
reduced activation by PACC under the acidic conditions caused by these
amino acids (see Fig. 10). These data also implied that PACC regulates
the expression of acvA, predominantly through PACC binding
site ipnA3 (see Fig. 10). The repressing effect caused by
L-lysine and L-methionine on acvA,
however, was even enhanced in one of the deletion clones and the
pacC5 mutant strain, suggesting that these amino acids act
independently of PACC by exerting effects on gene expression by unknown
mechanisms (Fig. 5). For L-methionine, the analysis of
deletion clones indicated that a major cis-acting DNA
element responsible for its effect on acvA-uidA expression
is located between nucleotides 433 and 569 of the intergenic region.
For L-lysine, no DNA region which could be involved has yet
been identified. The effects of L-methionine and
L-lysine in the medium are mediated by regulatory
mechanisms, which appear to differ even between these two amino acids
(318). It is interesting that L-lysine and
L-methionine are closely related to the precursor amino
acids L-
-AAA and L-cysteine, respectively.
Velasco et al. (335) noticed several consensus CANNTG sequences in the intergenic region of the A. chrysogenum cephalosporin biosynthesis genes acvA and ipnA whose transcription was increased after addition of D,L-methionine. Members of the basic region-helix-loop-helix (bHLH) protein family recognize such a consensus motif. There are many bHLH proteins which are involved in the regulation of a number of genes. These proteins can bind as homo- or heterodimers to DNA (190). Some of these transcription factors are involved in the transcriptional control of the sulfur network in S. cerevisiae (22, 59, 229, 321). Thus, the authors suggested that a member of the bHLH proteins might mediate these effects. By analogy, it is conceivable that the effect of L-methionine on the corresponding A. nidulans genes is due to the action of a similar regulator. However, since there is no conserved CANNTG consensus motif in the region spanned by nucleotides 433 to 569 of the intergenic region between acvA and ipnA, it remains to be elucidated how the effect of methionine is mediated at the molecular level.
Influence of Phosphate and Oxygen
Excess phosphate was found to exert a negative effect on cephalosporin production in A. chrysogenum W53253 (181). The basis of this effect is still a matter of debate, and the molecular mechanism is not understood. It was suggested that phosphate increased the consumption rate of glucose, thus enhancing glucose repression (181), whereas resting-cell experiments indicated that in the absence of glucose, phosphate itself decreased the overall flux to formation of cephalosporin C (213). This was further supported by Zhang et al. (348), who found a direct negative effect of phosphate on formation of several enzymes (ACVS, IPNS, and DAOC synthetase/DAC hydroxylase) of the cephalosporin biosynthesis pathway. It was suggested that phosphate acted on IPNS and DAOC synthetase/DAC hydroxylase by complexing the iron needed for enzyme activity, because the inhibition of these two enzymes could be reversed by adding more ferrous iron (197). However, even inhibition of ACVS, which does not require ferrous iron for activity, was reversed by the addition of Fe2+ (349). Therefore, the cause of the inhibitory effect of phosphate is not yet fully understood.
The availability of oxygen is clearly important for penicillin
production. Good aeration of mycelia with oxygen is a prerequisite for
high
-lactam titers (139; reviewed in reference
317). Since several enzymes, such as IPNS and DAOC
synthetase/DAC hydroxylase, require oxygen for their activity, it is
conceivable that this is the reason for the oxygen requirement. The
importance of oxygen is also supported by the possibility of increasing
cephalosporin production genetically by introducing a bacterial oxygen
binding protein into A. chrysogenum (89;
see "Applications" below). However, there is a contradictory report
which shows that reduction of oxygen led to increased acvA
and ipnA expression of P. chrysogenum, possibly
as part of a stress response (273).
The CCAAT Box Binding Protein Complex PENR1
Since several regulatory circuits affect the regulation of penicillin biosynthesis and presumably more remain to be discovered, a variety of cis-acting DNA elements and regulatory factors can be expected to be involved. Some of these have been found by analysis of mutants (pacC and pal) or by physiological and biochemical analyses (nre). For a comprehensive search of additional cis-acting DNA elements, a deletion analysis of the A. nidulans ipnA gene promoter (257) and a moving-window analysis of the intergenic region between the A. nidulans acvA and ipnA genes (319) were carried out. In the latter, the effects of deletions in the intergenic region were analyzed for the expression of both genes, acvA and ipnA, simultaneously.
Based on the results of this moving-window analysis and together with
band shift and methyl interference assays, a CCAAT-containing DNA motif
(box I) located 409 bp upstream of the ATG initiation codon of the
A. nidulans acvA gene, which is bound by a protein complex
designated PENR1 (penicillin regulator 1), was identified (319) (see Fig. 10). This CCAAT box I is of major importance
for the regulation of both genes, since a 4-bp deletion within this site (
CCA-G) led to an eightfold increase of acvA
expression and simultaneously to a reduction of ipnA
expression to about 30% of the original level (319).
Furthermore, scanning of the A. nidulans aatA promoter
region by band shift assays, using protein fractions eluted with
different KCl concentrations in the buffer from a heparin-agarose
column, led to the identification of an additional CCAAT-containing DNA
element (box II) located about 250 bp upstream of the transcriptional
start sites of aatA. All biochemical data suggested that it
was specifically bound by the same PENR1 regulatory protein complex.
Substitution of the CCAAT core sequence by GATCC led to a fourfold
reduction of expression of an aatA-lacZ gene fusion
(195), indicating that the identified binding site was
functional in vivo and positively influenced aatA expression
(see Fig. 10).
Because PENR1 bound to a CCAAT-containing DNA sequence, this suggested that it belongs to the class of CCAAT binding proteins (195, 319). CCAAT boxes are present in the promoters of many eukaryotic genes. They are bound by distinct transcription factors, which may explain the variety of functions that have been attributed to the CCAAT sequences in the modulation of transcript levels in eukaryotic cells (see, e.g., references 32, 225, 236, 261, 272, and 287; reviewed in references 158 and 233). Several CCAAT binding factors have been found to bind to their target sequence as a complex of heterologous subunits, or heteromers (see, e.g., references 67, 134, and 272). For the time being, it is unknown how many different CCAAT binding proteins exist in filamentous fungi.
Some genes of A. nidulans have also been reported to contain
functional CCAAT sequences in their promoter regions. Band shift experiments and deletion analysis showed that a CCAAT binding factor
(AnCF) is involved in the regulation of the acetamidase gene
amdS, which is required for the use of acetamide as the
nitrogen and C source (189, 332). In addition, the
intergenic region of the bidirectionally transcribed genes
lamA and lamB (needed for utilization of lactams)
and the promoter region of gatA (
-amino butyric acid
transaminase) contain CCAAT boxes which were bound by DNA binding
factors (278). For the gatA CCAAT sequence, this also most probably seems to be AnCF (252). An additional
CCAAT binding factor (AnCP) of A. nidulans was proposed
(163, 240) which bound in vitro to the Taka-amylase gene
promoter of A. oryzae. AnCP was later found to be most
probably identical to AnCF (see below). Finally, deletion of a CCAAT
box in the promoter of the developmentally regulated yA gene
of A. nidulans led to elevated expression of a
yA-lacZ gene fusion (15).
So far, the only CCAAT box binding factor that has been characterized in detail both genetically and biochemically in lower eukaryotes is the S. cerevisiae HAP complex, which consists of at least four subunits: HAP2, HAP3, and HAP5, which form a heterotrimeric complex that is essential for DNA binding, and HAP4, which is an acidic protein that acts as the transcriptional activation domain. Mutations in either of the hap genes led to the inability of yeast cells to grow on nonfermentable C sources such as lactate. It was shown that the HAP complex regulates, for example, the iso-1-cytochrome c (CYC1) gene required for respiration (see, e.g., reference 226; reviewed in reference 128).
Recently, Papagiannopoulos et al. (252) reported the cloning
of a gene from A. nidulans designated hapC that
exhibits significant similarity to the S. cerevisiae HAP3
gene. In a hapC deletion strain (
hapC), the activity of
the CCAAT binding factor AnCF, which is present in wild-type strains
and was detected by the binding of AnCF to CCAAT boxes present in the
promoter regions of the genes gatA and amdS, was
missing. In addition, the
hapC strain hardly grew on acetamide as
the sole nitrogen and C source, indicating that HAPC in fact plays a
role in regulating amdS expression. This was confirmed by
analyzing an amdS-lacZ gene fusion, which showed reduced
expression in a
hapC background. Hence, it seems very
likely that HAPC is a member of the proposed AnCF complex that binds at
least to the CCAAT motif in the gatA and amdS
promoters. Furthermore, band shift and supershift experiments with
polyclonal antibodies against HAPC revealed that AnCP also contains the
HAPC protein (164).
For the CCAAT-binding complex PENR1, its binding consensus motif was
determined by band shift assays as RRCCAAT(C/A)RCR
(320). The deviation of a single base from the consensus
motif reduced the percentage of bound DNA to at least 40% (for some
bases even to 2 to 10%). Since the surrounding bases of the CCAAT site
in the amdS promoter (AGCCAATCACC) match the
PENR1 binding consensus motif except for the last cytosine, it was
conceivable that HAPC is also part of PENR1 and, consequently, that
AnCF and PENR1 share at least some protein components. Partial
purification of PENR1 and Western blotting with anti-HAPC antibodies
indicated that HAPC was highly enriched during purification of PENR1.
Furthermore, band shift assays with partially purified crude extracts
of a
hapC mutant strain revealed that in such crude extracts no
PENR1 activity was detectable. Immunoprecipitation and supershift
experiments with anti-HAPC antibodies provided evidence that HAPC is a
component of the PENR1 complex (193). PENR1 thus represents
a HAP-like transcriptional complex, as does AnCF.
Deletion or mutagenesis of the PENR1 binding sites had opposite
effects; the expression of acvA was increased eightfold
(319), while the expression of ipnA
(319) and aatA (195) was reduced (see
Fig. 10). Formally, the CCAAT box I mediated a negative effect on
acvA, but a positive effect on ipnA, and box II a
positive effect on aatA expression (see Fig. 10). Consistent
with data obtained by deletion of the PENR1 binding site, expression of
an ipnA-lacZ gene fusion in a
hapC background was reduced
to about 15% compared with its expression in the wild type. A similar
effect was observed for the expression of an aatA-lacZ gene
fusion, which was reduced to 10% in the
hapC strain. Hence, PENR1
is of major importance as a positively acting factor of ipnA
and aatA expression. Interestingly, the expression of
ipnA and aatA gene fusions in the
hapC strains was even more reduced than in strains which had a deletion or substitution of the relevant CCAAT boxes. This might suggest that in
addition to the identified CCAAT boxes I and II, other CCAAT boxes are
important for the activity of PENR1 in vivo. Both in the intergenic
region between acvA and ipnA and in the
aatA promoter, there are additional CCAAT boxes. However,
the analysis of the whole aatA promoter by band shift assays
did not reveal another site apart from box II which was bound by PENR1
in vitro (195). This finding does not entirely exclude,
however, that another CCAAT site which is upstream of box II might be
relevant to a certain extent in vivo, although it can only be bound
with low affinity by PENR1 in vitro.
Penicillin titers were reduced in a
hapC background as well, but
only by about 30%. In addition, expression of an acvA-uidA gene fusion was hardly affected by the
hapC mutation
(193). The minor effect of lack of PENR1 on penicillin
production is consistent with the view that acvA expression
is rate limiting in A. nidulans wild-type strains
(165). Whereas overexpression of the acvA gene
led to a massively increased penicillin production (165),
simultaneous overexpression of both ipnA and aatA
had little effect on penicillin production (112). In
contrast, decreased expression of ipnA and aatA
even by a factor of 5, as observed in the
hapC strain, results in a
reduction of penicillin production of only about 30% when the
expression of the acvA gene is only marginally affected.
The observation that acvA expression was less strongly
affected in a
hapC strain was unexpected because it was shown that specific deletion of the four nucleotides CCA plus the 3' G of the
PENR1 binding site between acvA and ipnA (box I)
resulted in a strong increase of acvA expression
(319). It thus appears likely that in addition to PENR1, a
repressor protein binds closely to or overlaps the PENR1 binding site,
which would explain why the PENR1 binding site exhibits a repressing
effect on acvA expression in the wild type. Consistent with
this view, lack of PENR1 binding in the
hapC mutant did not prevent
binding of this putative repressor protein and hence
acvA-uidA expression was not increased. Deletion of the
PENR1 binding site, however, prevented binding of both PENR1 and the
repressor, causing the phenotype of increased acvA expression. However, the existence of such a putative repressor is
hypothetical and remains to be shown experimentally. Proteins binding
overlapping or adjacent to CCAAT boxes have been previously noted for
several CCAAT-containing sequences in vertebrates and fungi (32,
97, 332). It would thus be very interesting to elucidate whether
this also applies to the PENR1 binding sites (193). In
summary, PENR1 represents a HAP-like complex which shares core
proteins, at least HAPC, with AnCF. Because PENR1 does not bind to all
CCAAT-containing sequences in vitro (195, 319) and, in
addition, it is difficult to imagine that the amdS gene is
regulated by the identical complex to that regulating the penicillin
biosynthesis genes (and thus belongs to the same regulatory circuit),
it seems likely that PENR1 differs from AnCF in an accessory
protein(s). A. nidulans genes designated hapE (253) and hapB (192), exhibiting
similarity to the S. cerevisiae hap5 and hap2
genes, respectively, have been cloned and sequenced. The availability
of these genes will help to elucidate both PENR1 and its relation to
the AnCF complex of A. nidulans and, in addition, to search
for further proteins that may be part of the PENR1 complex.
As a result of PENR1 binding, a DNA fragment spanning the CCAAT box I between acvA and ipnA was distorted in vitro by more than 94°. The center of the flexure was predicted to be near or at the CCAAT sequence (193). A similar observation was made for the murine NF-Y complex, which is analogous to the S. cerevisiae HAP complex (281). Binding of NF-Y resulted in distortion of DNA to a degree dependent on the composition of neighboring sequences, varying between 62 and 82°. The center of the bend was also the CCAAT box (281).
The physiological function of HAP-like regulatory factors in lower
eukaryotes remains obscure. In yeast, the HAP complex activates the
expression of genes whose products are required for respiration. Hence,
Hap mutants are not able to grow on nonfermentable carbon sources (see,
e.g., reference 226; reviewed in reference
128). Because A. nidulans, however, is an
aerobic fungus, S. cerevisiae may not be a good model for
the role of HAP-like complexes in aerobic eukaryotes. Furthermore, the
lack of a functional HAP complex (
hapC strain) is not lethal for
A. nidulans (252). In addition, the HAP-like
PENR1 complex in A. nidulans regulates secondary-metabolism
genes (penicillin biosynthesis genes). Hence, it will be interesting to
elucidate whether this particular function of a HAP-like complex
requires as yet unknown accessory proteins, or, alternatively, which
mechanism is involved in allowing a HAP-like complex to regulate
certain sets of genes.
It is interesting that deletion of 4 bp of the PENR1 binding site led
to increased acvA expression and reduced ipnA
expression (319). It has not been clarified whether this
increase of acvA and decrease of ipnA expression
is of physiological relevance. It is tempting to speculate, however,
that under certain physiological conditions an increase of
acvA expression and a simultaneous reduction in the
expression of ipnA and aatA could lead to larger
cellular amounts of ACV. The tripeptide could have, apart from being
the precursor of
-lactams, additional functions, e.g., in amino acid transport, as suggested by Del Carmen Mateos and Sanchez
(83). ACV is structurally very similar to glutathione (GSH),
consisting of the tripeptide
-(L-glutamyl)-L-cysteinyl-glycine. Both ACV and GSH contain the free thiol group of the cysteine residue. They also
have one unusual peptide bond between the
-carbon atom of
L-
-AAA and the
-carbon atom of glutamate and the
cysteine residue in ACV and GSH, respectively. In higher eukaryotes,
GSH is a part of the
-glutamyl cycle, which, among other functions, serves to transport extracellular amino acids across the plasma membrane (228). Experiments with resting cells of P. chrysogenum implied that the ACV tripeptide might be important for
the uptake of glutamine from the medium (83). Consistent
with this hypothesis is the observation that early during a
fermentation run, both ACV tripeptide and the
-lactam OPC (cyclized
L-
-AAA) are found in the fermentation broth (52,
159). OPC appears very similar to 5-oxoproline, the cyclized
product of the
-glutamyl moiety of GSH, produced during
GSH-dependent amino acid transport. Under certain physiological
conditions, it might thus be advantageous for the fungus to produce the
tripeptide first (e.g., for amino acid transport). Then, when binding
of PENR1 and/or a putative repressor causes the expression of
acvA to be reduced and simultaneously the expression of
ipnA and aatA to be increased, the tripeptide is
channelled towards penicillin. In addition, ACV might serve the
function of fixing cysteine, which, at high levels, is toxic. Alternatively, the presence of a repressor could provide an additional possibility to fine-tune acvA expression. These assumptions,
however, are speculative and need to be tested in the future.
Since HAPC is part of PENR1, it seems very likely that the PENR1
complex is conserved among the industrially important
-lactam-producing fungi. This assumption is supported by the
observation that DNA fragments spanning the corresponding intergenic
regions between acvA and ipnA of P. chrysogenum and A. chrysogenum and the promoter region
of the P. chrysogenum aatA gene were able to dilute the complexes of the corresponding A. nidulans probes and
A. nidulans PENR1 protein (195, 319). Computer
analysis showed that DNA elements with a high degree of sequence
identity to the A. nidulans PENR1 site reside within the
intergenic regions of both P. chrysogenum and A. chrysogenum and the aatA promoter region of P. chrysogenum. These sites could be potential targets of homologous
PENR1 complexes in P. chrysogenum and A. chrysogenum.
trans-Acting Mutations Affecting the Expression of Penicillin Biosynthesis Genes
The molecular approaches so far described led to the identification of DNA binding proteins involved in the regulation of penicillin biosynthesis genes. These regulatory proteins seem to represent wide-domain regulators (PACC and NRE). For the HAP-like complex PENR1, this cannot be predicted with certainty at the moment, although it seems likely. However, by analogy to the regulation of biosynthesis of secondary metabolites in streptomycetes (reviewed in reference 39), it can be expected that pathway specific regulatory genes exist.
To identify both such putative genes and regulatory genes not belonging
to the family of DNA binding proteins (such as, e.g., coactivator
proteins or members of a signal transduction cascade), a combination of
classical and molecular techniques was independently used by
Pérez-Esteban et al. (256) and Brakhage and Van den Brulle (50). The aim was the isolation of mutants of
A. nidulans carrying mutations which are specifically
involved in trans in the regulation of expression of the
penicillin biosynthesis genes. The rationale of the approach can be
summarized as follows. A. nidulans strains carrying
ipnA-lacZ gene fusions integrated in double-copy at the
chromosomal argB gene locus were used (Fig. 9). On minimal agar plates supplemented
with
5-bromo-4-chloro-3-indolyl-
-D- galactopyranoside
(X-Gal) as an indicator for
-galactosidase activity, colonies of
such a strain stained blue, indicative of ipnA-lacZ
expression. After mutagenesis, colonies which did not produce a blue
color or produced only a faint blue color were isolated. Cells of such
colonies most probably carried mutations affecting the expression of
ipnA-lacZ gene fusions in trans. The identification of cis-acting mutations, i.e., in the
ipnA promoter or the lacZ gene, seemed to be
unlikely, because such mutations would probably not be detected due to
the second gene fusion located on the chromosome (Fig. 9).
|
By using this approach, mutants carrying recessive mutations were identified, and the genes were designated prg (penicillin regulation) (50) and npeE1 (impaired in penicillin biosynthesis) (256). In penicillin production medium, the mutants exhibited only 5 to 50% of the level of ipnA-lacZ expression and produced only 10 to 30% of the amount of penicillin compared with the wild-type strain. It was demonstrated that mutants Prg-1 (prgA1) and Prg-6 (prgB1) also differed in acvA-uidA expression levels from the wild type and, by Western blot analysis, that these mutants contained reduced amounts of the ipnA gene product, i.e., IPNS (50). Segregation analysis indicated that in both mutants the Prg phenotype resulted from mutation of a single gene. Two different complementation groups were identified, which were designated prgA1 (mutant strain Prg1) and prgB1 (mutant strain Prg6). However, the specific activity of the aatA gene product was essentially the same in the prgA1 and prgB1 mutants as in the wild type, implying that the last step of the penicillin biosynthetic pathway might not be affected, at least to the same extent, by these trans-acting mutations.
Genetic analysis showed that the npeE1 gene is located on linkage group IV (256). To date, it has not been clarified whether npeE1 differs from prgA1 and prgB1. The results obtained by genetic and biochemical analyses indicated that the mutants isolated most probably carry mutations in positively acting regulatory genes, which in the case of prgA1 and prgB1 specifically affect both acvA and ipnA and in the case of npeE1 affect at least ipnA expression (Fig. 10). Cloning of the corresponding genes will show to which kind of putative regulatory genes these mutations correspond and to which regulatory circuits they belong.
|
Using nitrosoguanidine, Cantoral et al. (60) isolated nine mutants of P. chrysogenum Wis54-1255 impaired in penicillin production. Biochemical and genetic analysis suggested that two of these (mutants Npe2 and Npe3) carry mutations in regulatory genes affecting the expression of the entire penicillin biosynthesis gene cluster.
Posttranscriptional Regulation
Discrepancies observed between the expression of structural genes and enzyme specific activities of the corresponding proteins suggested that besides transcriptional regulation, posttranscriptional regulation of penicillin biosynthesis genes occurs (47, 194, 346).
Mycelia of A. nidulans grown with glucose showed reduced IAT specific activities compared with those grown with lactose. When mycelia were first grown with glucose for 12 h, washed to remove remaining glucose, and subsequently transferred to medium with lactose, the IAT specific activities of mycelia rapidly increased, and reached even higher values after 24 h than did control cultures incubated with lactose only (194). This suggested that the effect of glucose on IAT specific activity was reversible. When cultures were first grown with lactose and then transferred to medium containing glucose, the IAT specific activity decreased compared with values measured in mycelia which were further incubated with lactose. In contrast, the expression of an aatA-lacZ gene fusion was only marginally reduced in glucose-grown mycelia compared with lactose-grown mycelia. Taken together, these results suggested that the effect of glucose on IAT specific activity was posttranscriptionally mediated (194).
For the A. chrysogenum ACVS, some posttranslational regulation was also observed with respect to its reduced activity measured in crude extracts obtained from glucose-grown mycelia (346, 349) (see "Carbon source regulation" above).
REGULATION OF
-LACTAM BIOSYNTHESIS IN FUNGAL
PRODUCTION STRAINS
|
|
|---|
Apart from the academic interest in elucidating the molecular
regulation of biosynthesis of secondary metabolites in lower eukaryotes, there is a strong interest from an industrial point of view
because
-lactam compounds are still the most widely sold antibiotics
in the world's antibiotic market (reviewed in reference 211). Hence, it is desirable to analyze highly
producing production strains which are highly mutated and have been
derived from several different strain development programs. This will
help to elucidate the molecular basis of deregulation and of the high
production and also any remaining bottlenecks.
Nowadays, industrial penicillin and cephalosporin production is carried out mainly with P. chrysogenum and A. chrysogenum, respectively. Most of these strains have been produced by mutagenesis followed by screening or selection. In 1972, the initial Panlabs Inc. P. chrysogenum strain made 20,000 U of penicillin per ml in 7 days (an activity equivalent to 12 mg of pure penicillin G, Na salt, per ml [317]). In 1990, the improved strain made 70,000 U per ml in 7 days. Penicillin titers in industry in 1993 were as high as 100,000 U per ml (reviewed in references 211 and 219).
Commercial production of penicillin began in 1941 with P. notatum NRRL 1249-B21 (Northern Regional Research Laboratory, Peoria, Ill.) in surface culture fermentation. The search for superior production strains led to the isolation of P. chrysogenum NRRL 1951 (271). This strain became the ancestor of strains developed at the University of Wisconsin, which resulted in a family of strains (Wis strains) producing ever higher titers of penicillin. Strains descended from members of this series continue to be isolated by pharmaceutical companies (243).
Two important genetic features of P. chrysogenum production strains have been identified: (i) amplification of structural genes and (ii) their massively increased steady-state mRNA levels.
Slot blot and densitometry analysis of genomic DNA from the highly producing strain P. chrysogenum BW1890 (Beecham Pharmaceuticals; derived from the Wisconsin series of strains [reviewed in reference 244]) probed with the ipnA gene indicated that between 8 and 16 copies are present in that strain (304). Furthermore, Southern analysis demonstrated that the entire 39-kb insert of cosmid pCX3.2 carrying all penicillin biosynthesis structural genes (305) is amplified in this high-titer production strain. Northern blot analysis established that the steady-state level of ipnA mRNA in strain BW1890 was 32- to 64-fold that of NRRL 1951, an increase too great to be due to the amplification alone (304). Independently, Barredo et al. (33) showed that in the P. chrysogenum high-titer-producing strains P-2 (a highly producing strain from Nippon Kayaku Co. which was used as the ancestor of many strains in the Panlab series [reviewed in reference 244]) and AS-P-78 (old production strain used by Antibióticos [reviewed in reference 244]), the copy numbers of penicillin biosynthesis genes are approximately nine- and sixfold, respectively.
Fierro et al. (114) showed that in the high-titer P. chrysogenum strains E1 and AS-P-78, the amplifications are organized in tandem repeats. A conserved TTTACA hexanucleotide sequence was suggested to be involved in their generation. This TTTACA sequence borders the 106.5-kb penicillin biosynthesis gene cluster in the wild-type strain NRRL 1951 and also in P. notatum ATCC 9478 (Fleming's isolate). Furthermore, three non-penicillin-producing P. chrysogenum mutants were independently isolated. It was shown that in all of these mutants deletion of the penicillin biosynthesis gene cluster had occurred at a specific site within the conserved hexanucleotide sequence (116). The authors suggested that this site may represent a hot spot for site-specific recombination after mutation with nitrosoguanidine, with the process possibly being part of a fungal SOS system similar to that found in E. coli (114, 116).
This analysis was extended to the characterization of other members of the SmithKline Beecham Pharmaceuticals strain improvement series (243). It was found that the amplicon was 57.5 kb long in these strains. Sequence analysis of the promoter regions of the acvA, ipnA, and aatA genes in the high titer strain BW1901 and comparison with wild-type sequences have not identified any potentially titer-enhancing mutations. Furthermore, cDNA screening has not identified any further transcribed elements within the coamplified region apart from those derived from the structural penicillin biosynthesis genes. The homogeneity of hybridization patterns and the identification and analysis of a single-copy revertant have shown that the amplification is of a direct tandem nature. It was proposed that whether or not the initial recombination event was homologous, once duplication had been achieved, a large stretch of homologous DNA was available for misalignment and hence further amplification or indeed deletion (243).
It appears that in both the SmithKline Beecham strain series and strain E1 (114), the amplified regions are bounded by the same nonamplified BamHI DNA fragments, although the amplicons are apparently not identical (243). Taken together, these data indicated the presence of recombinogenic regions flanking the penicillin biosynthesis gene cluster (114, 243).
Since sequence analysis of promoter regions has shown that no mutations have been generated within the promoter regions of the penicillin biosynthesis structural genes (243), these data suggest that the amplification of gene clusters may be accompanied by changes in trans-acting factors. This is also consistent with the observation that in the high-titer-producing P. chrysogenum strain BW1890 the increase in the steady-state level of ipnA mRNA was too great to be due to the amplification alone (304). However, data obtained with several production strains indicate that penicillin titers were not proportionally increased with copy number. Hence, in these strains the effect of other limiting factors, such as primary metabolic pathways or, in these cases, trans-acting regulatory factors, must be alleviated before the full potential of the extra copies is realized (243). Therefore, it will be of considerable interest to compare regulatory genes already found in both A. nidulans and P. chrysogenum between P. chrysogenum wild-type and production strains.
Furthermore, during the later stages of the fermentation in high-penicillin-producing strain BW1890, a high level of IPNS specific activity was maintained which was not due to increased transcription (304). The stability of IPNS might have increased, because results with A. nidulans imply that IPNS might be inactivated during its catalytic reaction (47).
The IAT specific activity was reduced in cells of A. nidulans and wild-type P. chrysogenum NRRL 1951 grown in medium containing glucose (46) but not in glucose-grown cells of the P. chrysogenum production strain AS-P-78 (277). The loss of the effect of glucose on IAT might be important for P. chrysogenum production strains.
In contrast to the gene amplification of structural genes reported in
P. chrysogenum production strains, the
-lactam
biosynthesis genes seem to be present in single copy in the
cephalosporin C production strain A. chrysogenum LU4-79-6
(299, 301). Kück et al. (179) showed that
A. chrysogenum DSM produces a considerably larger amount of
ipnA transcript and of cephalosporin C (10-fold larger
amount) than does strain ATCC 140553. Hence, as already demonstrated
for penicillin production, increased transcription and consequently
expression of biosynthesis genes seems to be an important feature of
A. chrysogenum production strains.
Several high-cephalosporin C-producing A. chrysogenum strains contained chromosome rearrangements which partly involve the chromosome carrying the acvA and ipnA gene (300, 302, 337). However, for the time being, it is unclear whether rearrangements have an impact on the cephalosporin biosynthesis in production strains.
There are certainly numerous other mutations involved which lead to a
high-producer phenotype. These also concern factors such as
deregulation of enzymes involved in amino acid biosynthesis pathways
and hence the amount of precursor amino acids produced. It was shown,
for instance, that improved P. chrysogenum penicillin production strains have reduced catabolism of L-
-AAA and
flux of L-
-AAA to L-lysine (143).
In addition,
-aminoadipate reductase activity from the lowest
penicillin producer of P. chrysogenum was least sensitive to
L-lysine inhibition whereas the enzyme activity of superior
penicillin producer strains was more strongly inhibited. This might
explain the ability of highly producing strains to accumulate increased
amounts of L-
-AAA, and consequently more penicillin
(196) (see "Amino acids as precursors and mediators of
regulation" above). Goulden and Chattaway (126) found that a high-producing P. chrysogenum strain had twice the
acetohydroxy acid synthase activity of an ancestral strain and that the
enzyme in the superior strain was deregulated to valine feedback
inhibition (Fig. 8). A similar observation was reported for an A. chrysogenum highly producing mutant, in which acetohydroxy acid
synthase was found to be partially desensitized to valine feedback
inhibition (224). These alterations seem to be required to
provide the large amounts of valine needed for penicillin production.
Furthermore, transport of the intermediates of penicillin biosynthesis
between organelles and the number of organelles can be predicted to
also be important for penicillin production strains.
APPLICATIONS
|
|
|---|
The increasing knowledge of the molecular genetics of
-lactam
biosynthesis has opened up new possibilities to rationally improve
-lactam production strains and to engineer new biosynthetic pathways. This leads to the question, however, whether an improvement of productivity is still possible. Cephalosporin C production by
A. chrysogenum is well below the productivity reached with P. chrysogenum for penicillin. Therefore, much effort is
needed to increase cephalosporin C production. For penicillin, several theoretical models have been established based on the available experimental data (summarized in reference 244). By
using detailed stoichiometric models, the theoretical yield was
calculated to be 0.47 to 0.50 mol of penicillin per mol of glucose
(136, 160). Up to now, the maximum theoretical yields
calculated are 8 to 10 times higher than the overall yields observed in
fed-batch cultures, and there is therefore a considerable potential for further improvement of the process. However, it seems unlikely that the
maximum theoretical yields can be reached in a real process, since the
penicillin biosynthesis is indirectly coupled to other cellular
reactions. Therefore, taking this into account, it was estimated that
it should still be possible to improve the current yields by a factor
of 4 to 5, which would have a dramatic effect on the economy of the
process (244).
Several molecular strategies have been followed to improve or alter
-lactam production. (i)
-Lactam biosynthesis genes have been
overexpressed by introducing additional copies or by using strong
promoters. Manipulation of regulatory genes has not been reported yet
because the regulatory genes have only recently been identified. (ii)
-Lactam biosynthetic pathways have been metabolically engineered by
expression of heterologous genes, e.g., production of cephalosporin
precursors in P. chrysogenum. (iii) The increasing knowledge
about peptide synthetase genes, such as those for ACVS enzymes, has
been used to produce novel compounds by genetic engineering (combinatorial biology [208, 312], as also discussed
for polyketide synthetases [137]).
Increase of Expression of
-Lactam Biosynthesis Genes
Kennedy and Turner (165) demonstrated that acvA expression in A. nidulans is rate limiting for penicillin production. The weak acvA gene promoter was replaced by the strong inducible ethanol dehydrogenase promoter (alcAp). The expression level of alcAp was determined by using a strain in which the reporter gene, lacZ, was under the control of alcAp. It was found to be up to 100 times higher than that from the acvA promoter when induced under fermentation conditions with the artificial inducer cyclopentanone (10 mM). Penicillin yields were increased by as much as 30-fold when the acvA gene was overexpressed by induction of the alcA promoter. Glucose, which strongly represses transcription from alcAp, also repressed penicillin biosynthesis in the overproducing strain.
Fernández-Cañón and Peñalva (112) overexpressed both the ipnA and aatA genes of A. nidulans. For this purpose, they placed the promoters of these genes under the control of the alcA promoter. Transcriptional induction of the chimeric genes resulted in 10-fold-higher levels of ipnA or aatA transcripts than of those resulting from transcription of the corresponding endogenous genes. This increase caused a 40-fold rise in IPNS activity or an 8-fold rise in IAT activity. Despite this rise in enzyme levels, forced expression of the ipnA gene resulted in only a modest increase in levels of exported penicillin (increase by about 25%), whereas forced expression of the aatA gene even reduced penicillin production (a decrease of about 10 to 30%), showing that neither of these enzymes is rate limiting for penicillin biosynthesis. These findings agree well with those of Kennedy and Turner (165) that the expression of acvA is rate limiting for penicillin production in A. nidulans. They are also consistent with the observation that the massive reduction of ipnA and aatA expression caused by deletion of the hapC gene, whose product is part of PENR1, resulted in only a moderate reduction of the penicillin titer because acvA expression was only marginally, if at all, affected by deletion of the hapC gene (193).
Furthermore, a genomic version of the alcAp-aatA fusion in which the aatA gene is interrupted by three introns was inducible by threonine (an inducer of alcAp) to a lesser extent (as determined by both aatA mRNA levels and IAT enzyme levels) than was the corresponding cDNA version. This finding suggests that processing of the introns present in the primary transcript may limit aatA overexpression (112).
Consistent with data obtained with A. nidulans, attempts to increase cephalosporin C yields in A. chrysogenum 394-4 (improved cephalosporin C production strain) by inserting multiple copies of the ipnA gene were unsuccessful (301). However, Veenstra et al. (334) transformed P. chrysogenum Wis 54-1255 (an early strain of the strain improvement series) with a DNA fragment containing the P. chrysogenum Wis 54-1255 ipnA and aatA genes. Some of the resulting transformants produced up to 40% more penicillin V, indicating that in this particular P. chrysogenum strain the products of aatA, ipnA, or both can be used to improve penicillin production.
Skatrud et al. (301) reported a 15% increase in cephalosporin C production in an industrial strain of A. chrysogenum (394-4) by transformation of the strain with an extra copy of the DAOC synthetase/DAC hydroxylase gene (cefEF) (to give strain LU4-97-6) (Fig. 2). However, when the experiments were carried out, it was not known that cefG encoding acetyl-CoA:DAC acetyltransferase is closely linked to cefEF (Fig. 3) and was also present on the plasmid used for transformation. Then it was demonstrated that transformants of wild-type A. chrysogenum, carrying additional copies of the cefG gene only, showed a direct relationship between cefG copy number, cefG mRNA levels, and cephalosporin C titers, suggesting that this enzyme might be a rate-limiting step in cephalosporin C production (219, 221). Hence, the effect of the cefEF gene alone in increasing cephalosporin C production remains unclear.
Taken together, these data show that in a wild-type strain of A. nidulans, expression of biosynthesis genes, at least of the acvA gene, is rate limiting. It remains to be elucidated, however, whether this holds for penicillin and cephalosporin production strains. Nevertheless, the expression level of biosynthesis genes, as shown for the cephalosporin C production, is of great importance.
Genetic Engineering of
-Lactam Biosynthetic Pathways
Cloned
-lactam biosynthesis genes can already be used for
rational improvement of
-lactam production. DAOC and cephalosporin C
can be enzymatically deacylated to form 7-aminodeacetoxycephalosporanic acid (7-ADCA) and 7-aminocephalosporanic acid (7-ACA), respectively; these are important intermediates in the manufacturing of oral cephalosporin antibiotics (Fig. 11).
Medically important oral cephalosporins, e.g., cephalexin and
cephradine, are synthesized by derivatizing the 7-amino group of 7-ADCA
or 7-ACA with appropriate side chain moieties (56). Although
cephalosporins are superior antibiotics compared to penicillins, their
production is limited because the process for producing 7-ADCA and
7-ACA is complex. Removal of the natural D-
-aminoadipyl
side chain from cephalosporins is inefficient (82, 222).
Hence, there have been efforts in both directions: isolation of
superior enzymes to remove the side chain directly and development of
alternative biosynthetic routes to 7-ACA and/or 7-ADCA (82,
222).
|
At Eli Lilly & Co., clinically important cephalosporins were apparently
produced by isolating penicillin G from P. chrysogenum and
by chemical ring expansion of this natural product, which requires
protection and sulfoxidation reactions followed by chemical deprotection (62, 264). The resulting deacetoxycephalosporin G is enzymatically deacylated to yield 7-ADCA (61, 62).
Cantwell et al. (62) proposed a biological process in which
penicillin V was used instead of penicillin G because P. chrysogenum strains that produce large amounts of penicillin V are
available. For expansion of the thiazolidine ring of penicillin V to
give a dihydrothiazine ring characteristic of ceph-3-ems, a modified
penicillin N expandase from S. clavuligerus with a changed
substrate specificity would be required. This enzyme should recognize
and convert penicillin V to deacetoxycephalosporin V by ring expansion
better than the wild-type enzyme does. In the last step,
deacetoxycephalosporin V is enzymatically hydrolyzed to 7-ADCA with a
penicillin amidase (62). Although this has apparently not
been achieved experimentally yet, initial experiments showed that it is
possible to express an S. clavuligerus penicillin N
expandase gene (cefE) in P. chrysogenum. The
cefEF gene of A. chrysogenum would not be useful
for this purpose because it also encodes the hydroxylase function
(61) (Table 4). 3'-hydroxylated cephalosporins, however, are
not useful for the manufacturing of 7-ADCA (62). Based on
this, Crawford et al. (82) expressed the S. clavuligerus cefE (expandase) or A. chrysogenum cefEF
(expandase-hydroxylase) gene, with and without the acetyltransferase
gene (cefG), in P. chrysogenum by fusing the
genes to the P. chrysogenum ipnA or the
-tubulin gene
promoter (Fig. 11). Feeding of such transformants with adipic acid led
to the production of cephalosporins having an adipyl side chain (Fig. 11). This proved that adipyl-6-APA is a substrate for either enzyme in
vivo. Transformants expressing cefE (expandase) produced
adipyl-7-ADCA, whereas transformants expressing cefEF
(expandase-hydroxylase) produced both adipyl-7-ADCA and
adipyl-7-aminodeacetylcephalosporanic acid (adipyl-7-ADAC).
Transformants expressing cefEF and cefG (acetyltransferase) produced adipyl-7-ADCA, adipyl-7-ADAC, and adipyl-7-ACA. The adipyl side chain of these cephalosporins was easily
removed with a Pseudomonas-derived glutaryl amidase to yield
the cephalosporin intermediates (Fig. 11). Hence, by these measures, an
important step in cephalosporin manufacturing could be improved
(82).
Cephalosporin C biosynthesis is regulated by the oxygen content of the medium (139). The overall rate of cephalosporin C synthesis is severely reduced under conditions of low oxygen. Reduction of the oxygen supply leads to the accumulation of penicillin N (Fig. 2). The mechanism of oxygen control is not understood. It may be connected to the oxygen-requiring reactions involved in cephalosporin biosynthesis (see "Influence of phosphate and oxygen" above). DeModena et al. (89) improved aerobic metabolism in A. chrysogenum by using the oxygen binding heme protein hemoglobin from the bacterium Vitreoscilla. Its structural gene (VHb) was fused with the strong constitutive TR1 promoter from Trichoderma reseii. After transformation of A. chrysogenum C10, the protein was produced as demonstrated by Western blotting. Several transformants produced significantly higher yields of cephalosporin C than did control strains in batch culture experiments.
Generation of Novel Compounds by Genetic Engineering of Peptide Synthetases
In general, peptide synthetases such as ACVS enzymes possess a highly conserved domain structure. The arrangement of these domains determines the number and order of the amino acid constituents of the peptide product (reviewed in reference 169). Hence, the shuffling of domains, i.e., reprogramming of the protein template, should result in the synthesis of new peptides exhibiting novel amino acid orders. This was achieved by Stachelhaus et al. (312), who exchanged domain-coding regions of bacterial and fungal origin. The authors developed a system allowing targeted substitution of amino acid-activating domains within the srfA operon, which encodes the protein templates for the synthesis of the lipopeptide antibiotic surfactin in Bacillus subtilis. By this method, new hybrid genes were produced whose products showed altered amino acid specificities. The genes were expressed in B. subtilis and led to the production of novel peptides, indicating that the rational design of bioactive peptides by recombinatorial biology is feasible (reviewed in reference 208).
CONCLUSIONS AND FUTURE DIRECTIONS
|
|
|---|
Research on the regulation of biosyntheses of
-lactam
antibiotics is heading toward the elucidation of (i) further regulatory circuits involved, (ii) inducing and repressing signals, (iii) signal
transduction pathways (missing links between regulatory circuits and
regulatory genes), (iv) additional regulators (transcriptional factors,
coactivators, and corepressors), and (v) the mode of action of these
regulatory proteins. Understanding these aspects will also help to
elucidate the physiological and ecological functions of
-lactams for
the producing fungi. The application of this knowledge will contribute
not only to a further increase of
-lactam production and the
production of novel related compounds but also to the identification of
new
-lactam-producing organisms by genetic means. For some of these
aspects, a considerable increase in our knowledge has already been
accumulated; the following discussion summarizes the underlying results
and their future directions.
-Lactam biosynthesis genes are transcribed from specific promoters
and regulated transcriptionally and very probably
posttranscriptionally. Transcription of biosynthesis genes is subject
to sophisticated control by nutritional factors (e.g., glucose,
nitrogen which is putatively mediated by NRE in P. chrysogenum), the amino acids lysine and methionine, and ambient
pH. It can be assumed that there are other regulatory circuits which
remain to be discovered.
With the exception of PACC, which mediates pH-dependent transcription, the regulatory factors responsible for the other regulatory circuits remain unknown. For the repressing effects on A. nidulans gene expression mediated by both L-lysine and L-methionine, their mechanistic basis (signals, regulatory factors) is still obscure. The same applies to the effect of methionine in A. chrysogenum. The effects are regulated at the transcriptional level, and for the methionine effect in A. nidulans a region probably containing the cis-acting DNA element responsible could be located. Nevertheless, the underlying mechanisms are unknown and even seem to differ for L-lysine and L-methionine.
For both penicillin and cephalosporin biosynthesis, the carbon source
is important. Glucose and sucrose lead to reduced
-lactam production. It was shown that some
-lactam biosynthesis genes are
repressed by these C sources. Interestingly, the repressor CREA, which
mediates C-source-dependent repression of some A. nidulans
genes, is not involved. This implies that C-source regulation of
-lactam biosynthesis genes does not follow the general mechanism of
C-source regulation.
Nitrogen regulation of the penicillin biosynthesis genes in P. chrysogenum is most probably due to the action of NRE, which appears to represent a wide-domain nitrogen regulator homologous to the A. nidulans AREA factor. However, the involvement of NRE in nitrogen regulation of P. chrysogenum penicillin biosynthesis genes remains to be confirmed by in vivo studies.
Major questions concern the mechanistic basis of the regulatory circuits identified, and in the case of the HAP-like regulatory complex PENR1, the physiological signals activating this factor.
Much of our knowledge about the molecular regulation of penicillin biosynthesis genes has resulted from work on the fungal pH regulatory system (104, 246, 295, 322). This regulation is particularly interesting because it involves the proteolytic activation of a transcription factor by unknown molecular signals which are triggered by an alkaline ambient pH. Furthermore, several components of the regulation have already been elucidated, i.e., the regulatory circuit including the signal (alkaline ambient pH) and the mechanistic basis (transcriptional factor PACC). Based on the identified and available regulatory pal mutants, the tools are available to investigate the underlying signal transduction pathway.
It is interesting that although the overall patterns of penicillin production are similar in A. nidulans and P. chrysogenum, it appears that differences exist. Suarez and Peñalva (316) proposed that in P. chrysogenum the genes seem to be regulated more strictly than in A. nidulans, e.g., with respect to pH regulation but also with respect to C source and nitrogen regulation. The authors proposed that penicillin production might be more important for the competitiveness and survival of P. chrysogenum. This seems to be supported by the fact that wild-type P. chrysogenum isolates generally produce more penicillin than A. nidulans. However, this cannot be concluded with certainty because for screening of penicillin-producing isolates, only strains which showed increased penicillin production were selected. Thus, this might represent the (pathological) exception rather than the usual production level of P. chrysogenum.
Another question of particular interest is whether the genes are
regulated by pathway-specific or wide-domain regulators. This question
cannot be answered yet. However, the participation of PACC and possibly
NRE, which are also present in non-penicillin-producing fungi, and the
fact that the genes are expressed in the non-
-lactam producer
A. niger (194, 306) indicate that they are
regulated, at least in part, by wide-domain regulatory genes. For the
HAP-like complex PENR1, this has not been confirmed yet, although it
seems likely. PENR1 consists of subunits which are also involved in the
regulation of other than
-lactam biosynthesis genes, such as
amdS. However, since not all components of PENR1 have been determined yet, it is unclear whether this particular complex only
regulates penicillin biosynthesis. Since PENR1 binds to only certain
CCAAT sequences with high affinity in vitro, it appears possible that
PENR1 regulates only some genes. The physiological function of HAP-like
regulatory complexes in lower eukaryotes remains obscure. In S. cerevisiae, the HAP complex activates the expression of genes
whose products are required for respiration. S. cerevisiae
predominantly ferments carbon sources. Therefore, hap
mutants are not able to grow on nonfermentable carbon sources (reviewed
in reference 128). However, because A. nidulans is an aerobic fungus, S. cerevisiae may not be
a good model for the role of HAP-like complexes in aerobic eukaryotes.
Hence, further characterization of the regulatory complexes PENR1 and
AnCF, which at least have common protein components, even if they are
not identical, is needed to elucidate the structure and function of these complexes. If PENR1 regulates other genes than the penicillin biosynthesis genes, such as amdS and gatA, it
will be very interesting to elucidate why these genes belong to a
common regulatory circuit. Candidates for pathway-specific genes,
however, might be found among the recessive mutations identified
(prgA1, prgB1, and npeE1) in A. nidulans and by the mutations carried by the P. chrysogenum mutants Npe2 and Npe3, which seem to specifically
affect the expression of penicillin biosynthesis genes.
In addition to positively acting regulators, all data are consistent with the involvement of negatively acting regulatory factors. A repressor of acvA expression has been proposed in A. nidulans which binds close to or overlaps the PENR1-binding site (box I) (Fig. 10).
Also, because fungi are eukaryotes, it can be expected that the
regulation of
-lactam genes differs from that in prokaryotes. This
view is consistent with the finding that all regulators identified in
fungal
-lactam biosynthesis which are summarized here have no
counterpart in prokaryotes and vice versa. A regulatory gene (ccaR) of both cephamycin and clavulanic acid biosynthesis
was found to be located in the cephamycin biosynthesis gene cluster of
S. clavuligerus (Fig. 3). This gene shows high similarity to regulatory genes involved in the biosynthesis of other secondary metabolites in streptomycetes, such as actinorhodin biosynthesis (258). Furthermore, some fungal regulators might be part of
larger complexes, as proposed for the HAP-like transcriptional complex PENR1. This would also have some effect on strain improvement programs,
because it might be required to overproduce all components of such
complexes in order to obtain overexpression of
-lactam biosynthesis
genes and thus overproduction of
-lactams.
So far, only alkaline ambient pH has been identified as a physiological
signal which triggers penicillin biosynthesis (104). It
appears that the expression of genes is to a certain extent intrinsically constitutive, although this cannot be concluded with
absolute certainty. It might well be that signals that have not yet
been identified, such as cell density, which was proposed to stimulate
-lactam production in streptomycetes (285), are important. In addition, despite significant levels of gene expression in minimal medium, there is only little penicillin production, even
when sufficient amounts of side chain precursor molecules are fed. This
might imply that not only is the production of penicillin of relevance,
but also the production of the ACV and/or IPN precursor molecule, which
could serve additional physiological functions, is relevant.
Nevertheless, the presence of a basal gene expression level implies
that the presence of penicillin and/or precursor molecules is
advantageous to the fungus under different physiological conditions,
although their production consumes energy. This basal gene expression
level seems to be modulated in response to the different environmental
and/or endogenous stimuli; e.g., growth is maximal in the presence of
rapidly metabolizable carbon sources whereas gene expression and
production of penicillin is reduced. Possibly, fungi do not need to
produce large amounts of antibiotics to compete with bacteria when
their growth rate is maximal as a result of the availability of good C
and N sources. In general,
-lactam production seems to be optimal
when the growth of fungi is suboptimal. Therefore, the elucidation of
regulatory genes might also contribute to our understanding of such
questions related to the physiological function of these compounds for
the producing fungus.
It is unclear whether
-lactams serve another function such as
defending the habitat against bacteria. It was suggested that the ACV
tripeptide could have a function in amino acid transport or could help
to fix cysteine, which is toxic at high concentrations. Alternatively,
because the last step of penicillin biosynthesis occurs in microbodies
and can lead to the attachment of aromatic rings to IPN, this might
represent a mechanism of detoxifying these compounds and excreting them
to the environment. There are numerous such compounds in the
environment of penicillin-producing fungi, e.g., derived from the
degradation of lignin. All of these theories, however, have yet to be
proved experimentally.
Since gene expression has a major effect on the production of
-lactam antibiotics in production processes, the knowledge of the
molecular regulation of their biosynthesis genes can be expected to be
of great importance for rational strain improvement programs. This is
particularly relevant because theoretical calculations based on flux
analyses have indicated that there is still an enormous potential to
increase
-lactam productivity. Therefore, overexpression of
regulatory genes that positively affect the expression of both the
-lactam biosynthesis genes and precursor amino acid biosynthesis genes will be attempted and negatively acting regulatory genes will be
inactivated.
Although considerable progress has been made in the understanding of the molecular regulation of penicillin and cephalosporin biosynthesis in fungi, our picture is far from complete.
ACKNOWLEDGMENTS
|
|
|---|
The members of my laboratory, in particular Katharina Then Bergh, Olivier Litzka, Stefan Steidl, Jan Van den Brulle, and Gerhard Weidner, who have generated some of the results summarized here, are gratefully acknowledged for their dedicated work and helpful discussions. I thank Geoffrey Turner, Hans von Döhren, and Arnold L. Demain for comments on the manuscript and Roger Newbert, Miguel A. Peñalva, Norihiro Tsukagoshi, and Geoffrey Turner for kindly communicating results prior to publication. Thanks are due to Natalie Domke for excellent technical assistance and Kim Langfelder for help in improving the manuscript. I am indebted to August Böck for generous support and valuable discussions.
Research in my laboratory was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 369) and the European Union (BIO CT 94-2100 and EUROFUNG).
FOOTNOTES
* Mailing address: Institut für Mikrobiologie und Genetik, Technische Universität Darmstadt, Schnittspahnstrasse 10, D-64287 Darmstadt, Germany, Fax: 49 6151 162956. E-mail: Brakhage{at}bio1.bio.tu-darmstadt.de.
REFERENCES
|
|
|---|
| 1. |
Abraham, E. P.
1983.
History of -lactam antibiotics, p. 1-14.
In
A. L. Demain, and N. A. Solomon (ed.), Antibiotics containing the -lactam structure, vol. I. Springer-Verlag KG, Berlin, Germany.
|
| 2. |
Abraham, E. P.
1990.
Selective reminiscences of -lactam antibiotics: early research on penicillin and cephalosporins.
Bioessays
12:601-606[Medline].
|
| 3. | Abraham, E. P., and G. G. F. Newton. 1961. The structure of cephalosporin C. Biochem. J. 79:377-393. |
| 4. |
Affenzeller, K.,
W. M. Jaklitsch,
C. Hönlinger, and C. P. Kubicek.
1989.
Lysine biosynthesis in Penicillium chrysogenum is regulated by feedback inhibition of -aminoadipate reductase.
FEMS Microbiol. Lett.
58:293-298.
|
| 5. |
Affenzeller, K., and C. P. Kubicek.
1991.
Evidence for a compartmentation of penicillin biosynthesis in a high- and a low-producing strain of Penicillium chrysogenum.
J. Gen. Microbiol.
137:1653-1660 |
| 6. |
Aharonowitz, Y.,
Y. Av-Gay,
R. Schreiber, and G. Cohen.
1993.
Characterization of a broad-range disulfide reductase from Streptomyces clavuligerus and its possible role in -lactam antibiotic biosynthesis.
J. Bacteriol.
175:623-629 |
| 7. |
Aharonowitz, Y.,
J. Bergmeyer,
J. M. Cantoral,
G. Cohen,
A. L. Demain,
U. Fink,
J. R. Kinghorn,
H. Kleinkauf,
A. MacCabe,
H. Palissa,
E. Pfeifer,
T. Schwecke,
H. van Liempt,
H. von Döhren,
S. Wolfe, and J. Zhang.
1993.
-(L- -Aminoadipyl)-L-cysteinyl-D-valine synthetase, the multienzyme integrating the four primary reactions in -lactam biosynthesis, as a model peptide synthetase.
Bio/Technology
11:807-810[Medline].
|
| 8. | Aharonowitz, Y., G. Cohen, and J. F. Martin. 1992. Penicillin and cephalosporin biosynthetic genes: structure, organisation, regulation, and evolution. Annu. Rev. Microbiol. 46:461-495[Medline]. |
| 9. | Alonso, M. J., F. Bermejo, A. Reglero, J. M. Fernández-Cañón, G. González de Buitrago, and J. M. Luengo. 1988. Enzymatic synthesis of penicillins. J. Antibiot. XLI:1074-1084. |
| 10. |
Alvarez, E.,
J. M. Cantoral,
J. L. Barredo,
B. Diez, and J. F. Martin.
1987.
Purification to homogeneity and characterization of acyl coenzyme A:6-amino penicillanic acid acyltransferase of Penicillium chrysogenum.
Antimicrob. Agents Chemother.
31:1675-1682 |
| 11. | Alvarez, E., B. Meesschaert, E. Montenegro, S. Gutiérrez, B. Diez, J. L. Barredo, and J. F. Martin. 1993. The isopenicillin N acyltransferase of Penicillium chrysogenum has isopenicillin N amidohydrolase, 6-aminopenicillanic acid acyltransferase and penicillin amidase activities, all of which are encoded by the single penDE gene. Eur. J. Biochem. 215:323-332[Medline]. |
| 12. | Alvi, K. A., C. D. Reeves, J. Peterson, and J. Lein. 1995. Isolation and identification of a new cephem compound from Penicillium chrysogenum strains expressing deacetoxycephalosporin synthase activity. J. Antibiot. 48:338-340[Medline]. |
| 13. | Aplin, R. T., J. E. Baldwin, S. C. Cole, J. D. Sutherland, and M. B. Tobin. 1993. On the production of alpha, beta-heterodimeric acyl-coenzyme A:isopenicillin N-acyltransferase of Penicillium chrysogenum. Studies using a recombinant source. FEBS Lett. 319:166-170[Medline]. |
| 14. | Aplin, R. T., J. E. Baldwin, P. L. Roach, C. V. Robinson, and C. J. Schofield. 1993. Investigations into the post-translational modification and mechanism of isopenicillin N:acyl-CoA acyltransferase using electrospray mass spectrometry. Biochem. J. 294:357-363. |
| 15. | Aramayo, R., and W. E. Timberlake. 1993. The Aspergillus nidulans yA gene is regulated by abaA. EMBO J. 12:2039-2048[Medline]. |
| 16. |
Arnstein, H. R. V., and D. Morris.
1960.
The structure of a peptide containing -aminoadipic acid, cysteine and valine, present in the mycelium of Penicillium chrysogenum.
Biochem. J.
76:357-361[Medline].
|
| 17. | Arst, H. N., Jr. 1968. Genetic analysis of the first steps of sulphate metabolism in Aspergillus nidulans. Nature 219:268-270[Medline]. |
| 18. | Arst, H. N., Jr. 1996. Regulation of gene expression by pH, p. 235-240. In R. Brambl, and G. A. Marzluf (ed.), The Mycota. III. Biochemistry and molecular biology. Springer-Verlag KG, Berlin, Germany. |
| 19. | Arst, H. N., Jr., E. Bignell, and J. Tilburn. 1994. Two new genes involved in signalling ambient pH in Aspergillus nidulans. Mol. Gen. Genet. 245:787-790[Medline]. |
| 20. | Arst, H. N., Jr., and C. Scazzocchio. 1985. Formal genetic methodology of Aspergillus nidulans as applied to the study of control systems, p. 309-343. In J. W. Bennett, and L. L. Lasure (ed.), Gene manipulations in fungi. Academic Press, Inc., New York, N.Y. |
| 21. | Bailey, C., and H. N. Arst, Jr. 1975. Carbon catabolite repression in Aspergillus nidulans. Eur. J. Biochem. 51:573-577[Medline]. |
| 22. |
Baker, R. E., and D. C. Masison.
1990.
Isolation of the gene encoding the Saccharomyces cerevisiae centromere binding protein CP1.
Mol. Cell. Biol.
10:2458-2467 |
| 23. | Baldwin, J. E., and E. P. Abraham. 1988. The biosynthesis of penicillins and cephalosporins. Nat. Prod. Rep. 5:129-145[Medline]. |
| 24. |
Baldwin, J. E.,
R. M. Adlington,
S. E. Moroney,
L. D. Field, and H.-H. Ting.
1984.
Stepwise ring closure in penicillin biosynthesis. Initial -lactam formation.
J. Chem. Soc. Chem. Commun.
1984:984-986.
|
| 25. | Baldwin, J. E., J. W. Bird, R. A. Field, N. M. O'Callaghan, and C. J. Schofield. 1990. Isolation and partial characterization of ACV synthetase from Cephalosporium acremonium and Streptomyces clavuligerus. J. Antibiot. XLIII:1055-1057. |
| 26. | Baldwin, J. E., J. W. Bird, R. A. Field, N. M. O'Callaghan, C. J. Schofield, and A. C. Willis. 1991. Isolation and partial characterization of ACV synthetase from Cephalosporium acremonium and Streptomyces clavuligerus. Evidence for the presence of phosphopantothenate in ACV synthetase. J. Antibiot. 44:241-248[Medline]. |
| 27. | Baldwin, J. E., J. Gagnon, and H. Ting. 1985. N-terminal amino acid sequence and some properties of isopenicillin-N synthetase from Cephalosporium acremonium. FEBS Lett. 188:253-256[Medline]. |
| 28. |
Baldwin, J. E.,
C.-Y. Shiau,
M. F. Byford, and C. J. Schofield.
1994.
Substrate specificity of -(L- -aminoadipyl)-L-cysteinyl-D-valine synthetase from Cephalosporium acremonium: demonstration of the structure of several unnatural tripeptide products.
Biochem. J.
301:367-372.
|
| 29. | Baldwin, J. E., and T. E. Wan. 1981. Penicillin biosynthesis. Retention of configuration at C-3 of valine during its incorporation into the Arnstein tripeptide. Tetrahedron 37:1589-1595. |
| 30. |
Banko, G.,
A. L. Demain, and S. Wolfe.
1986.
Cell-free synthesis of -(L- -aminoadipyl)-L-cysteine, the first intermediate of penicillin and cephalosporin biosynthesis.
Biochem. Biophys. Res. Commun.
137:528-535[Medline].
|
| 31. |
Banko, G.,
A. L. Demain, and S. Wolfe.
1987.
-(L- -Aminoadipyl)-L-cysteinyl-D-valine synthetase (ACV synthetase): a multifunctional enzyme with broad substrate specificity for the synthesis of penicillin and cephalosporin precursors.
J. Am. Chem. Soc.
109:2858-2860.
|
| 32. | Barberis, A., G. Superti-Furga, and M. Busslinger. 1987. Mutually exclusive interaction of the CCAAT-binding factor and of a displacement protein with overlapping sequences of a histone gene promoter. Cell 50:347-359[Medline]. |
| 33. | Barredo, J. L., B. Diez, E. Alvarez, and J. F. Martin. 1989. Large amplification of a 35-kb DNA fragment carrying two penicillin biosynthetic genes in high penicillin producing strains of P. chrysogenum. Curr. Genet. 16:453-459[Medline]. |
| 34. | Barredo, J. L., J. M. Cantoral, E. Alvarez, B. Diez, and J. F. Martin. 1989. Cloning, sequence analysis and transcriptional study of the isopenicillin N synthase of Penicillium chrysogenum AS-P-78. Mol. Gen. Genet. 216:91-98[Medline]. |
| 35. | Barredo, J. L., P. van Solingen, B. Diez, E. Alvarez, J. M. Cantoral, A. Kattevilder, E. B. Smaal, M. A. M. Groenen, A. E. Veenstra, and J. F. Martin. 1989. Cloning and characterization of the acyl-coenzyme A:6- amino-penicillanic-acid-acyltransferase gene of Penicillium chrysogenum. Gene 83:291-300[Medline]. |
| 36. |
Behmer, C. J., and A. L. Demain.
1983.
Further studies on carbon catabolite regulation of -lactam antibiotic synthesis in Cephalosporium acremonium.
Curr. Microbiol.
8:107-114.
|
| 37. | Betterton, H., T. Fjellstedt, M. Matsuda, M. Ogur, and R. Tate. 1968. Localisation of the homocitrate pathway. Biochim. Biophys. Acta 170:459-461[Medline]. |
| 38. |
Bhattacharjee, J. K.
1992.
Evolution of -aminoadipate pathway for the synthesis of lysine in fungi, p. 47-80.
In
R. P. Mortlock (ed.), The evolution of metabolic function. CRC Press, Inc., Boca Raton, Fla.
|
| 39. |
Bibb, M.
1996.
The regulation of antibiotic production in Streptomyces coelicolor A3(2).
Microbiology
142:1335-1344 |
| 40. | Böck, A., R. Wirth, G. Schmid, G. Schumacher, G. Lang, and P. Buckel. 1983. The penicillin acylase from Escherichia coli ATCC11105 consists of two dissimilar subunits. FEMS Microbiol. Lett. 135:135-139. |
| 41. | Böck, A., R. Wirth, G. Schmid, G. Schumacher, G. Lang, and P. Buckel. 1983. The two subunits of penicillin acylase are processed from a common precursor. FEMS Microbiol. Lett. 20:141-144. |
| 42. | Borges-Walmsley, M. I., G. Turner, A. M. Bailey, J. Brown, J. Lehmbeck, and I. G. Clausen. 1995. Isolation and characterisation of genes for sulphate activation and reduction in Aspergillus nidulans: implications for evolution of an allosteric control region by gene duplication. Mol. Gen. Genet. 247:423-429[Medline]. |
| 43. | Borovok, I., O. Landman, R. Kreisberg-Zakarin, Y. Aharonowitz, and G. Cohen. 1996. Ferrous active site of isopenicillin N synthase: genetic and sequence analysis of the endogenous ligands. Biochemistry 35:1981-1987[Medline]. |
| 44. | Brakhage, A. A. Unpublished data. |
| 45. | Brakhage, A. A. 1997. Molecular regulation of the penicillin biosynthesis in Aspergillus nidulans. FEMS Microbiol. Lett. 148:1-10[Medline]. |
| 46. |
Brakhage, A. A.,
P. Browne, and G. Turner.
1992.
Regulation of Aspergillus nidulans penicillin biosynthesis and penicillin biosynthesis genes acvA and ipnA by glucose.
J. Bacteriol.
174:3789-3799 |
| 47. | Brakhage, A. A., P. Browne, and G. Turner. 1994. Analysis of penicillin biosynthesis and the expression of penicillin biosynthesis genes of Aspergillus nidulans by targeted disruption of the acvA gene. Mol. Gen. Genet. 242:57-64[Medline]. |
| 48. | Brakhage, A. A., and G. Turner. 1992. L-Lysine repression of penicillin biosynthesis and expression of penicillin biosynthesis genes acvA and ipnA in Aspergillus nidulans. FEMS Microbiol. Lett. 98:123-128. |
| 49. | Brakhage, A. A., and G. Turner. 1995. Biotechnical genetics of antibiotic biosynthesis, p. 263-285. In U. Kück (ed.), The Mycota. II. Genetics and biotechnology. Springer-Verlag KG, Berlin, Germany. |
| 50. |
Brakhage, A. A., and J. Van den Brulle.
1995.
Use of reporter genes to identify recessive trans-acting mutations specifically involved in the regulation of Aspergillus nidulans penicillin biosynthesis genes.
J. Bacteriol.
177:2781-2788 |
| 51. | Brotzu, G. 1948. Richerche su di un nuovo antibiotico. Lav. Ist. d'Igiene Cagliari1948:1-11 |
| 52. | Brundidge, S. P., F. C. A. Gaeta, D. J. Hook, C. Sapino, Jr., R. P. Elander, and R. B. Morin. 1980. Association of 6-oxo-piperidine-2-carboxylic acid with penicillin V production in Penicillium chrysogenum fermentations. J. Antibiot. 33:1348-1351[Medline]. |
| 53. | Brunner, R., and M. Röhr. 1975. Phenylacyl:CoA ligase. Methods Enzymol. 43:476-481[Medline]. |
| 54. | Brunner, R., and M. Zinner. 1968. Zur Biosynthese des Penicillins. Hoppe-Seyler's Z. Physiol. Chem. 349:95-103[Medline]. |
| 55. | Brzywczy, J., S. Yamagata, and A. Paszewski. 1993. Comparative studies on O-acetylhomoserine sulfhydrylase: physiological role and characterization of the Aspergillus nidulans enzyme. Acta Biochim. Pol. 40:421-428[Medline]. |
| 56. |
Bunnel, C. A.,
W. D. Luke, and F. M. Perry, Jr.
1986.
Industrial manufacture of cephalosporins, p. 255-284.
In
S. F. Queener, J. A. Webber, and S. W. Queener (ed.), -Lactam antibiotics for clinical use. Marcel Dekker Inc., New York, N.Y.
|
| 57. | Caddick, M. X., A. G. Brownlee, and H. N. Arst, Jr. 1986. Regulation of gene expression by pH of the growth medium in Aspergillus nidulans. Mol. Gen. Genet. 203:346-353[Medline]. |
| 58. | Caddick, M. X., D. Peters, and A. Platt. 1994. Nitrogen regulation in fungi. Antonie Leeuwenhoek 65:169-177. |
| 59. | Cai, M., and R. W. Davis. 1990. Yeast centromere binding protein CBF1, of the helix-loop-helix protein family, is required for chromosome stability and methionine prototrophy. Cell 61:437-446[Medline]. |
| 60. |
Cantoral, J. M.,
S. Gutiérrez,
F. Fierro,
S. Gil-Espinosa,
H. van Liempt, and J. F. Martin.
1993.
Biochemical characterisation and molecular genetics of nine mutants of Penicillium chrysogenum impaired in penicillin biosynthesis.
J. Biol. Chem.
268:737-744 |
| 61. | Cantwell, C., R. Beckmann, P. Whiteman, S. W. Queener, and E. P. Abraham. 1992. Isolation of deacetoxycephalosporin C from fermentation broths of Penicillium chrysogenum transformants: construction of a new fungal biosynthetic pathway. Proc. R. Soc. London Ser. B 248:283-289[Medline]. |
| 62. | Cantwell, C. A., R. J. Beckmann, R. J. Dotzlaf, D. L. Fisher, P. L. Skatrud, W.-K. Yeh, and S. W. Queener. 1990. Cloning and expression of a hybrid S. clavuligerus cefE gene in P. chrysogenum. Curr. Genet. 17:213-221[Medline]. |
| 63. | Carr, L. G., P. L. Skatrud, M. E. Scheetz II, S. W. Queener, and T. D. Ingolia. 1986. Cloning and expression of the isopenicillin N synthetase gene from Penicillium chrysogenum. Gene 48:257-266[Medline]. |
| 64. | Charlier, J. 1972. Isoleucyl-transfer ribonucleic acid synthetase from Bacillus stearothermophilus. 2. Dynamics of the enzyme-substrate interactions. Eur. J. Biochem. 25:175-180[Medline]. |
| 65. |
Chen, V. J.,
A. M. Orville,
M. R. Harpel,
C. A. Frolik,
K. K. Surerus,
E. Münck, and J. D. Lipscomb.
1989.
Spectroscopic studies of isopenicillin N synthase. A mononuclear nonheme Fe2+ oxidase with metal coordination sites for small molecules and substrate.
J. Biol. Chem.
264:21677-21681 |
| 66. | Chiang, T. Y., and G. A. Marzluf. 1994. DNA recognition by the NIT2 nitrogen regulatory protein: importance of the number, spacing, and orientation of GATA core elements and their flanking sequences upon NIT2 binding. Biochemistry 33:576-582[Medline]. |
| 67. | Chodosh, L. A., J. Olesen, S. Hahn, A. S. Baldwin, L. Guarente, and P. A. Sharp. 1988. A yeast and a human CCAAT-binding protein have heterologous subunits that are functionally interchangeable. Cell 53:25-35[Medline]. |
| 68. | Chu, Y.-W., D. Renno, and G. Saunders. 1995. Detection of a protein which binds specifically to the upstream region of the pcbAB gene in Penicillium chrysogenum. Curr. Genet. 27:184-189[Medline]. |
| 69. | Clarke, D. L., R. W. Newbert, and G. Turner. 1997. Cloning and characterisation of the adenosyl phosphosulphate kinase gene from Aspergillus nidulans. Curr. Genet. 32:408-412[Medline]. |
| 70. | Clutterbuck, A. J. 1993. Aspergillus nidulans, nuclear genes, p. 371-384. In S. J. O'Brien (ed.), Genetic maps, 6th ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 71. |
Clutterbuck, P. W.,
R. Lovell, and R. Raistrick.
1932.
The formation from glucose by members of the Penicillium chrysogenum series of a pigment, an alkali-soluble protein and penicillin the antibacterial substance of Fleming.
Biochem. J.
26:1907-1918.
|
| 72. |
Cohen, G.,
A. Argaman,
R. Schreiber,
M. Mislovati, and Y. Aharonowitz.
1994.
The thioredoxin system of Penicillium chrysogenum and its possible role in penicillin biosynthesis.
J. Bacteriol.
176:973-984 |
| 73. | Cohen, G., D. Shiffman, M. Mevarech, and Y. Aharonowitz. 1990. Microbial isopenicillin N synthase genes: structure, function, diversity and evolution. Trends Biotechnol. 8:105-111[Medline]. |
| 74. |
Coque, J.-J. R.,
J. L. De La Fuente,
P. Liras, and J. F. Martin.
1996.
Overexpression of the Nocardia lactamdurans -aminoadipyl-cysteinyl-valine synthetase in Streptomyces lividans. The purified multienzyme uses cystathionine and 6-oxopiperidine 2-carboxylate as substrates for synthesis of the tripeptide.
Eur. J. Biochem.
242:264-270[Medline].
|
| 75. |
Coque, J.-J. R.,
F. J. Enguita,
J. F. Martin, and P. Liras.
1995.
A two-protein component 7 alpha-cephem-methoxylase encoded by two genes of the cephamycin C cluster converts cephalosporin C to 7-methoxycephalosporin C.
J. Bacteriol.
177:2230-2235 |
| 76. |
Coque, J.-J. R.,
P. Liras,
L. Laiz, and J. F. Martin.
1991.
A gene encoding lysine 6-aminotransferase, which forms the -lactam precursor -aminoadipic acid, is located in the cluster of cephamycin biosynthetic genes in Nocardia lactamdurans.
J. Bacteriol.
173:6258-6264 |
| 77. |
Coque, J.-J. R.,
P. Liras, and J. F. Martin.
1993.
Genes for a -lactamase, a penicillin-binding protein and a transmembrane protein are clustered with the cephamycin biosynthetic genes in Nocardia lactamdurans.
EMBO J.
12:631-639[Medline].
|
| 78. | Coque, J.-J. R., J. F. Martin, J. G. Calzada, and P. Liras. 1991. The cephamycin biosynthetic genes pcbAB, encoding a large multidomain peptide synthetase, and pcbC of Nocardia lactamdurans are clustered together in an organization different from the same genes in Acremonium chrysogenum and Penicillium chrysogenum. Mol. Microbiol. 5:1125-1133[Medline]. |
| 79. | Coque, J.-J. R., F. J. Perez-Llarena, F. J. Enguita, J. L. Fuente, J. F. Martin, and P. Liras. 1995. Characterization of the cmcH genes of Nocardia lactamdurans and Streptomyces clavuligerus encoding a functional 3'-hydroxymethylcephem O-carbamoyltransferase for cephamycin biosynthesis. Gene 162:21-27[Medline]. |
| 80. | Corbett, K. 1990. The history of antibiotic production. Biochemist 12:8-13. |
| 81. | Cortes, J., J. F. Martin, J. M. Castro, L. Laiz, and P. Liras. 1987. Purification and characterization of a 2-oxoglutarate-linked ATP-independent deacetoxycephalosporin C synthase of Streptomyces lactamdurans. J. Gen. Microbiol. 133:3165-3174[Medline]. |
| 82. | Crawford, L., A. M. Stepan, P. C. McAda, J. A. Rambosek, M. J. Conder, V. A. Vinci, and C. D. Reeves. 1995. Production of cephalosporin intermediates by feeding adipic acid to recombinant Penicillium chrysogenum strains expressing ring expansion activity. Bio/Technology 13:58-62[Medline]. |
| 83. | Del Carmen Mateos, R., and S. Sanchez. 1990. Transport of neutral amino acids and penicillin formation in Penicillium chrysogenum. J. Gen. Microbiol. 136:1713-1716. |
| 84. | Demain, A. L. 1957. Inhibition of penicillin formation by lysine. Arch. Biochem. Biophys. 67:244-245. |
| 85. | Demain, A. L. 1963. Synthesis of cephalosporin C by resting cells of Cephalosporium sp. Clin. Med. 70:2045-2051. [Medline] |
| 86. |
Demain, A. L.
1983.
Biosynthesis of -lactam antibiotics, p. 189-228.
In
A. L. Demain, and N. A. Solomon (ed.), Antibiotics containing the -lactam structure, vol. I. Springer-Verlag, New York, N.Y.
|
| 87. | Demain, A. L., Y. M. Kennel, and Y. Aharonowitz. 1979. Carbon catabolite regulation of secondary metabolism, p. 163-185. In A. T. Bull, D. C. Ellwood, and C. Ratledge (ed.), Microbial technology: current state, future prospects, vol. 29. Cambridge University Press, Cambridge, United Kingdom. |
| 88. |
Demain, A. L., and P. S. Masurekar.
1974.
Lysine inhibition of in vivo homocitrate synthesis in Penicillium chrysogenum.
J. Gen. Microbiol.
82:143-151 |
| 89. | DeModena, J. A., S. Gutiérrez, J. Velasco, F. J. Fernández, R. A. Fachini, J. L. Galazzo, D. E. Hughes, and J. F. Martin. 1993. The production of cephalosporin C by Acremonium chrysogenum is improved by the intracellular expression of a bacterial hemoglobin. Bio/Technology 11:926-929[Medline]. |
| 90. |
Denison, S. H.,
M. Orejas, and H. N. Arst, Jr.
1995.
Signaling of ambient pH in Aspergillus involves a cysteine protease.
J. Biol. Chem.
270:28519-28522 |
| 91. |
Diez, B. S.,
S. Gutiérrez,
J. L. Barredo,
P. van Solingen,
L. H. M. van der Voort, and J. F. Martin.
1990.
The cluster of penicillin biosynthetic genes. Identification and characterization of the pcbAB gene encoding the -aminoadipyl-cysteinyl-valine synthetase and linkage to the pcbC and penDE genes.
J. Biol. Chem.
265:16358-16365 |
| 92. | Dorn, G. 1965. Genetic analysis of the phosphatases in Aspergillus nidulans. Genet. Res. 6:13-26. |
| 93. |
Dotzlaf, J. E., and W.-K. Yeh.
1987.
Copurification and characterization of deacetoxycephalosporin C synthase/hydroxylase from Cephalosporium acremonium.
J. Bacteriol.
169:1611-1618 |
| 94. |
Dotzlaf, J. E., and W.-K. Yeh.
1989.
Purification and properties of deacetoxycephalosporin C synthase from recombinant Escherichia coli and its comparison with the native enzyme purified from Streptomyces clavuligerus.
J. Biol. Chem.
264:10219-10227 |
| 95. |
Dowzer, C. E. A., and J. M. Kelly.
1991.
Analysis of the creA gene, a regulator of carbon catabolite repression in Aspergillus nidulans.
Mol. Cell. Biol.
11:5701-5709 |
| 96. | Drew, S. W., and A. L. Demain. 1973. Methionine control of cephalosporin C formation. Biotechnol. Bioeng. 15:743-754[Medline]. |
| 97. | El-Hodiri, H. M., and M. Perry. 1995. Interaction of the CCAAT displacement protein with shared regulatory elements required for transcription of paired histone genes. Mol. Cell. Biol. 15:3587-3596[Abstract]. |
| 98. | Erickson, R. C., and L. D. Dean. 1966. Acylation of 6-aminopenicillanic acid by Penicillium chrysogenum. Appl. Microbiol. 14:1047-1048. |
| 99. |
Esmahan, C.,
E. Alvarez,
E. Montenegro, and J. F. Martin.
1994.
Catabolism of lysine in Penicillium chrysogenum leads to formation of 2-aminoadipic acid, a precursor of penicillin biosynthesis.
Appl. Environ. Microbiol.
60:1705-1710 |
| 100. | Espeso, E. A., J. M. Fernández-Cañón, and M. A. Peñalva. 1995. Carbon regulation of penicillin biosynthesis in Aspergillus nidulans: a minor effect of mutations in creB and creC. FEMS Microbiol. Lett. 126:63-68[Medline]. |
| 101. | Espeso, E. A., and M. A. Peñalva. 1992. Carbon catabolite repression can account for temporal pattern of expression of a penicillin biosynthetic gene in Aspergillus nidulans. Mol. Microbiol. 6:1457-1465[Medline]. |
| 102. |
Espeso, E. A., and M. A. Peñalva.
1996.
Three binding sites for the Aspergillus nidulans PacC zinc-finger transcription factor are necessary and sufficient for regulation by ambient pH of the isopenicillin N synthase gene promoter.
J. Biol. Chem.
271:28825-28830 |
| 103. | Espeso, E. A., and M. A. Peñalva. Unpublished data. |
| 104. | Espeso, E. A., J. Tilburn, H. N. Arst, Jr., and M. A. Peñalva. 1993. pH regulation is a major determinant in expression of a fungal biosynthetic gene. EMBO J. 12:3947-3956[Medline]. |
| 105. | Espeso, E. A., J. Tilburn, L. Sánchez-Pulido, C. V. Brown, A. Valencia, H. N. Arst, Jr., and M. A. Peñalva. 1997. Specific DNA recognition by the Aspergillus nidulans three zinc finger transcription factor PacC. J. Mol. Biol. 274:466-480[Medline]. |
| 106. | Fawcett, P. A., J. J. Usher, and E. P. Abraham. 1975. Behaviour of tritium-labelled isopenicillin N and 6-aminopenicillanic acid as potential penicillin precursors in an extract of Penicillium chrysogenum. Biochem. J. 151:741-746[Medline]. |
| 107. |
Fawcett, P. A.,
J. J. Usher,
J. A. Huddleston,
R. C. Bleaney,
J. J. Nisbet, and E. P. Abraham.
1976.
Synthesis of ( -aminoadipyl)cysteinylvaline and its role in penicillin biosynthesis.
Biochem. J.
157:651-660[Medline].
|
| 108. | Felix, H. R., J. Nüesch, and W. Wehrli. 1980. Investigation of the two final steps on the biosynthesis of cephalosporin C using permeabilised cells of Cephalosporium acremonium. FEMS Microbiol. Lett. 8:55-58. |
| 109. |
Feng, B.,
E. Friedlin, and G. A. Marzluf.
1994.
A reporter gene analysis of penicillin biosynthesis gene expression in Penicillium chrysogenum and its regulation by nitrogen and glucose catabolite repression.
Appl. Environ. Microbiol.
60:4432-4439 |
| 110. | Feng, B., E. Friedlin, and G. A. Marzluf. 1995. Nuclear DNA-binding proteins which recognize the intergenic control region of penicillin biosynthetic genes. Curr. Genet. 27:351-358[Medline]. |
| 111. |
Feng, D.-F.,
G. Cho, and R. F. Doolittle.
1997.
Determining divergence times with a protein clock: update and reevaluation.
Proc. Natl. Acad. Sci. USA
94:13028-13033 |
| 112. | Fernández-Cañón, J. M., and M. A. Peñalva. 1995. Overexpression of two penicillin structural genes in Aspergillus nidulans. Mol. Gen. Genet. 246:110-118[Medline]. |
| 113. | Fernández-Cañón, J. M., A. Reglero, H. Martinez-Blanco, and J. M. Luengo. 1989. I. Uptake of phenylacetic acid by Penicillium chrysogenum Wis54-1255: a critical regulatory point in benzylpenicillin biosynthesis. J. Antibiot. XLII:1389-1409. |
| 114. |
Fierro, F.,
J. L. Barredo,
B. Diez,
S. Gutiérrez,
F. J. Fernández, and J. F. Martin.
1995.
The penicillin gene cluster is amplified in tandem repeats linked by conserved hexanucleotide sequences.
Proc. Natl. Acad. Sci. USA
92:6200-6204 |
| 115. | Fierro, F., S. Gutiérrez, B. Diez, and J. F. Martin. 1993. Resolution of four large chromosomes in penicillin-producing filamentous fungi: the penicillin gene cluster is located on chromosome II (9.6 Mb) in Penicillium notatum and chromosome I (10.4 Mb) in Penicillium chrysogenum. Mol. Gen. Genet. 241:573-579[Medline]. |
| 116. | Fierro, F., E. Montenegro, S. Gutiérrez, and J. F. Martin. 1996. Mutants blocked in penicillin biosynthesis show a deletion of the entire penicillin gene cluster at a specific site within a conserved hexanucleotide sequence. Appl. Microbiol. Biotechnol. 44:597-604[Medline]. |
| 117. | Fleming, A. 1929. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenza. Br. J. Exp. Pathol. 10:226-236. |
| 118. |
Foster, B. A.,
S. M. Thomas,
J. A. Mahr,
F. Renosto,
H. C. Patel, and I. H. Segel.
1994.
Cloning and sequencing of ATP sulfurylase from Penicillium chrysogenum: identification of a likely allosteric domain.
J. Biol. Chem.
269:19777-19786 |
| 119. | Friedrich, C. G., and A. L. Demain. 1977. Homocitrate synthase as the crucial site of the lysine effect on penicillin biosynthesis. J. Antibiot. XXX:760-761. |
| 120. |
Friedrich, C. G., and A. L. Demain.
1978.
Uptake and metabolism of -aminoadipic acid by Penicillium chrysogenum Wis 54-1255.
Arch. Microbiol.
119:43-47[Medline].
|
| 121. |
Fu, Y. H., and G. A. Marzluf.
1990.
nit-2, the major positive-acting nitrogen regulatory gene of Neurospora crassa, encodes a sequence-specific DNA-binding protein.
Proc. Natl. Acad. Sci. USA
87:5331-5335 |
| 122. | Fujisawa, Y., and T. Kanzaki. 1975. Role of acetyl-CoA:deacetylcephalosporin C acetyltransferase in cephalosporin C biosynthesis in Cephalosporium acremonium. Agric. Biol. Chem. 39:2043-2048. |
| 123. | Gatenbeck, S., and H. Brunsberg. 1968. Biosynthesis of penicillins. I. Isolation of 6-aminopenicillanic acid acyltransferase from Penicillium chrysogenum. Acta Chem. Scand. 22:1059-1061[Medline]. |
| 124. | Gómez-Pardo, E., and M. A. Peñalva. 1990. The upstream region of the IPNS gene determines expression during secondary metabolism in Aspergillus nidulans. Gene 89:109-115[Medline]. |
| 125. |
Gould, S. J.,
G.-A. Keller,
N. Hosken,
J. Wilkinson, and S. Subramani.
1989.
A conserved tripeptide sorts proteins to peroxisomes.
J. Cell Biol.
108:1657-1664 |
| 126. |
Goulden, S. A., and F. W. Chattaway.
1969.
End product control of acetohydroxy acid synthetase by valine in Penicillium chrysogenum Q-176 and a high penicillin-yielding mutant.
J. Gen. Microbiol.
59:111-118 |
| 127. | Gravel, R. A., E. Kafer, A. Niklewicz-Borkenhagen, and P. Zambryski. 1970. Genetic accumulation studies in sulfite-requiring mutants of Aspergillus nidulans. Can. J. Genet. Cytol. 12:831-840[Medline]. |
| 128. | Guarente, L. 1992. Messenger RNA transcription and its control in Saccharomyces cerevisiae, p. 49-98. In E. W. Jones, J. R. Pringle, and J. R. Broach (ed.), The molecular and cellular biology of the yeast Saccharomyces cerevisiae, vol. 2. Gene expression. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 129. | Gutiérrez, S., B. Diez, E. Alvarez, J. L. Barredo, and J. F. Martin. 1991. Expression of the penDE gene of Penicillium chrysogenum encoding isopenicillin N acyltransferase in Cephalosporium acremonium: production of benzylpenicillin by the transformants. Mol. Gen. Genet. 225:56-64[Medline]. |
| 130. |
Gutiérrez, S.,
B. Diez,
E. Montenegro, and J. F. Martin.
1991.
Characterization of the Cephalosporium acremonium pcbAB gene encoding alpha-aminoadipyl-cysteinyl-valine synthetase, a large multidomain peptide synthetase: linkage to the pcbC gene as a cluster of early cephalosporin biosynthetic genes and evidence of multiple functional domains.
J. Bacteriol.
173:2354-2365 |
| 131. |
Gutiérrez, S.,
J. Velasco,
F. J. Fernandez, and J. F. Martin.
1992.
The cefG gene of Cephalosporium acremonium is linked to the cefEF gene and encodes a deacetylcephalosporin C acetyltransferase closely related to homoserine O-acetyltransferase.
J. Bacteriol.
174:3056-3064 |
| 132. | Haas, H., B. Bauer, B. Redl, G. Stöffler, and G. A. Marzluf. 1995. Molecular cloning and analysis of nre, the major nitrogen regulatory gene of Penicillium chrysogenum. Curr. Genet. 27:150-158[Medline]. |
| 133. | Haas, H., and G. A. Marzluf. 1995. NRE, the major nitrogen regulatory protein of Penicillium chrysogenum binds specifically to elements in the intergenic promoter regions of nitrate assimilation and penicillin biosynthetic gene clusters. Curr. Genet. 28:177-183[Medline]. |
| 134. |
Hahn, S., and L. Guarente.
1988.
Yeast HAP2 and HAP3: transcriptional activators in a heteromeric complex.
Science
240:317-321 |
| 135. | Heatley, N. G. 1990. Early work at Oxford on penicillin. Biochemist 12:4-7. |
| 136. | Hersbach, G. J. M., C. P. van der Beek, and P. W. M. van Dijck. 1984. The penicillins: properties, biosynthesis and fermentation, p. 45-140. In E. J. Vandamme (ed.), Biotechnology of industrial antibiotics. Marcel Dekker, Inc., New York, N.Y. |
| 137. | Hershberger, C. L. 1996. Metabolic engineering of polyketide biosynthesis. Curr. Opin. Biotechnol. 7:560-562[Medline]. |
| 138. | Higgens, C. E., R. C. Hamill, T. H. Sands, M. M. Hoehn, and N. E. Davis. 1974. The occurrence of deacetoxycephalosporin C in fungi and Streptomycetes. J. Antibiot. 27:298-300[Medline]. |
| 139. | Hilgendorf, P., V. Heiser, H. Diekmann, and M. Thoma. 1987. Constant dissolved oxygen concentrations in cephalosporin C fermentation: applicability of different controllers and effect on fermentation parameters. Appl. Microbiol. Biotechnol. XXVII:247-251. |
| 140. | Hillenga, D. J., H. J. M. Versantvoort, S. van der Molen, A. J. M. Driessen, and W. N. Konings. 1995. Penicillium chrysogenum takes up the penicillin G precursor phenylacetic acid by passive diffusion. Appl. Environ. Microbiol. 61:2589-2595[Abstract]. |
| 141. | Hodgkin, D. C., and E. N. Maslen. 1961. The X-ray analysis of the structure of cephalosporin C. Biochem. J. 79:393-402[Medline]. |
| 142. |
Hollander, I. J.,
V. Q. Shen,
J. Heim,
A. L. Demain, and S. Wolfe.
1984.
A pure enzyme catalyzing penicillin biosynthesis.
Science
224:610-612 |
| 143. |
Hönlinger, C., and C. P. Kubicek.
1989.
Metabolism and compartmentation of -aminoadipic acid in penicillin-producing strains of Penicillium chrysogenum.
Biochim. Biophys. Acta
993:204-211.
|
| 144. |
Hönlinger, C., and C. P. Kubicek.
1989.
Regulation of -(L- -aminoadipyl)-L-cysteinyl-D-valine and isopenicillin N biosynthesis in Penicillium chrysogenum by the -aminoadipate pool size.
FEMS Microbiol. Lett.
65:71-76.
|
| 145. | Hoskins, J. A., N. O'Callaghan, S. W. Queener, C. A. Cantwell, J. S. Wood, V. J. Chen, and P. L. Skatrud. 1990. Gene disruption of the pcbAB gene encoding ACV synthetase in Cephalosporium acremonium. Curr. Genet. 18:523-530[Medline]. |
| 146. | Hynes, M. J., and J. Kelly. 1977. Pleiotropic mutants of Aspergillus nidulans altered in carbon source metabolism. Mol. Gen. Genet. 150:193-204[Medline]. |
| 147. |
Ingolia, T. D., and S. W. Queener.
1989.
-Lactam biosynthetic genes.
Med. Res. Rev.
9:245-264[Medline].
|
| 148. | Jaklitsch, W. M., and C. P. Kubicek. 1990. Homocitrate synthase from Penicillium chrysogenum. Biochem. J. 269:247-253[Medline]. |
| 149. | Jaklitsch, W. M., M. Röhr, and C. P. Kubicek. 1987. Lysine biosynthesis in Penicillium chrysogenum: regulation by general amino acid control and absence of lysine repression. Exp. Mycol. 11:141-149. |
| 150. | Jakubowski, H., and J. Pawelkiewicz. 1975. Fractionation of plant aminoacyl-tRNA synthetases on t-RNA-sepharose columns. Eur. J. Biochem. 52:301-310[Medline]. |
| 151. | Jayatilake, S., J. A. Huddleston, and E. P. Abraham. 1981. Conversion of isopenicillin N into penicillin N in cell-free extracts of Cephalosporium acremonium. Biochem. J. 194:645-647[Medline]. |
| 152. | Jensen, S. E., and A. L. Demain. 1995. Beta-lactams, p. 239-268. In L. C. Vining, and C. Stuttard (ed.), Genetics and biochemistry of antibiotic production. Butterworth-Heinemann, Newton, Mass. |
| 153. | Jensen, S. E., B. K. Leskiw, L. C. Vining, Y. Aharonowitz, and D. W. S. Westlake. 1986. Purification of isopenicillin N synthetase from Streptomyces clavuligerus. Can. J. Microbiol. 32:953-958[Medline]. |
| 154. | Jensen, S. E., D. W. S. Westlake, and S. Wolfe. 1982. High performance liquid chromatographic assay of cyclisation activity in cell-free systems from Streptomyces clavuligerus. J. Antibiot. XXXV:1026-1032. |
| 155. | Jensen, S. E., D. W. S. Westlake, and S. Wolfe. 1983. Partial purification and characterization of isopenicillin N epimerase activity from Streptomyces clavuligerus. Can. J. Microbiol. 29:1526-1531[Medline]. |
| 156. | Jensen, S. E., D. W. S. Westlake, and S. Wolfe. 1985. Deacetoxycephalosporin C synthetase and deacetoxycephalosporin C hydroxylase are two separate enzymes in Streptomyces clavuligerus. J. Antibiot. XXXVIII:263-265. |
| 157. |
Jensen, S. E.,
A. Wong,
M. J. Rollins, and D. W. S. Westlake.
1990.
Purification and partial characterization of -(L- -aminoadipyl)-L-cysteinyl-D-valine synthetase from Streptomyces clavuligerus.
J. Bacteriol.
172:7269-7271 |
| 158. | Johnson, P. F., and S. L. McKnight. 1989. Eukaryotic transcriptional regulatory proteins. Annu. Rev. Biochem. 58:799-839[Medline]. |
| 159. | Jorgensen, H. S., J. Nielsen, J. Villadsen, and H. Molgaard. 1995. Analysis of the penicillin V biosynthesis during fed-batch cultivations with a high yielding strain of Penicillium chrysogenum. Appl. Microbiol. Biotechnol. 43:123-130[Medline]. |
| 160. | Jorgensen, H. S., J. Nielsen, J. Villadsen, and H. Molgaard. 1995. Metabolic flux distributions in Penicillium chrysogenum during fed-batch cultivations. Biotechnol. Bioeng. 46:117-131[Medline]. |
| 161. | Kakitani, M., B. Tonomura, and K. Hiromi. 1987. Order of binding of substrate to valyl-tRNA synthetase from Bacillus stearothermophilus in amino acid activation reaction. Biochemistry 14:597-603. |
| 162. |
Kallow, W.,
T. Neuhof,
B. Arezi,
P. Jungblut, and H. von Döhren.
1997.
Penicillin biosynthesis: intermediates of biosynthesis of -(L- -aminoadipyl)-L-cysteinyl-D-valine formed by ACV synthetase from Acremonium chrysogenum.
FEBS Lett.
414:74-78[Medline].
|
| 163. | Kato, M., A. Aoyama, F. Naruse, T. Kobayashi, and N. Tsukagoshi. 1997. An Aspergillus nidulans nuclear protein, AnCP, involved in enhancement of Taka-amylase A gene expression, binds to the CCAAT-containing taaG2, amdS, and gatA promoters. Mol. Gen. Genet. 254:119-126[Medline]. |
| 164. | Kato, M., A. Aoyama, F. Naruse, Y. Tateyama, K. Hayashi, M. Miyazaki, P. Papagiannopoulos, M. A. Davis, M. J. Hynes, T. Kobayashi, and N. Tsukagoshi. 1998. The Aspergillus nidulans CCAAT-binding factor, AnCP/AnCF, is a heteromeric protein analogous to the HAP complex of Saccharomyces cerevisiae. Mol. Gen. Genet. 257:404-411[Medline]. |
| 165. |
Kennedy, J., and G. Turner.
1996.
-(L- -Aminoadipyl)-L-cysteinyl-D-valine synthetase is a rate limiting enzyme for penicillin production in Aspergillus nidulans.
Mol. Gen. Genet.
253:189-197[Medline].
|
| 166. | Kimura, H., M. Izawa, and Y. Sumino. 1996. Molecular analysis of the gene cluster involved in cephalosporin biosynthesis from Lysobacter lactamgenus YK90. Appl. Microbiol. Biotechnol. 44:589-596[Medline]. |
| 167. | Kimura, H., H. Miyashita, and Y. Sumino. 1996. Organization and expression in Pseudomonas putida of the gene cluster involved in cephalosporin biosynthesis from Lysobacter lactamgenus YK90. Appl. Microbiol. Biotechnol. 45:490-501[Medline]. |
| 168. | Kleinkauf, H., and H. von Döhren. 1987. Biosynthesis of peptide antibiotics. Annu. Rev. Microbiol. 41:259-289[Medline]. |
| 169. | Kleinkauf, H., and H. von Döhren. 1996. A nonribosomal system of peptide biosynthesis. Eur. J. Biochem. 236:335-351[Medline]. |
| 170. |
Ko, L. J., and J. D. Engel.
1993.
DNA-binding specificities of the GATA transcription factor family.
Mol. Cell. Biol.
13:4011-4022 |
| 171. | Kodekar, R., and V. D. Deshpande. 1982. Biosynthesis of penicillin in vitro. Purification and properties of phenyl/phenoxyacetic acid activating enzyme. Indian J. Biochem. Biophys. 19:257-261[Medline]. |
| 172. | Kohsaka, M., and A. L. Demain. 1976. Conversion of penicillin N to cephalosporin(s) by cell-free extracts of Cephalosporium acremonium. Biochem. Biophys. Res. Commun. 70:465-473[Medline]. |
| 173. | Kolar, M., K. Holzmann, G. Weber, E. Leitner, and H. Schwab. 1991. Molecular characterization and functional analysis in Aspergillus nidulans of the 5'-region of the Penicillium chrysogenum isopenicillin N synthetase gene. J. Biotechnol. 17:67-80[Medline]. |
| 174. |
Konomi, T.,
S. Herchen,
J. E. Baldwin,
M. Yoshida,
N. A. Hunt, and A. L. Demain.
1979.
Cell-free conversion of -(L- -aminoadipyl)-L-cysteinyl-D-valine into antibiotic with the properties of isopenicillin N in Cephalosporium acremonium.
Biochem. J.
184:427-430[Medline].
|
| 175. |
Kovacevic, S., and J. R. Miller.
1991.
Cloning and sequencing of the -lactam hydroxylase gene (cefF) from Streptomyces clavuligerus: gene duplication may have led to separate hydroxylase and expandase activities in the actinomycetes.
J. Bacteriol.
173:398-400 |
| 176. |
Kovacevic, S.,
M. B. Tobin, and J. R. Miller.
1990.
The -lactam biosynthesis genes for isopenicillin N epimerase and deacetoxycephalosporin C synthetase are expressed from a single transcript in Streptomyces clavuligerus.
J. Bacteriol.
172:3952-3958 |
| 177. |
Kovacevic, S.,
B. J. Weigel,
M. B. Tobin,
T. D. Ingolia, and J. R. Miller.
1989.
Cloning, characterization, and expression in Escherichia coli of the Streptomyces clavuligerus gene encoding deacetoxycephalosporin C synthetase.
J. Bacteriol.
171:754-760 |
| 178. |
Kozma, J.,
G. Bartok, and A. Szentirmai.
1993.
Fructose-2,6-bisphosphate level and -lactam formation in Penicillium chrysogenum.
Int. J. Basic Microbiol.
33:27-34.
|
| 179. | Kück, U., M. Walz, G. Mohr, and M. Mracek. 1989. The 5'-sequence of the isopenicillin N-synthetase gene (pcbC) from Cephalosporium acremonium directs the expression of the prokaryotic hygromycin B phosphotransferase gene (hph) in Aspergillus niger. Appl. Microbiol. Biotechnol. 31:358-365. |
| 180. | Kudla, B., M. X. Caddick, T. Langdon, N. M. Martinez-Rossi, C. F. Benett, S. Silbey, R. W. Davis, and H. N. Arst, Jr. 1990. The regulatory gene areA mediating nitrogen metabolite repression in Aspergillus nidulans. Mutations affecting specificity of gene activation alter a loop residue of a putative zinc finger. EMBO J. 9:1355-1364[Medline]. |
| 181. | Küenzi, M. T. 1980. Regulation of cephalosporin synthesis in Cephalosporium acremonium by phosphate and glucose. Arch. Microbiol. 128:78-81[Medline]. |
| 182. |
Kupka, J.,
Y.-Q. Shen,
S. Wolfe, and A. L. Demain.
1983.
Partial purification and properties of the -ketoglutarate-linked ring expansion enzyme of -lactam biosynthesis.
FEMS Microbiol. Lett.
16:1-6.
|
| 183. | Kurzatkowski, W., J. D. Kurzatkowski, J. Filipek, J. Solecka, W. Holska, and W. Kurylowicz. 1990. Reversion of L-lysine inhibition of penicillin G biosynthesis by 6-oxopiperidine-2-carboxylic acid in Penicillium chrysogenum PQ96. Appl. Microbiol. Biotechnol. 34:397-398[Medline]. |
| 184. | Landan, G., G. Cohen, Y. Aharonowitz, Y. Shuali, D. Graur, and D. Shiffman. 1990. Evolution of isopenicillin N synthase genes may have involved horizontal gene transfer. Mol. Biol. Evol. 7:399-406[Abstract]. |
| 185. | Lara, F., R. del Carmen Mateos, D. Vazquez, and S. Sanchez. 1982. Induction of penicillin biosynthesis by glutamate in Penicillium chrysogenum. Biochem. Biophys. Res. Commun. 105:172-178[Medline]. |
| 186. | Lein, J. 1986. The Panlabs penicillin strain improvement program, p. 105-139. In Z. Vanek, and Z. Hostálek (ed.), Overproduction of microbial metabolites. Butterworths, Boston, Mass. |
| 187. |
Lendenfeld, T.,
D. Ghali,
M. Wolschek,
E. M. Kubicek-Pranz, and C. P. Kubicek.
1993.
Subcellular compartmentation of penicillin biosynthesis in Penicillium chrysogenum.
J. Biol. Chem.
268:665-671 |
| 188. | Li, W.-H., C.-C. Luo, and C.-I. Wu. 1985. Evolution of DNA sequences, p. 1-94. In R. J. MacIntyre (ed.), Molecular evolutionary genetics. Plenum Press, New York, N.Y. |
| 189. | Littlejohn, T. G., and M. J. Hynes. 1992. Analysis of the site of action of the amdR product for regulation of the amdS gene of Aspergillus nidulans. Mol. Gen. Genet. 235:81-88[Medline]. |
| 190. | Littlewood, T., and G. I. Evan. 1994. Protein profile. Transcription factors 2: helix-loop-helix, vol. 1, issue 6. Academic Press, Ltd., London, United Kingdom. |
| 191. | Litzka, O., and A. A. Brakhage. Unpublished data. |
| 192. | Litzka, O., and A. A. Brakhage. Unpublished data. EMBL accession no. Y13768. |
| 193. | Litzka, O., P. Papagiannopoulos, M. A. Davis, M. J. Hynes, and A. A. Brakhage. 1998. The penicillin regulator PENR1 of Aspergillus nidulans is a HAP-like transcriptional complex. Eur. J. Biochem. 251:758-767[Medline]. |
| 194. | Litzka, O., K. Then Bergh, and A. A. Brakhage. 1995. Analysis of the regulation of Aspergillus nidulans penicillin biosynthesis gene aat (penDE) encoding acyl coenzyme A:6-aminopenicillanic acid acyltransferase. Mol. Gen. Genet. 249:557-569[Medline]. |
| 195. | Litzka, O., K. Then Bergh, and A. A. Brakhage. 1996. The Aspergillus nidulans penicillin biosynthesis gene aat (penDE) is controlled by a CCAAT containing DNA element. Eur. J. Biochem. 238:675-682[Medline]. |
| 196. |
Lu, Y.,
R. L. Mach,
K. Affenzeller, and C. P. Kubicek.
1992.
Regulation of -aminoadipate reductase from Penicillium chrysogenum in relation to the flux from -aminoadipate into penicillin biosynthesis.
Can. J. Microbiol.
38:758-763[Medline].
|
| 197. | Lübbe, C., S. E. Jensen, and A. L. Demain. 1984. Prevention of phosphate inhibition of cephalosporin synthetases by ferrous ion. FEMS Microbiol. Lett. 25:75-79. |
| 198. | Luengo, J. M. 1995. Enzymatic synthesis of hydrophobic penicillins. J. Antibiot. 48:1195-1212[Medline]. |
| 199. | Luengo, J. M., J. L. Iriso, and M. J. López-Nieto. 1986. Direct evaluation of phenylacetyl-CoA:6-aminopenicillanic acid acyltransferase of Penicillium chrysogenum by bioassay. J. Antibiot. XXXIX:1565-1573. |
| 200. |
Luengo, J. M.,
G. Revilla,
M. J. López-Nieto,
J. R. Villanueva, and J. F. Martin.
1980.
Inhibition and repression of homocitrate synthetase by lysine in Penicillium chrysogenum.
J. Bacteriol.
144:869-876 |
| 201. | MacCabe, A. P., M. B. R. Riach, S. E. Unkles, and J. R. Kinghorn. 1990. The Aspergillus nidulans npeA locus consists of three contiguous genes required for penicillin biosynthesis. EMBO J. 9:279-287[Medline]. |
| 202. | MacCabe, A. P., J. P. T. W. van den Hombergh, J. Tilburn, H. N. Arst, Jr., and J. Visser. 1996. Identification, cloning and analysis of the Aspergillus niger gene pacC, a wide domain regulatory gene responsive to ambient pH. Mol. Gen. Genet. 250:367-374[Medline]. |
| 203. |
MacCabe, A. P.,
H. van Liempt,
H. Palissa,
S. E. Unkles,
M. B. R. Riach,
E. Pfeifer,
H. von Döhren, and J. R. Kinghorn.
1991.
-(L- -Aminoadipyl)-L-cysteinyl-D-valine synthetase from Aspergillus nidulans molecular characterization of the acvA gene encoding the first enzyme of the penicillin biosynthetic pathway.
J. Biol. Chem.
266:12646-12654 |
| 204. | Macdonald, K. D., and G. Holt. 1976. Genetics of biosynthesis and overproduction of penicillin. Sci. Prog. Oxford 63:547-573. |
| 205. |
Madurri, K.,
C. Stuttard, and L. C. Vining.
1989.
Lysine catabolism in Streptomyces spp. is primarily through cadaverine: -lactam producers also make -aminoadipate.
J. Bacteriol.
171:299-302 |
| 206. |
Madurri, K.,
C. Stuttard, and L. C. Vining.
1991.
Cloning and location of a gene governing lysine epsilon-aminotransferase, an enzyme initiating beta-lactam biosynthesis in Streptomyces spp.
J. Bacteriol.
173:985-988 |
| 207. | Malpartida, F., and D. A. Hopwood. 1986. Physical and genetic characterization of the gene cluster for the antibiotic actinorhodin in Streptomyces coelicolor A3(2). Mol. Gen. Genet. 205:66-73[Medline]. |
| 208. | Marahiel, M. A., T. Stachelhaus, and H. D. Mootz. 1997. Modular peptide synthetases involved in nonribosomal peptide synthesis. Chem. Rev. 97:2651-2673[Medline]. |
| 209. |
Martin, J. F., and Y. Aharonowitz.
1983.
Regulation of biosynthesis of -lactam antibiotics, p. 229-254.
In
A. L. Demain, and N. A. Solomon (ed.), Antibiotics containing the -lactam structure, vol. I. Springer-Verlag, KG, Berlin, Germany.
|
| 210. |
Martin, J. F., and A. L. Demain.
1980.
Control of antibiotic biosynthesis.
Microbiol. Rev.
44:230-251 |
| 211. |
Martin, J. F.,
S. Gutiérrez, and A. L. Demain.
1997.
-Lactams, p. 91-127.
In
T. Anke (ed.), Fungal biotechnology. Antibiotics. Chapman & Hall, Weinheim, Germany.
|
| 212. | Martin, J. F., and P. Liras. 1989. Organization and expression of genes involved in the biosynthesis of antibiotics and other secondary metabolites. Annu. Rev. Microbiol. 43:173-206[Medline]. |
| 213. | Martin, J. F., G. Revilla, D. M. Zanca, and M. J. López-Nieto. 1982. Carbon catabolite regulation of penicillin and cephalosporin biosynthesis, p. 258-268. In H. Umezawa, A. L. Demain, T. Hata, and C. R. Hutchinson (ed.), Trends in antibiotic research. Japanese Antibiotics Research Association, Tokyo, Japan. |
| 214. |
Martin, R. L.,
L. A. Daley,
Z. Lovric,
L. M. Wailes,
F. Renosto, and I. H. Segel.
1989.
The "regulatory" sulfhydryl group of Penicillium chrysogenum ATP sulfurylase.
J. Biol. Chem.
264:11768-11775 |
| 215. | Martinez-Blanco, H., M. Orejas, A. Reglero, J. M. Luengo, and M. A. Peñalva. 1993. Characterisation of the gene encoding acetyl-CoA synthetase in Penicillium chrysogenum: conservation of intron position in plectomycetes. Gene 130:265-270[Medline]. |
| 216. |
Martinez-Blanco, H.,
A. Reglero,
M. Fernández-Valverde,
M. A. Ferrero,
M. A. Moreno,
M. A. Peñalva, and J. M. Luengo.
1992.
Isolation and characterisation of the acetyl-CoA synthetase from Penicillium chrysogenum. Involvement of this enzyme in the biosynthesis of penicillins.
J. Biol. Chem.
267:5474-5481 |
| 217. | Marzluf, G. A. 1993. Regulation of sulfur and nitrogen metabolism in filamentous fungi. Annu. Rev. Microbiol. 47:31-55[Medline]. |
| 218. | Marzluf, G. A. 1997. Genetic regulation of nitrogen metabolism in the fungi. Microbiol. Mol. Biol. Rev. 61:17-32[Abstract]. |
| 219. | Mathison, L., C. Soliday, T. Stepan, T. Aldrich, and J. Rambosek. 1993. Cloning, characterization, and use in strain improvement of the Cephalosporium acremonium gene cefG encoding acetyl transferase. Curr. Genet. 23:33-41[Medline]. |
| 220. | Matsuda, A., H. Sugiura, K. Matsuyama, H. Matsumoto, S. Ichikawa, and K.-I. Komatsu. 1992. Molecular cloning of acetyl coenzyme A:deacetylcephalosporin C O-acetyltransferase cDNA from Acremonium chrysogenum: sequence and expression of catalytic activity in yeast. Biochem. Biophys. Res. Commun. 182:995-1001[Medline]. |
| 221. | Matsuda, A., H. Sugiura, K. Matsuyama, H. Matsumoto, S. Ichikawa, and K.-I. Komatsu. 1992. Cloning and disruption of the cefG gene encoding acetyl coenzyme A:deacetylcephalosporin C O-acetyltransferase from Acremonium chrysogenum. Biochem. Biophys. Res. Commun. 186:40-46[Medline]. |
| 222. | Matsumoto, K. 1993. Production of 6-APA, 7-ACA and 7-ADCA by immobilised penicillin and cephalosporin amidases, p. 67-88. In A. Tanaka, T. Tosa, and T. Kobayashi (ed.), Industrial application of immobilized biocatalysts. Marcel Dekker, Inc., New York, N.Y. |
| 223. | Matsumura, M., T. Imanaka, T. Yoshida, and H. Taguchi. 1978. Effect of glucose and methionine consumption rates on cephalosporin C production by Cephalosporium acremonium. J. Ferment. Technol. 56:345-353. |
| 224. | Matsumura, S., and M. Suzuki. 1986. Feedback regulation of acetohydroxy acid synthase in Cephalosporium acremonium M8650 and a high cephalosporin-producing mutant. Agric. Biol. Chem. 50:505-507. |
| 225. | McKnight, S., and R. Tjian. 1986. Transcriptional selectivity of viral genes in mammalian cells. Cell 46:795-805[Medline]. |
| 226. |
McNabb, D. S.,
Y. Xing, and L. Guarente.
1995.
Cloning of yeast HAP5: a novel subunit of a heterotrimeric complex required for CCAAT binding.
Genes Dev.
9:47-58 |
| 227. | Mehta, R. J., J. L. Speth, and C. H. Nash. 1979. Lysine stimulation of cephalosporin C synthesis in Cephalosporium acremonium. Eur. J. Appl. Microbiol. Biotechnol. 8:177-182. |
| 228. | Meister, A., and M. E. Anderson. 1983. Glutathione. Annu. Rev. Biochem. 52:711-760[Medline]. |
| 229. | Mellor, J., W. Jiang, M. Funk, J. Rathjen, J. C. Barnes, T. Hinz, J. H. Hegeman, and P. Philippsen. 1990. CBF1, a yeast protein which functions in centromeres and promoters. EMBO J. 9:4017-4026[Medline]. |
| 230. | Menne, S., M. Walz, and U. Kück. 1994. Expression studies with the bidirectional pcbAB-pcbC promoter region from Acremonium chrysogenum using reporter gene fusions. Appl. Microbiol. Biotechnol. 42:57-66[Medline]. |
| 231. | Merika, M., and S. H. Orkin. 1995. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Krüppel family proteins SP1 and EKLF. Mol. Cell. Biol. 15:2437-2447[Abstract]. |
| 232. | Ming, L.-J., L. Que, Jr., A. Kriauciunas, C. A. Frolik, and V. A. Chen. 1990. Coordination chemistry of the metal binding site of isopenicillin N synthase. Inorg. Chem. 29:1111-1112. |
| 233. |
Mitchel, P. J., and R. Tjian.
1989.
Transcriptional regulation in mammalian cells by sequence specific DNA binding proteins.
Science
245:371-378 |
| 234. | Montenegro, E., J. L. Barredo, S. Gutiérrez, B. Diez, E. Alvarez, and J. F. Martin. 1990. Cloning, characterization of the acyl-CoA:6-aminopenicillanic acid acyltransferase gene of Aspergillus nidulans and linkage to the isopenicillin N synthase gene. Mol. Gen. Genet. 221:322-330[Medline]. |
| 235. |
Montenegro, E.,
F. Fierro,
F. J. Fernandez,
S. Gutiérrez, and J. F. Martin.
1992.
Resolution of chromosomes III and VI of Aspergillus nidulans by pulsed-field gel electrophoresis shows that the penicillin biosynthetic pathway genes pcbAB, pcbC, and penDE are clustered on chromosome VI (3.0 megabases).
J. Bacteriol.
174:7063-7067 |
| 236. |
Morgan, W. D.,
G. T. Williams,
R. I. Morimoto,
J. Greene,
R. E. Kingston, and R. Tjian.
1987.
Two transcriptional activators, CCAAT-box-binding transcription factor and heat shock transcription factor, interact with a human hsp70 gene promoter.
Mol. Cell. Biol.
7:1129-1138 |
| 237. | Müller, W. H., R. A. L. Bovenberg, M. H. Groothuis, F. Kattevilder, E. B. Smaal, L. H. M. van der Voort, and A. Verkleij. 1992. Involvement of microbodies in penicillin biosynthesis. Biochim. Biophys. Acta 1116:210-213[Medline]. |
| 238. | Müller, W. H., T. P. van der Krift, A. J. J. Krouwer, H. A. B. Wösten, L. H. M. van der Voort, E. B. Smaal, and A. J. Verkleij. 1991. Localization of the pathway of the penicillin biosynthesis in Penicillium chrysogenum. EMBO J. 10:489-495[Medline]. |
| 239. | Nagarajan, R., L. D. Boeck, M. Gorman, R. L. Hamill, C. E. Higgens, M. M. Hoehn, W. M. Stark, and J. G. Whitney. 1971. Beta-lactam antibiotics from Streptomyces. J. Am. Chem. Soc. 93:2308-2310[Medline]. |
| 240. | Nagata, O., T. Takashima, M. Tanaka, and N. Tsukagoshi. 1993. Aspergillus nidulans nuclear proteins bind to a CCAAT element and the adjacent upstream sequence in the promoter region of the starch-inducible Taka-amylase A gene. Mol. Gen. Genet. 237:251-260[Medline]. |
| 241. | Natorff, R., M. Balinska, and A. Paszewski. 1993. At least four regulatory genes control sulfur metabolite repression in Aspergillus nidulans. Mol. Gen. Genet. 238:185-192[Medline]. |
| 242. |
Negrete-Urtasun, S.,
S. H. Denison, and H. N. Arst, Jr.
1997.
Characterization of the pH signal transduction pathway palA of Aspergillus nidulans and identification of possible homologs.
J. Bacteriol.
179:1832-1835 |
| 243. | Newbert, R. W., B. Barton, P. Greaves, J. Harper, and G. Turner. 1997. Analysis of a commercially improved Penicillium chrysogenum strain series: involvement of recombinogenic regions in amplification and deletion of the penicillin biosynthesis gene cluster. J. Ind. Microbiol. Biotechnol. 19:18-27[Medline]. |
| 244. | Nielsen, J. 1995. Physiological engineering aspects of Penicillium chrysogenum. Polyteknisk Forlag, Lyngby, Denmark. |
| 245. |
Nüesch, J.,
J. Heim, and H.-J. Treichler.
1987.
The biosynthesis of sulfur-containing -lactam antibiotics.
Annu. Rev. Microbiol.
41:51-75[Medline].
|
| 246. |
Orejas, M.,
E. A. Espeso,
J. Tilburn,
S. Sarkar,
H. N. Arst, Jr., and M. A. Peñalva.
1995.
Activation of the Aspergillus PacC transcription factor in response to alkaline ambient pH requires proteolysis of the carboxy-terminal moiety.
Genes Dev.
9:1622-1632 |
| 247. |
Orville, A. M.,
V. J. Chen,
A. Kriauciunas,
M. R. Harpel,
B. G. Fox,
E. Munck, and J. D. Lipscomb.
1992.
Thiolate ligation of the active site Fe2+ of isopenicillin N synthase derives from substrate rather than endogenous cysteine: spectroscopic studies of site-specific Cys Ser mutated enzymes.
Biochemistry
31:4602-4612[Medline].
|
| 248. |
O'Sullivan, J.,
R. C. Bleaney,
J. A. Huddleston, and E. P. Abraham.
1979.
Incorporation of 3H from -(L- -amino[4,5-3H]adipyl)-L-cysteinyl-D-[4,4-3H]valine into isopenicillin N.
Biochem. J.
184:421-426[Medline].
|
| 249. |
O'Sullivan, J., and R. B. Sykes.
1986.
-Lactam antibiotics, p. 247-281.
In
H. Pape, and H.-J. Rehm (ed.), Biotechnology, a comprehensive treatise in 8 volumes, vol. 4. VCH Verlagsgesellschaft, Weinheim, Germany.
|
| 250. |
Palissa, H.,
H. von Döhren,
H. Kleinkauf,
H. H. Ting, and J. E. Baldwin.
1989.
-Lactam biosynthesis in a gram-negative eubacterium: purification and characterization of isopenicillin N synthase from Flavobacterium sp. strain SC 12.154.
J. Bacteriol.
171:5720-5728 |
| 251. | Pang, C. P., B. Chakravarti, R. M. Adlington, H. H. Ting, R. L. White, G. S. Jayatilake, J. E. Baldwin, and E. P. Abraham. 1984. Purification of isopenicillin N synthetase. Biochem. J. 222:789-795[Medline]. |
| 252. | Papagiannopoulos, P., A. Andrianopoulos, J. A. Sharp, M. A. Davis, and M. J. Hynes. 1996. The hapC gene of Aspergillus nidulans is involved in the expression of CCAAT-containing promoters. Mol. Gen. Genet. 251:412-421[Medline]. |
| 253. | Papagiannopoulos, P., M. A. Davis, and M. J. Hynes. Unpublished data. GenBank accession no. U96847. |
| 254. | Peñalva, M. A., A. Moya, J. Dopazo, and D. Ramon. 1990. Sequences of isopenicillin N synthetase genes suggest horizontal gene transfer from prokaryotes to eukaryotes. Proc. R. Soc. London Ser. B 241:164-169[Medline]. |
| 255. | Peñalva, M. A., A. Vian, C. Patino, A. Perez-Aranda, and D. Ramon. 1989. Molecular biology of penicillin production in Aspergillus nidulans, p. 256-261. In C. L. Hershberger, S. W. Queener, and G. Hegeman (ed.), Genetics and molecular biology of industrial microorganisms. American Society for Microbiology, Washington, D.C. |
| 256. |
Pérez-Esteban, B.,
E. Gómez-Pardo, and M. A. Peñalva.
1995.
A lacZ reporter fusion method for the genetic analysis of regulatory mutations in pathways of fungal secondary metabolism and its application to the Aspergillus nidulans penicillin pathway.
J. Bacteriol.
177:6069-6076 |
| 257. | Pérez-Esteban, B., M. Orejas, E. Gómez-Pardo, and M. A. Peñalva. 1993. Molecular characterization of a fungal secondary metabolism promoter: transcription of the Aspergillus nidulans isopenicillin N synthetase gene is modulated by upstream negative elements. Mol. Microbiol. 9:881-895[Medline]. |
| 258. |
Pérez-Llarena, F. J.,
P. Liras,
A. Rodriguez-Garcia, and J. F. Martin.
1997.
A regulatory gene (ccaR) required for cephamycin and clavulanic acid production in Streptomyces clavuligerus: amplification results in overproduction of both -lactam compounds.
J. Bacteriol.
179:2053-2059 |
| 259. | Perry, D., E. P. Abraham, and J. E. Baldwin. 1988. Factors affecting the isopenicillin N synthetase reaction. Biochem. J. 255:345-351[Medline]. |
| 260. | Pieniazek, N. P., P. Stepien, and A. Paszewski. 1973. An Aspergillus nidulans mutant lacking cystathionine-synthase: identity of L-serine sulfhydrylase with cystathionine-synthase and its distinctness from O-acetyl-L-serine sulfhydrylase. Biochim. Biophys. Acta 297:37-47[Medline]. |
| 261. |
Pinkham, J. L., and L. Guarente.
1985.
Cloning and molecular analysis of the HAP2 locus: a global regulator of respiratory genes in Saccharomyces cerevisiae.
Mol. Cell. Biol.
5:3410-3416 |
| 262. | Pontecorvo, G., J. A. Roper, L. M. Hemmons, K. D. MacDonald, and A. W. J. Bufton. 1953. The genetics of Aspergillus nidulans. Adv. Genet. 5:141-238[Medline]. |
| 263. |
Pruess, D. L., and M. J. Johnson.
1967.
Penicillin acyltransferase in Penicillium chrysogenum.
J. Bacteriol.
94:1502-1508 |
| 264. |
Queener, S. W.
1990.
Molecular biology of penicillin and cephalosporin biosynthesis.
Antimicrob. Agents Chemother.
34:943-948 |
| 265. |
Queener, S. W., and N. Neuss.
1982.
Biosynthesis of -lactam antibiotics, p. 1-81.
In
R. B. Morin, and M. Gorman (ed.), Chemistry and biology of -lactam antibiotics, vol. 3. Academic Press, Ltd., London, United Kingdom.
|
| 266. |
Ramon, D.,
L. Carramolino,
C. Patino,
F. Sanchez, and M. A. Peñalva.
1987.
Cloning and characterization of the isopenicillin N synthetase gene mediating the formation of the -lactam ring in Aspergillus nidulans.
Gene
57:171-181[Medline].
|
| 267. |
Ramos, F. R.,
M. J. López-Nieto, and J. F. Martin.
1985.
Isopenicillin N synthetase of Penicillium chrysogenum, an enzyme that converts -(L- -aminoadipyl)-L-cysteinyl-D-valine to isopenicillin N.
Antimicrob. Agents Chemother.
27:380-387 |
| 268. | Ramos, F. R., M. J. López-Nieto, and J. F. Martin. 1986. Coordinate increase of isopenicillin N synthetase, isopenicillin N epimerase and deacetoxycephalosporin C synthetase in a high cephalosporin-producing mutant of Acremonium chrysogenum and simultaneous loss of the three enzymes in a non-producing mutant. FEMS Microbiol. Lett. 35:123-127. |
| 269. | Ramsden, M., B. A. McQuade, K. Saunders, M. K. Turner, and S. Harford. 1989. Characterization of a loss-of-function mutation in the isopenicillin N synthetase gene of Acremonium chrysogenum. Gene 85:267-273[Medline]. |
| 270. | Randall, R. C., Y. Zang, A. E. True, L. Que, Jr., J. M. Charnock, C. D. Garner, Y. Fujishima, C. J. Schofield, and J. E. Baldwin. 1993. X-ray absorption studies of the ferrous active site of isopenicillin N synthase and related model complexes. Biochemistry 32:6664-6673[Medline]. |
| 271. |
Raper, K. B.,
D. F. Alexander, and R. D. Coghill.
1944.
Penicillin: natural variation and penicillin production in Penicillium notatum and allied species.
J. Bacteriol.
48:639-659 |
| 272. |
Raymondjean, M.,
S. Cereghini, and M. Yaniv.
1988.
Several distinct "CCAAT" box binding proteins coexist in eukaryotic cells.
Proc. Natl. Acad. Sci. USA
85:757-761 |
| 273. | Renno, D. V., G. Saunders, A. T. Bull, and G. Holt. 1992. Transcript analysis of penicillin genes from Penicillium chrysogenum. Curr. Genet. 21:49-54[Medline]. |
| 274. |
Renosto, F.,
R. L. Martin,
L. M. Wailes,
L. A. Dailey, and I. H. Segel.
1990.
Regulation of inorganic sulfate activation in filamentous fungi.
J. Biol. Chem.
265:10300-10308 |
| 275. | Retey, J. 1990. Reaktionsselektivität von Enzymen durch negative Katalyse oder wie gehen Enzyme mit hochreaktiven Intermediaten um? Angew. Chem. 102:373-379. (Angew. Chem. Int. Ed. 29:355.) |
| 276. | Revilla, G., M. J. López-Nieto, J. M. Luengo, and J. F. Martin. 1984. Carbon catabolite repression of penicillin biosynthesis by Penicillium chrysogenum. J. Antibiot. XXXVII:781-789. |
| 277. |
Revilla, G.,
F. R. Ramos,
M. J. López-Nieto,
E. Alvarez, and J. F. Martin.
1986.
Glucose represses formation of -(L- -aminoadipyl)-L-cysteinyl-D-valine and isopenicillin N synthase but not penicillin acyltransferase in Penicillium chrysogenum.
J. Bacteriol.
168:947-952 |
| 278. |
Richardson, I. B.,
M. E. Katz, and M. J. Hynes.
1992.
Molecular characterization of the lam locus and sequences involved in the regulation of the AmdR protein of Aspergillus nidulans.
Mol. Cell. Biol.
12:337-346 |
| 279. | Roach, P. L., I. J. Clifton, V. Fülöp, K. Harlos, G. J. Barton, J. Hajdu, I. Andersson, C. J. Schofield, and J. E. Baldwin. 1995. Crystal structure of isopenicillin N synthase is the first from a new structural family of enzymes. Nature 375:700-704[Medline]. |
| 280. | Roach, P. L., I. J. Clifton, C. M. H. Hensgens, N. Shibata, C. J. Schofield, J. Hajdu, and J. E. Baldwin. 1997. Structure of isopenicillin N synthase complexed with substrate and the mechanism of penicillin formation. Nature 387:827-830[Medline]. |
| 281. |
Ronchi, A.,
M. Bellorini,
N. Mongelli, and R. Mantovani.
1995.
CCAAT-box binding protein NF-Y (CBF, CP1) recognizes the minor groove and distorts DNA.
Nucleic Acids Res.
23:4565-4572 |
| 282. | Rossi, A., and H. N. Arst, Jr. 1990. Mutants of Aspergillus nidulans able to grow at extremely acidic pH acidify the medium less than wild type when grown at more moderate pH. FEMS Microbiol. Lett. 66:51-53. |
| 283. | Samson, S. M., R. Belagaje, D. T. Blankenship, J. L. Chapman, D. Perry, P. L. Skatrud, R. M. van Frank, E. P. Abraham, J. E. Baldwin, S. W. Queener, and T. D. Ingolia. 1985. Isolation, sequence determination and expression in Escherichia coli of the isopenicillin N synthetase gene from Cephalosporium acremonium. Nature 318:191-194[Medline]. |
| 284. | Samson, S. M., J. E. Dotzlaf, M. L. Slisz, G. W. Becker, R. M. van Frank, L. E. Veal, W.-K. Yeh, J. R. Miller, S. W. Queener, and T. D. Ingolia. 1987. Cloning and expression of the fungal expandase/hydroxylase gene involved in cephalosporin biosynthesis. Bio/Technology 5:1207-1214. |
| 285. |
Sánchez, L., and A. F. Braña.
1996.
Cell density influences antibiotic biosynthesis in Streptomyces clavuligerus.
Microbiology
142:1209-1220 |
| 286. | Sanchez, S., M. E. Flores, and A. L. Demain. 1988. Nitrogen regulation of penicillin and cephalosporin fermentations, p. 121-136. In S. Sanchez-Esquival (ed.), Nitrogen source control of microbial processes. CRC Press, Inc., Boca Raton, Fla. |
| 287. | Santoro, C., N. Mermod, P. C. Andrews, and R. Tjian. 1988. A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs. Nature 334:218-224[Medline]. |
| 288. |
Sawada, Y.,
J. E. Baldwin,
P. D. Singh,
N. A. Solomon, and A. L. Demain.
1980.
Cell-free cyclization of -(L- -aminoadipyl)-L-cysteinyl-D-valine to isopenicillin N.
Antimicrob. Agents Chemother.
18:465-470 |
| 289. |
Sawada, Y.,
T. Konomi,
N. A. Solomon, and A. L. Demain.
1980.
Increase in activity of -lactam synthetases after growth of Cephalosporium acremonium with methionine or norleucine.
FEMS Microbiol. Lett.
9:281-284.
|
| 290. |
Scheidegger, A.,
M. T. Küenzi, and J. Nüesch.
1984.
Partial purification and catalytic properties of a bifunctional enzyme in the biosynthetic pathway of -lactams in Cephalosporium acremonium.
J. Antibiot.
XXXVII:522-531.
|
| 291. |
Schlumbohm, W.,
T. Stein,
C. Ullrich,
J. Vater,
M. Krause,
M. A. Marahiel,
V. Kruft, and B. Wittmann-Liebold.
1991.
An active serine is involved in covalent substrate amino acid binding at each reaction center of gramicidin S synthetase.
J. Biol. Chem.
266:23135-23141 |
| 292. |
Schwecke, T.,
Y. Aharonowitz,
H. Palissa,
H. von Döhren,
H. Kleinkauf, and H. van Liempt.
1992.
Enzymatic characterisation of the multifunctional enzyme -[L- -aminoadipyl]-L-cysteinyl-D-valine synthetase from Streptomyces clavuligerus.
Eur. J. Biochem.
205:687-694[Medline].
|
| 293. | Segel, I. H., F. Renosto, and P. A. Seubert. 1987. Sulfate-activating enzymes. Methods Enzymol. 143:334-349[Medline]. |
| 294. | Seno, E. T., and R. H. Baltz. 1989. Structural organization and regulation of antibiotic biosynthesis and resistance genes in actinomycetes, p. 1-48. In S. Shapiro (ed.), Regulation of secondary metabolism in actinomycetes. CRC Press, Inc., Boca Raton, Fla. |
| 295. | Shah, A. J., J. Tilburn, M. W. Adlard, and H. N. Arst, Jr. 1991. pH regulation of penicillin production in Aspergillus nidulans. FEMS Microbiol. Lett. 77:209-212. |
| 296. |
Shen, Y.-Q.,
J. Heim,
N. A. Solomon,
S. Wolfe, and A. L. Demain.
1984.
Repression of -lactam production in Cephalosporium acremonium by nitrogen sources.
J. Antibiot.
37:503-511[Medline].
|
| 297. |
Shiau, C.-Y.,
J. E. Baldwin,
M. F. Byford,
W. J. Sobey, and C. J. Schofield.
1995.
-(L- -Aminoadipyl)-L-cysteinyl-D-valine synthetase: the order of peptide bond formation and timing of the epimerisation reaction.
FEBS Lett.
358:97-100[Medline].
|
| 298. | Shirafuji, H., Y. Fujisawa, M. Kida, T. Kanzaki, and M. Yoneda. 1979. Accumulation of tripeptide derivatives by mutants of Cephalosporium acremonium. Agric. Biol. Chem. 43:155-160. |
| 299. |
Skatrud, P. L.
1991.
Molecular biology of the -lactam-producing fungi, p. 364-395.
In
J. W. Bennett, and L. L. Lasure (ed.), More gene manipulations in fungi. Academic Press, Inc., New York, N.Y.
|
| 300. | Skatrud, P. L., and S. W. Queener. 1989. An electrophoretic molecular karyotype for an industrial strain of Cephalosporium acremonium. Gene 79:331-338. |
| 301. | Skatrud, P. L., A. J. Tietz, T. D. Ingolia, C. A. Cantwell, D. L. Fisher, J. L. Chapman, and S. W. Queener. 1989. Use of recombinant DNA to improve production of cephalosporin C by Cephalosporium acremonium. Bio/Technology 7:477-485. |
| 302. | Smith, A. W., K. Collis, M. Ramsden, H. M. Fox, and J. F. Peberdy. 1991. Chromosome rearrangements in improved cephalosporin C-producing strains of Acremonium chrysogenum. Curr. Genet. 18:235-237. |
| 303. | Smith, A. W., M. Ramsden, M. J. Dobson, S. Harford, and J. F. Peberdy. 1990. Regulation of isopenicillin N synthetase (IPNS) gene expression in Acremonium chrysogenum. Bio/Technology 8:237-240[Medline]. |
| 304. | Smith, D. J., J. H. Bull, J. Edwards, and G. Turner. 1989. Amplification of the isopenicillin N synthetase gene in a strain of Penicillium chrysogenum producing high levels of penicillin. Mol. Gen. Genet. 216:492-497[Medline]. |
| 305. |
Smith, D. J.,
M. R. K. Burnham,
J. H. Bull,
J. E. Hodgson,
J. M. Ward,
P. Browne,
J. Brown,
B. Barton,
A. J. Earl, and G. Turner.
1990.
-Lactam antibiotic biosynthetic genes have been conserved in clusters in prokaryotes and eukaryotes.
EMBO J.
9:741-747[Medline].
|
| 306. | Smith, D. J., M. R. K. Burnham, J. Edwards, A. J. Earl, and G. Turner. 1990. Cloning and heterologous expression of the penicillin biosynthetic gene cluster from Penicillium chrysogenum. Bio/Technology 8:39-41[Medline]. |
| 307. | Smith, D. J., A. J. Earl, and G. Turner. 1990. The multifunctional peptide synthetase performing the first step of penicillin biosynthesis is a 421 073 dalton protein similar to Bacillus brevis peptide antibiotic synthetases. EMBO J. 9:2743-2750[Medline]. |
| 308. | Smith, M. W., D.-F. Feng, and R. F. Doolittle. 1992. Evolution by acquisition: the case for horizontal gene transfers. Trends Biochem. Sci. 17:489-493[Medline]. |
| 309. | Soltero, F. V., and M. J. Johnson. 1952. The effect of the carbohydrate nutrition on penicillin production by Penicillium chrysogenum Q-176. Appl. Microbiol. 1:52-57. |
| 310. |
Somerson, N. L.,
A. L. Demain, and T. D. Nunheimer.
1961.
Reversal of lysine inhibition of penicillin production by -aminoadipic or adipic acid.
Arch. Biochem. Biophys.
93:238-241.
|
| 311. | Spencer, B., and C. Maung. 1970. Multiple activities of penicillin acyltransferase of Penicillium chrysogenum. Biochem. J. 118:29-30. |
| 312. |
Stachelhaus, T.,
A. Schneider, and M. A. Marahiel.
1995.
Rational design of peptide antibiotics by targeted replacement of bacterial and fungal domains.
Science
269:69-72 |
| 313. |
Stein, T.,
J. Vater,
V. Kruft,
A. Otto,
B. Wittmann-Liebold,
P. Franke,
M. Panico,
R. McDowell, and H. R. Morris.
1996.
The multiple carrier model of nonribosomal peptide biosynthesis at modular multienzymatic templates.
J. Biol. Chem.
271:15428-15435 |
| 314. | Stein, T., J. Vater, V. Kruft, B. Wittmann-Liebold, P. Franke, M. Panico, R. McDowell, and H. R. Morris. 1994. Detection of 4'-phosphopantetheine at the thioester binding site for L-valine of gramicidin S synthetase 2. FEBS Lett. 340:39-44[Medline]. |
| 315. | Suárez, T., M. V. de Queiroz, N. Oestreicher, and C. Scazzocchio. 1995. The sequence and binding specificity of UaY, the specific regulator of the purine utilisation pathway in Aspergillus nidulans, suggest an evolutionary relationship with the PPR1 protein of Saccharomyces cerevisiae. EMBO J. 14:1453-1467[Medline]. |
| 316. | Suárez, T., and M. A. Peñalva. 1996. Characterisation of a Penicillium chrysogenum gene encoding a PacC transcription factor and its binding sites in the divergent pcbAB-pcbC promoter of the penicillin biosynthetic cluster. Mol. Microbiol. 20:529-540[Medline]. |
| 317. | Swartz, R. W. 1985. Penicillins, p. 7-47. In H. W. Blanch, S. Drew, and D. I. C. Wang (ed.), Comprehensive biotechnology. The principles, applications and regulations of biotechnology in industry, agriculture and medicine, vol. 3. The practice of biotechnology: current commodity products. Pergamon Press, Oxford, United Kingdom. |
| 318. |
Then Bergh, K., and A. A. Brakhage.
1998.
Regulation of the Aspergillus nidulans penicillin biosynthesis gene acvA (pcbAB) by amino acids: implication for involvement of transcription factor PACC.
Appl. Environ. Microbiol.
64:843-849 |
| 319. |
Then Bergh, K.,
O. Litzka, and A. A. Brakhage.
1996.
Identification of a major cis-acting DNA element controlling the bidirectionally transcribed penicillin biosynthesis genes acvA (pcbAB) and ipnA (pcbC) of Aspergillus nidulans.
J. Bacteriol.
178:3908-3916 |
| 320. | Then Bergh, K., O. Litzka, and A. A. Brakhage. Unpublished data. |
| 321. |
Thomas, D.,
I. Jacquemin, and Y. Surdin-Kerjan.
1992.
MET4, a leucine zipper protein, and centromere binding factor I are both required for transcriptional activation of sulfur metabolism in Saccharomyces cerevisiae.
Mol. Cell. Biol.
12:1719-1727 |
| 322. | Tilburn, J., S. Sarkar, D. A. Widdick, E. A. Espeso, M. Orejas, J. Mungroo, M. A. Peñalva, and H. N. Arst, Jr. 1995. The Aspergillus PacC zinc finger transcription factor mediates regulation of both acidic- and alkaline-expressed genes by ambient pH. EMBO J. 14:779-790[Medline]. |
| 323. | Tobin, M. B., J. E. Baldwin, S. C. J. Cole, J. R. Miller, P. L. Skatrud, and J. D. Sutherland. 1993. The requirement for subunit interaction in the production of Penicillium chrysogenum acyl-coenzyme A: isopenicillin N acyltransferase in Escherichia coli. Gene 132:199-206[Medline]. |
| 324. | Tobin, M. B., S. C. J. Cole, J. R. Miller, J. E. Baldwin, and J. D. Sutherland. 1995. Amino-acid substitutions in the cleavage site of acyl-coenzyme A:isopenicillin N acyltransferase from Penicillium chrysogenum: effect on proenzyme cleavage and activity. Gene 162:29-35[Medline]. |
| 325. |
Tobin, M. B.,
M. D. Fleming,
P. L. Skatrud, and J. R. Miller.
1990.
Molecular characterization of the acyl-coenzyme A:isopenicillin N acyltransferase gene (penDE) from Penicillium chrysogenum and Aspergillus nidulans and activity of recombinant enzyme in Escherichia coli.
J. Bacteriol.
172:5908-5914 |
| 326. |
Tobin, M. B.,
S. Kovacevic,
K. Madduri,
J. A. Hoskins,
P. L. Skatrud,
L. C. Vining,
C. Stuttard, and J. R. Miller.
1991.
Localization of the lysine -aminotransferase (lat) and -(L- -aminoadipyl)-L-cysteinyl-D-valine synthetase (pcbAB) genes from Streptomyces clavuligerus and production of lysine -aminotransferase activity in Escherichia coli.
J. Bacteriol.
173:6223-6229 |
| 327. | Treichler, H. J., M. Liersch, J. Nüesch, and H. Döbeli. 1979. Role of sulfur metabolism in cephalosporin C and penicillin biosynthesis, p. 97-104. In O. K. Sebeck, and A. I. Laskin (ed.), Genetics of industrial microorganisms. American Society for Microbiology, Washington, D.C. |
| 328. | Trown, P. W., B. Smith, and E. P. Abraham. 1963. Biosynthesis of cephalosporin C from amino acids. Biochem. J. 86:284-291[Medline]. |
| 329. | Turgay, K., M. Krause, and M. A. Marahiel. 1992. Four homologous domains in the primary structure of GrsB are related to domains in a superfamily of adenylate-forming enzymes. Mol. Microbiol. 6:529-546[Medline]. |
| 330. | Turner, G., P. E. Browne, and A. A. Brakhage. 1993. Expression of genes for the biosynthesis of penicillin. NATO ASI Ser. Ser. H 69:125-138. |
| 331. | Umbarger, H. E. 1978. Amino acid biosynthesis and its regulation. Annu. Rev. Microbiol. 47:533-606. |
| 332. |
Van Heeswijck, R., and M. J. Hynes.
1991.
The amdR product and a CCAAT-binding factor bind to adjacent, possibly overlapping DNA sequences in the promoter region of the Aspergillus nidulans amdS gene.
Nucleic Acids Res.
19:2655-2660 |
| 333. |
van Liempt, H.,
H. von Döhren, and H. Kleinkauf.
1989.
-[L- -Aminoadipyl]-L-cysteinyl-D-valine synthetase from Aspergillus nidulans.
J. Biol. Chem.
264:3680-3684 |
| 334. | Veenstra, A. E., P. van Solingen, R. A. L. Bovenberg, and L. H. M. van der Voort. 1991. Strain improvement of Penicillium chrysogenum by recombinant DNA techniques. J. Biotechnol. 17:81-90[Medline]. |
| 335. |
Velasco, J.,
S. Gutiérrez,
F. J. Fernandez,
A. T. Marcos,
C. Arenos, and J. F. Martin.
1994.
Exogenous methionine increases levels of mRNAs transcribed from pcbAB, pcbC, and cefEF genes, encoding enzymes of the cephalosporin biosynthetic pathway, in Acremonium chrysogenum.
J. Bacteriol.
176:985-991 |
| 336. | Vogel, H. J. 1960. Two modes of lysine synthesis among lower fungi: evolutionary significance. Biochim. Biophys. Acta 41:172-173. |
| 337. | Walz, M., and U. Kück. 1991. Polymorphic karyotypes in related Acremonium strains. Curr. Genet. 19:73-76[Medline]. |
| 338. | Weidner, G., B. Steffan, and A. A. Brakhage. 1997. The Aspergillus nidulans lysF gene encodes homoaconitase, an enzyme involved in the fungus specific lysine biosynthesis. Mol. Gen. Genet. 255:237-247[Medline]. |
| 339. |
Weigel, B. J.,
S. G. Burgett,
V. J. Chen,
P. L. Skatrud,
C. A. Frolik,
S. W. Queener, and T. D. Ingolia.
1988.
Cloning and expression in Escherichia coli of isopenicillin N synthetase genes from Streptomyces lipmanii and Aspergillus nidulans.
J. Bacteriol.
170:3817-3826 |
| 340. | White, R. L., E. M. John, J. E. Baldwin, and E. P. Abraham. 1982. Stoichiometry of oxygen consumption in the biosynthesis of isopenicillin from a tripeptide. Biochem. J. 203:791-793[Medline]. |
| 341. | Whiteman, P. A., E. P. Abraham, J. E. Baldwin, M. D. Fleming, C. J. Schofield, J. D. Sutherland, and A. C. Willis. 1990. Acyl coenzyme A:6-aminopenicillanic acid acyltransferase from Penicillium chrysogenum and Aspergillus nidulans. FEBS Lett. 262:342-344[Medline]. |
| 342. |
Wolfe, S.,
A. L. Demain,
S. E. Jensen, and D. W. S. Westlake.
1984.
Enzymatic approach to synthesis of unnatural -lactams.
Science
226:1386-1392 |
| 343. |
Xiao, X.,
G. Hintermann,
A. Hausler,
P. J. Barker,
F. Foor,
A. L. Demain, and J. Piret.
1993.
Cloning of a Streptomyces clavuligerus DNA fragment encoding the cephalosporin 7 alpha-hydroxylase and its expression in Streptomyces lividans.
Antimicrob. Agents Chemother.
37:84-88 |
| 344. | Zanca, D. M., and J. F. Martin. 1983. Carbon catabolite regulation of the conversion of penicillin N into cephalosporin C. J. Antibiot. XXXVI:700-708. |
| 345. | Zhang, J., and A. L. Demain. 1990. Purification from Cephalosporium acremonium of the initial enzyme unique to the biosynthesis of penicillins and cephalosporins. Biochem. Biophys. Res. Commun. 169:1145-1152[Medline]. |
| 346. | Zhang, J., and A. L. Demain. 1992. Regulation of ACV synthetase activity by carbon sources and their metabolites. Arch. Microbiol. 158:364-369. |
| 347. | Zhang, J., and A. L. Demain. 1992. ACV synthetase. Crit. Rev. Biotechnol. 12:245-260[Medline]. |
| 348. |
Zhang, J.,
S. Wolfe, and A. L. Demain.
1988.
Phosphate repressible and inhibitible -lactam synthetases in Cephalosporium acremonium strain C-10.
Appl. Microbiol. Biotechnol.
29:242-247.
|
| 349. | Zhang, J., S. Wolfe, and A. L. Demain. 1989. Carbon source regulation of the ACV synthetase in Cephalosporium acremonium C-10. Curr. Microbiol. 18:361-367. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»